Diagnostic and prognostic research in paediatrics: Children with meningeal signs by Oostenbrink, R. (Rianne)
Diagnostic and prognostic research in paediatrics: 
Children with meningeal signs 
Diagnostisch en prognostisch onderzoek in de kindergeneeskunde: 
Kinderen met meningeale prikkeling 
Proefschri.ft 
Ter verkrijging van de graad van doctor 
aan de Erasmus Universteit Rotterdam 
op gezag van de Rector Magnificus 
Prof.dr.ir. J. H. van Bemmel 
en volgens besluit van het College voor Promoties 
De openbare verdecliging zal plaatsvinden op 
woensdag 13 juni 2001 om 15.45 uur 
door 
Rianne Oostenhrink 
geboren te Culemborg 
Promotiecommissie 
Promotores: 
Overige leden: 
Copromotor: 
Prof-dr. D. E. Grobbee 
Prof.dr. H. A. Billier 
Prof.dr. R. de Groot 
Prof. dr. W. F. M. Arts 
Prof.dr. F. F. H. Rutten 
Dr. H.A. Moll 
The studies described in this thesis were supported by a grant from the Health Care 
Insurance Council of the Netherlands. The printing of this thesis was financially supported 
by the Julius Centre for Patient Oriented Research, Utrecht and Glaxo Wellcome B.V. 
Cover:Chopin's Waterloo, 1962 ArrnanArchives, APA 8203.62.001 reprinted with kind 
permission from the artist. 
© Rianne Oostenbrink, 200 I. 
No part of this thesis may be reproduced or transmitted in any form, by any means, 
electronic or mechanical, without written permission from the copyright owner. 
ISBN 90-73235-34-0 
VoorArjan 

Contents 
1 Introduction 
1.1 Clinical presentation and diagnostic dilemmas 
in children with meningeal signs..... ......................... ................. 9 
1.2 Outline of the thesis and aims of the study................................... 23 
2 Diagnostic procedures in children with meningeal signs 
2.1 Signs of meningeal irritation at the emergency department: 
How often bacterial meningitis? ........... ................................. ... 27 
2.2 Prediction of bacterial meningitis in childhood: 
reduction of lumbar punctures....................... ......... ......... ...... ... 37 
2.3 Children with meningeal signs: 
when to start empirical antibiotic treatment?.............................. 49 
2.4 A diagnostic decision rule for management of 
children with meningeal signs.................................................. 61 
3 Prognostic aspects of bacterial meningitis 
3.1 Sequelae after bacterial meningitis..................... ......... ......... ..... 73 
3.2 Early prediction of neurological sequelae after 
bacterial meningitis..... ....... ........................ ............................ 79 
3.3 The EQ-5D and the Health Utilities Index for permanent 
sequelae after meningitis - a head-to-head comparison..... ........... 91 
4 Economic evaluation in paediatrics 
4.1 Cost reduction by introduction of a diagnostic decision 
rule in children with meningeal signs ......................................... 109 
4.2 Cost-utility analysis of patient care in children 
with meningeal signs ............................................................... 121 
5 Diagnostic research in clinical practice: 
prospects and problems ............................................................... 137 
6 Summary 
6.1 Summaryandfutureperspectives ............................................. 149 
6.2 Samenvatting ......................................................................... 167 
7 List of co-authors .......................................................................... 176 
Dankwoord ......................................................................................... 180 
Curriculum vitae ................................................................................. 183 

Introduction 

Clinical presentation and diagnostic dileIIlIIlas in 
children with IIleningeal signs 
Clinical presentation 
Meningeal signs are indicative of bacterial meningitis and therefore necessitate a 
full diagnostic work-up, although these signs are not pathognomonic. Meningeal 
signs are present in 50 - 70% of children older than one with bacterial meningitis, 
as well as in 25 % of the children without meningitis in whom a lumbar puncture is 
performed. 1-3 In about 60% of children who have meningeal signs, another 
diagnosis may be assessed. 2.4 This diagnostic dilemma in children with 
meningeal signs is illustrated by the two case descriptions in Figure 1. 
Meningeal irritation arises from inflammation of nerve roots and meninges in the 
cervical region. Flexion of the neck leads to stretching of these inflamed nerve 
roots and meninges, causing pain and muscular resistance manifesting itself as 
neck stiffness. 5 Typical tests evoking this nuchal spasm are the Brudszinsky I sign 
(flexion of the head causes flexion of the legs), the Brudszinsky 2 sign (flexion of 
one leg causes flexion of the contralateral leg) or the Kernig sign (extension of the 
knees while hips are 90° flexed evokes pain or resistance). Other characteristics 
are the tripod phenomenon and nuchal rigidity. 1.6 In children younger than one, 
meningeal signs are difficult to assess and often absent. 1,7 Additional signs such 
as irritability during manipulation or a bulging fontanel may cause suspicion of 
meningeal irritation in these infants. 7 Meningeal signs can also be present when 
there is no meningitis. This is known as 'meningism'. Children with pneumonia, in 
particular of the right upper lobe, often present with meningism due to pleural 
irritation in the apical region. Meningism may be caused by cervical 
lymphadenitis in children with upper respiratory tract infections or by non-
infectious causes like torticollis or myalgia. 2,4 In chapter 2.1 we evaluate the 
differential diagnosis in children visiting the emergency department with 
meningeal signs (aim I, as specified in chapter 1.2). 
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In children younger than one, non-specific signs, such as fever, respiratory 
distress, feeding refusal, lethargy, bulging fontanelle or irritability usually raise 
suspicion of bacterial meningitis. 1.7 In those older than one other clirical 
symptoms of meningitis include nausea, vomiting, headache, fever, mental 
confusion or decreased consciousness. 1.8 Seizures may also occur in patients with 
meningitis, usually presenting with additional features such as a focal seizure, 
long duration of seizure (> 15 min), paresiS or paralysis and decreased 
consciousness. 9.10 .Although fever is present in almost all children with meningitis 
(about 94%), absence offever does not rule out meningitis. 1 In children with viral 
meningitis a sudden onset of the disease, a non-toxic appearance, or signs of 
photophobia or exanthema are also observed. II," 
In a survey we evaluated the main symptoms of 160 children with bacterial 
meningitis, admitted to the emergency department of the Sophia Children's 
Hospital from 1988 to 1998 (Table I). Presence of meningeal signs was the main 
symptom (95/160; 59%); others were septicaemia (18/160; 11%), seizures 
(16/160; 10%) and fever without localising signs (28/160; 18%). The clinical 
presentation was dependent on the causative pathogens. 
Table 1 Pathog:en accordinSl to clinical Eresentation of menin5ti:tis" 
Meningeal Septicaemia Fever Seizures Othe£t Total 
signs without 
source 
N. Meningitidis 47 (49%) 12 (67%) 12 (43%) 7 (44%) 2 (67 %) 
S. Pneumoniae 10 (11%) 2 (11 %) 0 8 (50%) 0 
H. lnf1uenzae 26 (27%) 1 (6%) 9 (32%) 0 0 
Other 12 (13%) 3 (170/0} 7 (2S0/0} 1 (6%) 1 (33%) 
Total 95 18 28 16 3 
.. based on data from hospital infonnation system and problem oriented patient 
classification system, Sophia Children's Hospital between 1988-1998 
t other presentations as documented in the problem-oriented patient 
classification system 
80 
20 
36 
24 
160 
This thesis discusses diagnostic and prognostic aspects of children with 
meningeal signs. These are the most frequent signs at the onset of bacterial 
meningitis, but they may also be present in children with other bacterial 
infections or self-limiting diseases. 
Diagnostic aspects 
Bacterial meningitis is defined as an increased leukocyte cell count in 
cerebrospinal fluid (CSF) with a bacterial isolate from CSF or blood. 8 After the 
neonatal period, the most prominent pathogen in childhood bacterial meningitis 
is Neisseria meningitis, followed by Streptococcus pneumoniae. Haemophilus 
influenzae type B (HIE) has almost been eradicated since the introduction of the 
routine vaccination against HIE in the Netherlands in 1993. 13,14 If it is not possible 
to perform a lumbar puncture (e.g. increased intracranial pressure, instable 
patient, coagulation disorders), a blood culture will reveal the causative pathogen 
10 
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in 80% of the cases. 8 In neonates and young infants, a urine culture may also be 
useful to reveal the etiologic agent for bacterial meningitis. 8 Bacterial meningitis 
in older children frequently results from bacterial invasion through the 
nasopharyngeal mucosa, and subsequent spread by the bloodstream and 
passage through the blood-brain barrier. 15 Cultures of nose and throat 
specimens, however, are not informative, because they prove to be positive as a 
result of non-invasive carriers. 8 Although precise identification of the pathogen 
may require more time, most positive CSF cultures are detected within 48 hours. 
16.17 The Gram stained smear of CSF may confirm presence of bacteria in CSF 
early. However, it appears negative in about 25% of the cases with bacterial 
meningitis, in particular when low number of organisms are present, and false 
positives may occur in cases of aseptic meningitis. 8,18,19 Therefore the Gram stain 
is not reliable for ruling out bacterial meningitis in an early phase. If CSF culture 
is negative for bacterial microorganism, viral cultures may reveal the pathogen. 
The most frequent viral cause of meningitis is enterovirus (80-90%), with a peak 
incidence in summer and autumn. If no virus can be isolated from CSF, a stool 
culture with enterovirus and CSF pleocytosis confirms viral meningitis as well. 12 
Due to poor growth of some enteroviral serotypes, viral cultures may require up 
to 14 days to identify the viral pathogen and have low sensitivity. 12.20.21 DNA 
amplification techniques such as the polymerase chain reaction techniques will 
identify the viral pathogen earlier with better sensitivity. These techniques, 
however, are not yet routinely available. 
At the end of the 19th century the diagnostic value of the biochemical analysis of 
the cerebrospinal fluid (CSF) was reported for the first time. 22 CSF indices, 
indicative of bacterial meningitis while awaiting the culture results, are a high CSF 
leukocyte count (with a predominance of polymorphonuclear cells), a low CSF 
glucose concentration, and a high CSF protein concentration. 8.23 Antibiotic 
treatment in a child with meningeal signs preceding the performance of a Iwnbar 
puncture may result in a negative CSF gram stain smear and a sterile culture. 
Other CSF characteristics for bacterial infections like pleocytosis, high protein 
and low glucose levels do not change substantially after pre-treatment with 
antibiotics. 23 In viral meningitis, less pleocytosis is usually seen, comprising 
mainly lymphocytes, with normal CSF glucose levels and CSF protein levels. 12 
For the CSF indices, however, there is no threshold value which discriminates 
completely between bacterial and viral or aseptic meningitis, since values found 
in bacterial meningitis overlap the range of values found in patients with viral or 
aseptic meningitis. 24-26 In addition to the CSF variables such as 
polymorphonuclear cell count, glucose ratio and protein level, a blood leukocyte 
count and serum CRP are useful in the differential diagnosis of bacterial 
meningitis. 19,26~29 More advanced tests, such as determination of lactate, 
cytokines, tumour necrosis factor or interleukine-6 in CSF, still do not completely 
differentiate between the presence and the absence of meningitis. 30,31 
In practice, most physicians will perform a Iwnbar puncture in every child with 
meningeal irritation at physical examination. When the cytology and biochemical 
II 
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analysis of the cerebrospinal fluid cause Susplclon of bacterial meningitis, 
empirical antibiotic treatment is started, since delayed treatment of bacterial 
meningitis worsens its prognosis. 32 This empirical treatment can be discontinued 
when cultures remain sterile after 2 - 3 days with improving clinical course. 16,17 
Although a safe strategy, it results in a large proportion of patients with a less 
serious disease, for whom the lumbar puncture or empirical treatment may be 
considered unnecessary in retrospect. 
Most studies on predictors for the presence or absence of bacterial meningitis 
selected their patients on the diagnosis or on whether they had undergone a 
lumbar puncture. 1,1,11,19,25,26,28,29 However, this method of patient selection leads 
to the inclusion of the most severe or most evident cases and subsequent 
overestimation of the value of diagnostic tests. 33 In clinical practice, the physician 
is faced with a patient showing a particular symptom, before any tests have been 
performed or a diagnosis has been assessed. Based on the findings of clinical 
evaluation, the physician will perform additional laboratory tests to assess or rule 
out meningitis. Laboratory tests may appear unnecessary after the clinical 
evaluation, since they provide the same but not additional information on the 
possible diagnosis. 34,35 Following this sequential diagnostic process in clinical 
practice, the reason of visiting the emergency department determined our 
selection of patients in this study. The patients were traced using the problem-
oriented patient classification system, as applied in the Sophia Children's Hospital 
since 1988. 36,37 In brief, every medical problem at referral is characterised in a 
matrix by an internal organ system or disease entity, and by either a complaint or 
symptom, abnormal laboratory results or (presumed) diagnosis. The problem list 
contains 18 main categories of internal organ systems or diseases entities (e.g. 
infection, gastro-intestinal complaints, endocrinology, etc.) with a total of 144 
items. For each patient, at initial referral to the emergency or outpatients 
department, the main problem is prospectively coded and eventually linked to a 
final diagnosis according to the international classification of diseases (ICD-9). 
In patients with meningeal signs, two questions are at issue: I) when should a 
lumbar puncture be performed to diagnose or to rule out bacterial meningitis? 
(aim 2) and, after a lumbar puncture has been performed, 2) when should 
empirical antibiotic treatment be started while awaiting the final culture results? 
(aim 3) At issue is whether and which clinical characteristics and diagnostic tests, 
as routinely performed in children visiting the emergency department with 
meningeal signs, independently contribute to the diagnosis of bacterial 
meningitis. Combining these independent predictors in a diagnostic rule may 
provide the physician with a rationale for performing a lumbar puncture, and to 
help ascertain the diagnosis of bacterial meningitis using the added valued of CSF 
indices. Therefore it may improve clinical efficiency. Once a diagnostic rule has 
been developed, the prospective performance of the rule in a similar patient 
group needs to be estimated. 34,35,38 Therefore, prospective evaluation of the rule 
in clinical practice is essential (aim 4). 
12 
Introduction 
Prognosis of bacterial meningitis 
Despite adequate treatment, bacterial meningitis still has a mortality risk of 5%. In 
addition, a proportion of 15% of the survivors suffers from late serious sequelae, 
involving auditive and visual function, mental and motor development and 
neurological functioning (Table 2). 39.4. 
The most important neurological sequela after bacterial meningitis is hearing 
impairment, present in about 10% of patients. 39.41.42 Bacterial meningitis is the 
leading cause of acquired deafness in children (90%), which means 6 - 10% of all 
deafness in childhood. 43 Deafness results from cochlear damage after direct 
bacterial invasion during the acute phase or from bacterial endotoxin release. 
8,44,45 There are some rare case reports of retrocochlear deafness, occurring 
within a few months after recovering from the acute phase of meningitis, although 
controversial ideas exist on its mechanism. 42,46 Hearing loss is present more 
frequently during the acute phase of meningitis with subsequent spontaneous 
recovery by reduction of the inflammation process. 45.47 Hearing loss based on 
sensoneurinal damage, however, should be differentiated from conductive loss 
caused by otitis media with effusion. Sensoneurinal damage can reliably be 
detected by hearing function assessment within 4-6 weeks after the acute phase of 
meningitis. 42 
Table 2 ~O;cUC'tc;oo~me:e=s,-,o"-f",b",ac",to;en;;':::al=m"e;::run::''-'91",',,,tis=b:Ly",e",ti",ol",o"91"" c:..:a"g"'e"'n"'(==:-;;c;;-______ _ 
Pathogen Mortality Outcome (%) 
(%) Mental Spasticity / Seizures 
H. iniluenzae 
N. meningitidis 
S. pneumoniae 
Total 
3.8 
7.5 
15.3 
4.8 
retardation 
6.1 
2.1 
17.0 
4.2 
paresis 
53.1 
2.1 
11.5 
3.5 
" based on a meta~analysis of 4400 children, Baraff et al. 39 
6.1 
1.4 
14.3 
4.2 
Hearing 
impainnent 
10.2 
6.4 
27.7 
10.5 
Motor abnormalities are seen in 3.5% of the survivors of childhood bacterial 
meningitis and include hemiplegia, diplegia or quadriplegia, spastic disorders or 
ataxic disorders. Cognitive disorders occur in 4.5%; cortical blindness in 2 - 4% on 
long-term follow-up, varying from hemi-anopsia to total cortical blindness. Late 
seizures develop in 2 - 8% of the cases with meningitis and usually appear within 
two years after the acute illness. 8,$9,40,48 With exception of hearing impairment, 
which usually occurs as an isolated deficit, the other persistent neurological 
deficits often occur in combination. 40 Minor neurological sequelae such as 
behavioural disorders and mild learning or attention disorders are reported in 
18% of the cases, based on patients including HIB cases. 49.50 Information on the 
frequency of these minor sequelae since the HIB~vaccinati.on, however, is scarce. 
Persistent neurological sequelae are due to cerebral ischemia during acute 
bacterial meningitis or to neural damage caused by the host inflammatory 
response in the meningitis patient itself. The latter has led to the application of 
steroids in the early treatment phase, in order to modify inflammation processes 
13 
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and diminish the neural damage. The beneficial effect of steroids to the prognosis 
has been proven most clearly in patients with HIE-meningitis, in particular for 
hearing function sequelae. An effect has been reported neither for other 
pathogens, nor for other neurological sequelae. Therefore, since HIE-meningitis is 
rare due to vaccination nowadays, the available evidence is not strong enough to 
support routine use of dexarnethason in acute bacterial meningitis. 51,52 The 
choice for antibiotic treatment should be based on the epidemiology of potential 
pathogens related to the patient's age and predisposing factors. Before 
identification of the pathogen, empirical treatment should be started with either a 
third generation cephalosporin, in combination with amoxicillin in infants 
younger than two months old to cover the more prevalent Listeria monocytogenes 
and Streptococcus agalactiae. 53.54 Meningitis caused by Neisseria meningitidis and 
penici11in-susceptible Streptococcus pneumoniae strains should be treated with 
penici11in G. In penici11in-resistant pneumococcal strains, a third generation 
cephalosporin and vancomycin are indicated. 54,55 
Several factors have been identified as being associated with the prognosis of 
bacterial meningitis. The risk of complications depends on the causative 
microorganism (Table 2). 39 Of all pathogens, S. pneumoniae is most frequently 
associated with death and neurological sequelae (15% and 36%, respectively), 
but an increased risk of hearing impairment has not been proven. 39,41,42,56 Clinical 
characteristics related to a higher risk of neurological sequelae or death are a 
male gender, young age « 12 months) and a disturbed consciousness, focal 
neurological signs and seizures at examination. 40,41,56~63 Controversial reports 
exist on the relationship between the duration of complaints before admission and 
the prognosis. 40,57 ,60,62~65 The presence of ataxia or vestibular disturbance is 
associated with a higher risk of hearing impairment. 44 Seizures during the acute 
phase of meningitis resulting from systematic metabolic disturbances do not 
mean an increased risk of late seizures, in contrast to those resulting from direct 
brain involvement. 40 Low CSF glucose levels or a low glucose CSF !blood ratio 
during the acute phase of meningitis is associated with late seizures and 
persistent neurological sequelae. 40,41,56,58,59,61,63,66 Although not confinned in all 
studies, a low CSF leukocyte count and a high protein level may also be related to 
neurological sequelae or death. 59,62,63 Transient neurological disorders during 
the acute phase of the disease are not associated with an increased risk of late 
seizures, in contrast to persistent neurological deficits. The presence of hearing 
impairment is not related to the incidence of late seizures, 40 Only a few studies 
have evaluated the independent prognostic value of variables by multivartate 
analysis. 57,59,60,63,66 The combination of independent prognostic variables into a 
scoring rule allows classification of patients into increased risk categories. Such a 
rule provides the physician with a rationale for parental counselling on the 
prognosis of their child in an early phase of the disease and to characterise the 
clinical condition of patients for clinical trials on new therapy (aim 5 and 6). 
14 
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Quality-of-life measurement 
To describe the consequences of a disease and the effects of treatment, mortality 
or survival time used to be important measures. Due to improving medical care, 
morbidity and the psychological and social consequences of a disease have 
become more important. The World Health Organisation defined 'health' as 'a 
state of complete physical, mental and social well-being and not merely the 
absence of disease and irfumity'. 61 This definition was the basis of the notion of 
'Quality-of-life' (QoL) , including physical, mental, social, emotional and 
behavioural components of well being and functioning. 68 Within the context of 
evaluating effects of disease and medical care, the quality-of-life related to 
disease, or treatment ('health-related quality-of-life' (HRQoL) , or 'health status') 
are preferably included. It should be noted that HRQoL does not consider the 
detenninants of quality-of-life that are not directly related to health or treatment. It 
merely addresses one's physical, psychological and social functioning rather than 
the broader 'well-being'. At the start of this study, no other outcome measure than 
disease-related mortality and morbidity, including the broader aspects of quality-
of-life, was available for children with bacterial meningitis. 
HRQoL can be assessed by measuring a subject's functioning related to the 
functional status, disease and treatment related physical and mental symptoms, 
and social consequences. HRQoL instruments generally address several 
dimensions, covering the main domains of health-related quality-of-life, such as 
motor function, self-care, emotional state and pain. Several types of instruments 
are available for measuring HRQoL. 68.69 Generic instruments are used in patients 
with a broad range of diseases and in healthy persons as well, and hence allow for 
the comparison of HRQoL consequences of different diseases. Generic measures 
comprehensively cover the three domains ofHRQoL (physical, mental and social). 
Disease-specific instruments are focussed on the disease-specific consequences 
on HRQoL and are generally more sensitive for small changes (over time within 
one person or between groups at one moment) within a disease. For meningitis, 
no such disease-specific instrument is available. 
Most health status measures are descriptive, yielding a score on each of the 
dimensions of the instrument. Health status is characterised by a profile of scores 
across the different dimensions. Using such profile scores, effects of treatment on 
each of the dimensions can be estimated separately. If an intervention affects the 
dimensions differently (e.g. increasing the score on one dimension, but 
decreasing another one), problems arise in drawing conclusions on the treatment 
effect. To compare the combined consequences for health status and survival time 
into one outcome measure, the profile scores need to be summarised. Such 
summary scores are obtained by an additional step, in which the health status 
descriptions are valued by a representative sample of the general population 
(including patients). Only a few instruments allow for a link between descriptive 
profiles and a one-dimensional preference score (e.g. Health Utilities Index and 
EQ-5D). 10-12 Such a preference score can be regarded as a quality weight, scaled 
on a continuum from zero (death) to one (perfect health), reflecting the relative 
15 
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severity of the sub-optimal health state compared to perfect health and death. 
Initially, the Health Utilities Index (HUI) has been developed in the field of 
paediatric oncology, but has been proven to be applicable to other diseases as 
well. 71 The EQ-SD has been designed for various groups of diseases, and for 
persons over 12 years of age. 70 
To include the final consequences of diagnostic procedures, in terms of an 
increase or decrease of adverse outcomes in our decision rule on diagnostic and 
therapeutic strategies in children with meningeal signs, we needed preference 
scores for permanent disabling health states caused by sequelae of bacterial 
meningitis. 73·75 Optimal estimation of these scores can theoretically be achieved 
by a prospective descriptive health status assessment of a sufficiently large 
representative sample of children and parents of children with permanent 
sequelae after meningitis, followed by a valuation of the resulting health state 
descriptions. Our study, based on retrospective data, did not allow for an 
empirical description estimation of the health states associated with permanent 
sequelae after meningitis. Therefore, an expert panel evaluated representative 
narrative health-state descriptions of outcomes of bacterial meningitis in order to 
assess preference scores and to determine which instrument was most 
appropriate for eliciting preference scores for health states after bacterial 
meningitis (aim 7). 
Economic evaluation of clinical practice 
In the evaluation of clinical care, the economic evaluation of diagnostic or 
therapeutic interventions is of growing interest. Four standard types of economic 
evaluations exist. 73,76~78 A cost minimisation analysis provides infonnation on the 
absolute cost difference between two strategies, neglecting the health effects. 
This type of analysis can be used in comparing strategies with a similar outcome 
with regard to mortality or morbidity. Cost-effectiveness analysis incorporates the 
health benefits in natural units, such as life years saved, achieved clinical 
endpoints, or improvement in health expressed in e.g. units of blood pressure. In 
this analysis, the benefits of two interventions expressed by similar units are 
compared. Cost-utility analysis involves measuring the effect on the quantitative 
and qualitative aspects of health (morbidity and mortality) using a measure such 
as quality-adjusted life-years. In principle, this type of analysis allows for a 
comparison of costs and effects between various diseases. In cost-benefit analysis, 
the health benefits are expressed in monetary values. By valuing all costs and 
benefits in the same units, the net cost can be estimated and comparisons 
between interventions can be made. Controversies, however, remain about 
valuing methods of effects in monetary terms. 76 Therefore, a cost-utility analysis 
is generally preferred in economic evaluations. 73,79 
Economic investigation generally consists of several steps. 80 The first step 
involves definition of the study perspective and time-horizon. The costs to be 
16 
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included in the analysis depend on the perspective of the study, e.g. the society, 
the insurance companies, the general public or the patient (consumer). The basic 
principle of medical economic studies is the societal perspective 73.80, such that 
medical and non-medical costs indirectly and directly related to the intervention 
are necessarily included. The time span of the study should be defined such that 
all cost consequences related to the intervention at issue are included in the 
analysis. Further steps involve the definition of the costs categories (direct and 
indirect medical and non-medical costs), identification of resources within each 
category (e.g. nursing days, laboratory tests), their frequency use and the 
estimation of their unit costs. Unfortunately, discrepancies still remain in the 
methods employed by those conducting economic studies. 81 Additionally, 
epidemiology of diseases and the clinical practice may vary between countries 
and institutions. Consequently, the ability to draw generalisations from cost-
effectiveness analysis results is usually rather limited. 73.82 
A diagnostic strategy can influence total costs by a large reduction of the nuruber 
of cheap tests, a small reduction of the nuruber of expensive tests or the 
prevention of an expensive treatment. In general, diagnostic tests serve to rule 
out the necessity of therapeutic interventions. Intuitively, one can assume that a 
decrease in costs associated with a reduction in treatment (hospitalisation in 
particular) will outweigh the higher costs associated with the increase of 
diagnostic tests in patients. Performing diagnostic tests more frequently, 
however, will result in more false positives as well, leading to inappropriate 
follow-up testing and treatment. 83.84 The question is whether the introduction of a 
new diagnostic strategy will lead to a cost-reduction and what aspects contribute 
to these cost changes (aim 8). 
17 
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Figure 1 Case descriptions of children presenting with meningeal signs 
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Case 1 
A six year-old boy was referred to the paediatric emergency department by the 
general practitioner for neck stiffness. He had a I-day history of fever up to 40°C, 
vomiting, drowsiness, abdominal pain, headache and pain in neck. He refused to 
eat, was coughing and complained about tlu:oatache. Micturation and defecation 
were nonnal. On examination, a feverish, non-toxic child was seen. He was alert, 
well circulated and hydrated. He had a temperature of 39.8 9C, a pulse of 120 beats 
per minute and a respiration frequency of 36 breaths per minute. Nuchal rigidity 
was detected when the neck was flexed. Petechiae were absent. At pulmonary 
auscultation, symmetrical respiration sounds were heard, without rales. Additional 
laboratory tests were perfonned under suspicion of meningitis or septicaemia. In 
peripheral blood 39 x 109 leukocytesll were present, with 77% segmented 
neutrophils and 9% bands; the serum C-reactive protein concentration was 189 
mgll. Acid-base balance of blood showed a pH of 7.42, a pC02 of 4.7 kPa, an 
actual bicarbonate of 23.1 rnmol/l, a base-excess of -0.2 mmolll and a saturation of 
94%. In cerebrospinal fluid (CSF) 3 cellsl 1J1 were present (no polymorphonuclear 
cells), protein concentration was 0.33 gil and glucose concentration 4.1 rnmol/l 
(CSFlblood glucose ratio 0.64). The gram stain smear of CSF was negative for 
bacteria. Chest radiograph showed a segmental pneumonia of the right upper 
lobe. The boy was hospitalised and treated with antibiotics for pneumonia. 
Cultures of blood and CSF remained sterile. Control visit within two weeks showed 
uneventful recovery. 
CaseZ 
A 14 month-old boy was referred to the paediatric emergency department by the 
general practitioner for irritability and neck stiffness. He had a 3-day history of 
fever, feeding problems. drowsiness. He had no history of vomiting; micturation 
and defecation were normal. On examination the child had a toxic appearance and 
was irritable. Nuchal rigidity was present. He had a temperature of 40.4 9C, a pulse 
of 168 beats per minute, respiration frequency of 32 breaths per minute. blood 
pressure of 120/80 rom Hg, and a cutaneous oxygen saturation of 99%. His reaction 
to pain stimuli was decreased, and his peripheral perfusion impaired. Petechiae 
were absent. Based on this presentation. meningitis was suspected. Additional 
laboratory tests showed 8 x 109 leukocytes/l, with 43% segmented neutrophils and 
3% bands in peripheral blood and a C-reactive protein concentration of 228 mgll 
in serum. In cerebrospinal fluid (CSF) 700 cells! 1J1 were present (80% 
polymorphonuclear cells), the protein concentration was 2.0 gil and the glucose 
concentration 0.5 mmolll (CSFlblood glucose ratio 0.1). Microscopic CSF analysis 
revealed multiple gram stain positive cocci. The boy was hospitalised and treated 
with antibiotics for bacterial meningitis intravenously. Streptococcus pneamoniae, 
sensitive for penicillin were isolated from CSF and blood. He was discharged 
without neurological deficits. During follow-up at the outpatient department, he 
had a normal psychomotor development. Brainstem response audiometry' after 6 
weeks revealed a hearing loss of 80 dB in both ears. Now. at the age of 5 years, he 
uses a hearing aid for both ears and visits a special school for hearing disabled 
children. 
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Outline ofthe thesis and aims ofthe study 
The overall aim of this thesis is to contribute to our knowledge of diagnoses and 
prognosis of children with meningeal signs. A diagnostic study on bacterial 
meningitis in chlldren presenting with meningeal signs at the emergency 
department is performed and predictors of neurological sequelae and the health-
related quality-of-life after bacterial meningitis were determined. 
The specific aims are: 
I. To describe the diagnoses in children visiting the emergency department with 
meningeal signs. 
2. To derive and validate a scoring rule for the indication of a lumbar puncture 
using independent predictors from patient history, physical examination and 
blood laboratory tests. 
3. To derive and validate a diagnostic decision rule, using cerebrospinal fluid 
indices and the patient's clinical profile, to guide decisions on empirical 
antibiotic treatment of bacterial meningitis. 
4. Prospective validation of the diagnostic decision rule in children with 
meningeal signs 
5. To describe the major neurological sequelae after childhood bacterial 
meningitis. 
6. To assess independent predictors of neurological sequelae in children with 
bacterial meningitis 
7. To obtain preference scores for quality-of-life of health states associated with 
neurological sequelae after bacterial meningitis. 
8. To perform an economical evaluation of the diagnostic decision rule using cost 
rni.ni.rnisation and cost-utility analyses. 
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Chapter 2 of this thesis focuses on the diagnostic aspects of children with 
meningeal signs. In chapter 2.1 the differential diagnosis in children suspected of 
having bacterial meningitis because of meningeal signs, and the presenting 
symptoms and signs, are discussed. As a first step in the diagnostic process we 
study in chapter 2.2 the clinical signs and symptoms of a patient at the emergency 
department, that are independently related to the presence of bacterial 
meningitis. With these predictors, a clinical score is developed that may help the 
physician in decisions on whether or not to perform a lumbar puncture. 
Subsequently, in chapter 2.3, indices from the cerebrospinal fluid (CSF) are 
identified, that contribute to the discrimination between presence or absence of 
bacterial meningitis, in addition to the clinical signs and symptoms. These CSF 
variables are combined with the previously derived clinical score to formulate a 
diagnostic decision rule, to guide decisions on whether empirical treatment 
should be initiated or not. The prospective application of this diagnostic decision 
rule as described in the previous two chapters (2.2 and 2.3) is evaluated in 
chapter 2.4 in order to predict the performance of the rule in new patients from 
different hospitals. 
In chapter 3, the prognosis of children with bacterial meningitis, presenting with 
meningeal signs is addressed. Chapter 3.1 describes the long-term prognosis of 
bacterial meningitis in these children. In chapter 3.2, potential predictors of 
neurological sequelae after bacterial meningitis are assessed and a scoring rule is 
developed to classify patients with increased risk of mortality and morbidity after 
bacterial meningitis. Chapter 3.3 concerns the measurement of health-related 
quality-of-life of children with neurological sequelae after bacterial meningitis. 
Two instruments (EQ-5D and Health Utility Index) available for measuring health-
related quality-of-life are compared in terms of feasibility, reliability, and the 
value obtained for the preference scores for the health states under evaluation. 
Chapter 4 describes the economic evaluation of the diagnostic decision rule. In 
chapter 4.1 the potential costs associated with the application of the decision rule 
are estimated, on the assumption that the rule will lead to similar morbidity and 
mortality rates as in current clinical practice, but with less intervention. In chapter 
4.2, we design a hypothetical model to assess the consequences of adequate 
diagnosis and treatment in patients with meningeal signs in terms of health-
related quality-of-life and costs. Changes in costs and health-related quality-of-life 
due to changes in diagnostic or therapeutic strategies are evaluated in a cost-
utility analysis. 
In chapter S the methodological aspects of this study are discussed in view of the 
prevailing ideas on diagnostic research. 
Finally, in chapter 6 the results of previous studies are summarised and 
suggestions for future studies are put forward. 
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Signs of meningeal irritation at the emergency 
department: How often bacterial meningitis? 
Rianne Oostenbrink, Karel GM Moons, Chantal CW Theunissen, Gerarda Derksen-
Lubsen, Diederick E Grobbee, Henriette A Moll 
Pediatric Emerg Care, in preparation 
Abstract 
Although signs of meningeal irritation are highly indicative of meningitis, they are 
not pathognomonic. In this study we describe the final diagnoses in children with 
signs of meningeal irritation and we assess the frequency of bacterial meningitis 
related to specific signs of meningeal irritation. 
Information was collected from records of 326 patients (aged I month to 15 
years) who visited the emergency department of the Sophia Children's Hospital 
between 1988 and 1998 with signs of meningeal irritation, assessed by either the 
general practitioner or the paediatrician. 
Bacterial meningitis was diagnosed in 99 patients (30%), viral or aseptic 
meningitis in 43 (13%). Other diagnoses were pneumonia (8%), other serious 
bacterial infections (2%) and upper respiratory tract infections or other self-
limiting diseases (46%). Presence of one of the signs of meningeal irritation 
assessed by the paediatrician was related to bacterial meningitis in 39 %. Specific 
tests eliciting meningeal irritation, such as Brudzinski and Kernig sign, were not 
related to a higher frequency of bacterial meningitis than neck stiffness and the 
tripod phenomenon. In children:;; I year, bacterial meningitis is more frequently 
related to presence of irritability and a bulging fontanelle. 
In conclusion, bacterial meningitis is present in 30% of children with signs of 
meningeal irritation. Presence of meningeal irritation as assessed by the 
paediatrician is related to bacterial meningitis in 39 %. By using more specific 
tests for signs of meningeal irritation a better prediction of bacterial meningitis 
was not achieved. 
Introduction 
Signs of meningeal irritation are considered highly indicative of meningitis. 1 
These signs include neck stiffness, tripod phenomenon and the specific clinical 
tests evoking meningeal irritation, such as Kernig sign and Brudzinski nape of the 
neck and contralateral leg sign (Brudzinski I and II, respectively). 2 All these tests 
aim to stretch the inflamed nerve roots and meninges of the cervical region by 
flexion of the neck, causing protective muscle spasm manifesting as neck 
stiffness. 3 The presence of meItingeal irritation, however 1 is not pathognomonic 
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for meningitis. In about 20% of children with meningitis, signs of meningeal 
irritation are absent. 4-6 Studies among children, in whom a lumbar puncture was 
performed, have reported a 40% prevalence of meningitis (bacterial meningitis in 
8% and aseptic meningitis in 32%), whereas in those with normal cerebrospinal 
fluid findings the most common diagnoses were pneumonia, pharyngo-tonsillitis, 
urinary tract infections and gastro-enteritis. 78 These studies, however, described 
the frequency of the different diagnoses or clinical features in children that all had 
undergone a lumbar puncture. Clinical practice, in contrast, starts with a child 
with signs of meningeal irritation as reason for consultation, before any diagnostic 
procedures have been performed. To our knowledge, frequencies of final 
diagnoses in children selected on the clinical profile 'signs of meningeal 
irritation' have never been studied. 
The objective of this study is to determine the frequency of diagnoses in children 
with signs of meningeal irritation as reason for consultation in a large paediatric 
emergency department. In addition, the frequency of bacterial meningitis in 
children with positive results on tests evoking meningeal irritation is investigated. 
Methods 
Patients 
We collected routinely documented information from records of children aged 
from one month to 15 years, who visited the emergency department of the Sophia 
Children's Hospital between 1988 and 1998 with signs of meningeal irritation. 
Patients with a history of severe neurological diseases, or ventricular drainage, or 
those referred from other hospitals were excluded. The latter were excluded, 
since in these patients treatment may have been initiated already and iniluenced 
the clinical signs at examination. The Sophia Children's University Hospital 
Rotterdam in The Netherlands has a catchment area of nearly two million 
inhabitants. The general paediatric emergency department is open 24 hours a 
day, and receives 2,500 new patients yearly (± 90% basic paediatric care); either 
referred by a general practitioner (70%) or self-referred (30%). 
Since 1988 a problem-oriented patient classification system is applied at the 
outpatient and emergency department of the Sophia Children's Hospital. In brief, 
every medical problem at referral is characterised in a matrix by an internal 
organ system or disease entity, and by either a complaint or symptom, abnormal 
laboratory result or (presumed) diagnosis. The problem list contains 18 main 
categories of internal organ systems or disease entities with a total of 144 items. 
For each patient, at first referral the main problem is prospectively coded and 
eventually linked to a final diagnosis according to the international classification 
of diseases (ICD-9). In a sample, the coding system was complete for 95% of the 
visits. 'Meningeal signs' is a defined code, applied to children referred by the 
general practitioner for (suspected) signs of meningeal irritation or in whom the 
paediatrician has assessed meningeal irritation. For further details on this 
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classification system, we refer to previous publications. 9 10 To ensure the 
enrolment of all patients with signs of meningeal irritation, we compared the 
hospital problem oriented classification system data to all patients with fever as 
documented in the emergency department log. 
Definitions 
Meningeal irritation as assessed by the paediatrician at the emergency 
department was defined as presence of either one or more of the following six 
symptoms: neck stiffness, Brudzinski nape of the neck or contralateral leg sign, 
Kernig sign and the tripod-phenomenon in children> I year, and one of the 
previous signs or irritability or a bulging fontanelle in children:; I year. 2 3 In 
children with missing information on some tests, but with at least one of these 
signs present, meningeal irritation was considered present. Fever (body 
temperature;, 38.0°C) could be present or absent. 
The final exclusive diagnosis was determined either by a reference standard 
(bacteriologic cultures of blood, spinal fluid, urine, etc.), or based on a 
combination of symptoms and signs agreed upon by three independent 
paediatricians (consensus diagnosis). Bacterial meningitis was defined as the 
presence of elevated leukocyte count (> 5 cells/~I) in cerebrospinal fluid (CSF) 
and a positive pathogenic bacterial culture of CSF and! or blood 1 4 J Viral 
meningitis was defined as the presence of elevated CSF leukocyte count with a 
positive viral culture of CSF, blood or stool 1 47; aseptic meningitis was defined as 
an elevated CSF leukocyte count of a non-traumatic lumbar puncture, without any 
bacterial or viral isolate. Aseptic meningitis in a child who recently used 
antibiotics was considered as a pre-treated case of meningitis. 11 
If lumbar puncture or follow-up ruled out meningitis, the following difierential 
diagnoses were distinguished: 
Septicaemia, defined as a positive bacterial blood culture with symptoms of 
generalised infection and signs of hypoperfusion. 1 
Pneumonia, defined as presence of five clinical symptoms according to the WHO 
criteria 12 or an infiltrate on the chest radiograph with one of the clinical signs. 
Upper respiratory tract infection, defined as presence of fever with signs of rhinitis 
(nasal secretion), pharyngitis (redness, swollen tonsils either with or without 
purulent secretion) or acute otitis media (red or bulging eardrum). 13 
Urinary tract infection, defined as urine mono culture ;, 10' bactlml (urine collected 
by bag) with clinical symptoms (fever, toxic-appearance, lethargy, irritability, 
vomiting, dysuria or changed voiding pattern) and abnormal microscopic 
urinalysis (> 20 leukocytes per high power field in centrifuged specimen). 141' 
Gastro-enteritis, defined as diarrhoea and vomiting without clinical indication for 
parenteral diarrhoea, either with or without presence of bacterial or viral micro-
organism isolated from stool. 
Other causes included self-limiting non-specified viral infections and non-
infectious causes, like trauma, torticollis and myalgia. 
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AIzalysis 
We estimated the prevalence and 95 % confidence intervals (95 % CI) of the final 
diagnoses in our study population. Additionally, the frequency of bacterial 
meningitis among children with a positive test result on various tests evoking 
meningeal irritation was estimated. Differences were tested by Chi-square 
analysis. 
Table 1 Characteristics of the study population (n;326). 
Characteristic 
Male gender 
Age (years) i' 
Referral pattern:(: 
General practitioner 
Self referral 
Other 
Meningeal irritation assessed by general practitioner 
(GP) 
Meningeal irritation assessed by paediatrician 
Meningeal irritation assessed by GP and paediatrician 
Fever (;?:38.0°C) 
Number (% )§ 
206 (63%) 
2.2 (0.7-5.2) 
275 (84%) 
26 (8%) 
8 (2.4%) 
203 (62%) 
256 (79%) 
133 (41 %) 
In history 309 (95%) 
At examination 276 (85%) 
No fever in history nor at examination 12 (4%) 
Body temperature at examination (OC) " 39.2 (1.0) 
Hospitalisation 217 (67%) 
%Values represent absolute numbers and percentage between parentheses, 
otherwise if stated 
tmedian (25th and 75th percentiles) 
:Jtn 17 patients the referral pattern was unknown 
"mean (standard deviation) 
Results 
We included 326 consecutive patients with (suspected) signs of meningeal 
irritation either assessed by the general practitioner or by the paediatrician. In a 
comparison of the hospital problem oriented classification system to the 
emergency department log, three patients appeared to be missed. The general 
characteristics of all patients are provided in Table 1. In 133 of the 203 children 
referred by the general practitioner for signs of meningeal irritation, the 
paediatrician confirmed this finding. The paediatrician also assessed meningeal 
irritation in the 80 children referred for other reasons and in the self-referrals. The 
final diagnoses of the children are presented in Table 2. Bacterial meningitis was 
diagnosed in 30% (95% CI: 25 - 35%), viral or aseptic meningitis in 13% (95% CI: 
10 - 17%). A lumbar puncture had been performed in 256 of the 326 patients 
(79%). In eight patients the lumbar puncture was traumatic, but none of them was 
excluded from the study. Bacterial cultures proved a bacterial meningitis in one of 
them; in the seven patients with negative cultures we concluded another 
diagnosis based on the presence of clinical symptoms and additional diagnostic 
tests. In II children with signs of meningeal irritation at examination, a lumbar 
puncture had been withheld. Almost all of them (n = 9) had neck stiffness as the 
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only meningeal sign. None of the 70 children without a lumbar puncture appeared 
to have bacterial meningitis during follow-up, which involved an outpatient 
department visit or telephone call by one of the paediatricians or a renewed 
referral within 14 days after discharge. In 18 of the 27 patients with pneumonla as 
final diagnosis a lumbar puncture had been performed (66%, Table 2), and in all 8 
children with a septicaemia, urinary tract infection or bacterial gastro-enteritis. In 
children with upper respiratory tract infections or other self-limiting diseases a 
lumbar puncture had been performed in 88 (59 %). 
Table 2 Diagnoses in children with signs of meningeal irritation 
Diagnosis Number Number of1umbar 
(%)§ punctures§ 
Meningitis 
Bacterial 99 (30%) 99 
Viral/aseptic 43 (13%) 43 
Pneumonia 27 (8%) 18 
Other bacterial infectioni" 8 (3%) 8 
Selflinriting diseases* 149 (46%) 88 
Total 326 (100%) 256 (79%) 
!Values represent absolute numbers and percentages between parentheses. 
t other bacterial infection include septicaemia, urinary tract infection, bacterial gastro-
enteritis 
*self-limiting diseases included upper respiratory tract infection, non-specified viral 
infection and non~i.nfectious causes like myalgia, torticollis 
Of the 203 patients referred by the general practitioner because of signs of 
meningeal irritation, 49 indeed had bacterial meningitis (24%; 95% CI: 18 - 30%). 
The paediatrician assessed meningeal irritation (presence of one of the six signs 
of meningeal irritation) in 256 children, of whom 99 had bacterial meningitis 
(39%; 95% CI: 33 - 45%). Among the latter group, Table 3 shows the frequency of 
bacterial meningitis for the six signs of meningeal irritation separately. Bacterial 
meningitis was present in 42% of the children with neck stiffness, and in 30% and 
36% of those with a positive Kernig or one of the Brudzinski signs, respectively. In 
31 of all children with signs of meningeal irritation, both the Kernig sign and neck 
stiffness were present; nine of these children had bacterial meningitis (29%; 95% 
CI: 14 - 48 %). Combination of one of the Brudzinski signs with neck stiffness was 
present in 41 children, of whom 15 had bacterial meningitis (37%; 95% CI: 22 -
53%). 
Table 3 Frequency of bacterial meningitis related to specific signs of meningeal irritation among 
children with meningeal irritation assessed by the paediatrician 
Positive sign Children:$ 1 Children> 1 All children 
year {n = 88~ year {n = 168~ (n = 256) 
Neck stiffness 18/56 (32%) 641141 (45%) 82/197 (42%: 35 - 49%) 
Kernig sign 0/5 (0%) 10/28 (36%) 10/33 (30%; 16 - 49%) 
Brudzinsld sign I or n lI8 (13%) 15/36 (42%) 16/44 (36%; 22 - 52%) 
Tripod phenomenon not applicable 4/22 (18%) 4/22 (18%; 5 - 40%) 
Irritability at manipulation 12/37 (32%) not applicable 12/37 (32%; 18 - 50%) 
of head or legs 
Bulqing fontanelle 11/34 (32%) not applicable 11/34 ~32%;17 ~ 51 %~ 
At least one sign of 23/88 (26%) 761168 (45%) 99/256 (39%; 33 - 45%) 
menin9:eal irritation 
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In a separate analysis of children younger and older than one year with signs of 
meningeal irritation, the frequency of bacterial meningitis was 26% (95% CI: 17 -
37%) and 45% (95% CI: 38 - 53%), respectively (Table 3). In children aged ~ I 
year, bacterial meningitis was present in 32% of the children with a bulging 
fontanel or in those with irritability. These frequencies were much higher than for 
the Kernig or Brudzinski signs in this age group. 
Among all included patients, we evaluated whether the prevalence of bacterial 
meningitis cllifered among patients with and without fever. Children with bacterial 
meningitis had a mean temperature of 39.3 °C (95% CI: 39.1 - 39.5 °C), those 
without 39.2°C (95% CI: 39.1 - 39.3 °C). In the 314 children with either fever at 
presentation or in history, bacterial meningitis was diagnosed in 99 (32%; 95% CI: 
26 - 37%). None of the 12 children with neither fever in history nor at presentation 
had bacterial meningitis (0%; 95% CI: 0 - 27%). 
Discussion 
In this study of 326 children with signs of meningeal irritation, bacterial meningitis 
was present in 30% and viral meningitis in 13%. Upper respiratory tract infection 
and other self-limiting infections, however, were commonly diagnosed in these 
children. The presence of signs of meningeal irritation in children without 
meningitis can be explained by nuchal spasm associated with cervical 
lymphadenitis in case of upper respiratory infections. 7 8 Also pneumonia, 
diagnosed in 8% of our population, is known to elicit meningism by pleural 
irritation. 16 In almost 80% of the children with signs of meningeal irritation at 
physical examination a lumbar puncture has been performed. In 59% of the 
patients with self-limiting diseases a lumbar puncture has been performed, that 
may be judged unnecessary afterwards. Missing the diagnosis bacterial 
meningitis, however, is not acceptable. Therefore, these 'unnecessary' punctures 
are unavoidable until another clinical or laboratory test will be available to 
reliably exclude the possibility of bacterial meningitis. In a future study we will 
evaluate clinical characteristics in a child with signs of meningeal irritation that 
may be associated with the presence of meningitis, in order to improve the basis 
for well-founded decisions on the management of these children. 
Presence of one of the six signs of meningeal irritation as assessed by the 
paediatrician, was related to bacterial meningitis in 39 %. The frequency of other 
diagnoses than bacterial meningitis is still very high among patients with 
meningeal irritation (61%). Since some signs of meningeal irritation may be 
stronger related to bacterial meningitis than other 2 6 8 17, we evaluated the 
frequency of bacterial meningitis among children with positive results on each of 
the six evaluated tests evoking meningeal irritation separately (Table 3). None of 
the separate signs, however, showed a significantly higher frequency of bacterial 
meningitis than another. Furthermore, the combination of presence of neck 
stiffness with either Kernig or Brudzinski sign was not stronger related to bacterial 
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meningitis than presence of neck stiffness alone. Since in the presentation of 
young children with meningitis specific signs of meningeal irritation are often 
absent, we evaluated children younger and older than one year separately. 6 8 
Indeed, in children,; 1 year with signs of meningeal irritation, the frequency of 
bacterial meningitis was lower than in older ones. In children,; 1 year, a bulging 
fontanelle and irritability seem to be related to bacterial meningitis more 
frequently. Kernig and Brudzinski signs were often absent or not assessed in these 
children. 
Since fever is often associated with bacterial meningitis 1 8, we evaluated its 
relation to bacterial meningitis. The mean body temperature at physical 
examination was not significantly different between children with and without 
meningitis. Absence of fever was related to the absence of bacterial meningitis in 
this study. The latter, however, is based on a very small group (n = 12) and 
therefore should be interpreted with care. 
It should be noted that in this study selection of patients is based on suspicion of 
having meningitis because of (referral for) signs of meningeal irritation at a 
general paediatric emergency department. Thls is conform clinical practice 
though in contrast to other studies, whlch selected their study population on the 
presence of a lumbar puncture result or diagnosis. 6-8 17 Patient selection on the 
presence of lumbar puncture or diagnosis, however, often leads to a biased 
selection of the most evident or more severe cases of meningitis. The selection of 
our patient population corresponds more to clinical practice, in whlch the 
physician is faced with a patient in whom the diagnosis is not yet known and 
choices towards diagnostic tests and treatment has to be made. 
In order to appreciate the present results, some limitations of thls study need to 
be discussed. First, due to our study design, our population of patients with signs 
of meningeal irritation does not include all cases of bacterial meningitis, since 
other reasons for encounter that are indicative for meningitis (such as a pre-
dominance of convulsions, coma, etc.) are not included. 1 Secondly, presence or 
absence of the six signs of meningeal irritation were not always documented for 
each patient. Documentation of neck stiffness was most frequently completed in 
this study (87%) but Kernig and Brudxinski signs were often not included by the 
paediatrician in the clinical evaluation in this study (about 40% missing). Presence 
or absence of the bulging fontanelle and irritability (for,; 1 years only) was not 
documented in 17% and 51 % respectively. Because of these missing variables, 
the analysis of the separate signs of meningeal irritation is based on small 
numbers and conclusions should be drawn with care. The missing of these data, 
however, reflects clinical practice. Apparently, Brudxinski and Kernig signs are 
not applied frequently to young children or are difficult to interpret. Since it is not 
known whether these missings result from the sign being negative or not 
evaluated, only the presence of bacterial meningitis in presence of the separate 
signs of meningeal irritation could be evaluated. Finally, not all children in this 
study had a lumbar puncture performed, whlch may bias the frequencies of the 
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diagnoses in this study as we assessed. For bacterial meningitis this is unlikely. 
since we included the follow-up (outpatient visits or telephone call) for 
determining the final diagnosis. Though. we may have missed some viral or 
aseptic meningitis cases. Viral or aseptic meningitis in children aged 1 month or 
more, however, is a self-limiting disease with a fair prognosis and therefore the 
importance of truly setting this diagnosis is questionable. 18 
In conclusion, in a population of children aged from 1 month to 15 years referred 
because of signs of meningeal irritation or with meningeal irritation at physical 
examination at the paediatric emergency department, the frequency of bacterial 
meningitis is 30%. Other frequent diagnoses are pneumonia, upper respiratory 
tract infections and self-limiting viral infections. Presence of one of the signs of 
meningeal irritation at physical examination is related to bacterial meningitis in 
39 %, which is not increased by using specific tests such as the Brudzinski or 
Kernig sign, evoking meningeal irritation. Further evaluation of clinical 
characteristics that are predictive for the presence of bacterial meningitis, 
additional to signs of meningeal irritation will improve the basis of well-founded 
decisions for the performance of lumbar punctures in children with meningeal 
irritation. 
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Prediction of bacterial meningitis in childhood: 
Reduction of lumbar punctures. 
Abstract 
Rianne Oostenbrink, Karel GM Moons, A Rogier T Donders, 
Diederick E Grobbee, Henriette A Moll 
Acta Paediatrica, in preparation 
Physicians have a low tbreshold to perform a lumbar puncture to ascertain the 
diagnosis in patients with meningeal signs. because of the serious consequences 
of missing bacterial meningitis. The aim of this study was to derive and validate a 
clinical rule to predict bacterial meningitis in children with meningeal signs, in 
order to guide decisions on the performance oflumbar punctures. 
Information was collected from records of patients (aged 1 month to 15 years) 
consulting the emergency department of the Sophia Children's Hospital between 
1988 and 1998 with meningeal signs. Bacterial meningitis was defined as 
cerebrospinal fluid (CSF) leukocyte count> 5 cells/f!l, with a positive bacterial 
culture of CSF or blood. The diagnostic value of predictors was judged using 
multivariate logistic modelling and area under the receiver operating 
characteristic curves (ROC-area). 
In the derivation set (286 patients, years 1988 - 1995) the duration of the main 
complaint, vomiting, meningeal irritation, cyanosis, petechiae and disturbed 
consciousness were independent cliuical predictors of bacterial meningitis. The 
ROC-area of this model was 0.92. The only independent predictor from 
subsequent laboratory tests was serum C-reactive protein concentration, 
increasing the ROC-area to 0.95. Without missing a single case, this final model 
identified 99 patients (35%) without bacterial meningitis. Validation on 74 
consecutive patients of subsequent tbree years (1996 - 1998) yielded similar 
results. 
In conclusion, this prediction rule identifies about 35% of the patients with 
meningeal signs in whom a lumbar puncture can be withheld without missing one 
case of bacterial meningitis. For the individual patient this prediction rule is 
valuable to decide whether or not to perform a lumbar puncture. 
Introduction 
A child with meningeal signs is suspected of having bacterial meningitis, a 
serious disease that needs immediate treatment. 1.2 Because of the serious 
consequences of missing this diagnosis, physicians have a low thteshold to 
perform a lumbar puncture. In a substantial part of patients with meningeal signs, 
however, bacterial meningitis is absent and a lumbar puncture may be 
considered unnecessary in retrospect. 3.4 Given patient burden and the risk of 
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side effects, a decrease in the number of unnecessary lumbar punctures is 
desirable. 
Previous studies have shown that clinical signs like meningeal irritation, vomiting, 
headache and fever are associated with the presence of bacterial meningitis and 
may be useful in early prediction of meningitis. 2.3.5-8 These studies, however, all 
selected their patients on the availability of results of a lumbar puncture. Such a 
patient selection often leads to a biased selection of the most evident cases of 
meningitis, resulting in a potential overestimation of the diagnostic value of tests 
that are applied in practice to all patients with meningeal signs. 9·11 In this study, 
therefore, patients were selected on the presence of meningeal signs conform 
clinical practice. In this group of patients, independent predictors of bacterial 
meningitis have never been established. 
The objective of this study is to determine whether easy obtainable results from 
clinical evaluation and subsequent tests can predict the presence or absence of 
bacterial meningitis in children with meningeal signs. A scoring rule was 
developed and validated to identify a subgroup of patients with a low risk of 
bacterial meningitis, in whom a lumbar puncture can be withheld, without missing 
any case of meningitis. 
Methods 
Patients aged from I month up to 15 years, visiting the emergency department of 
the Sophia Children's Hospital in Rotterdam, the Netherlands between 1988 and 
1998 with meningeal signs were eligible. These patients were identified using a 
problem oriented patient classification system, as has been applied at the 
outpatient department of the Sophia Children's Hospital since 1988. 12 For each 
patient the main reason for consulting the outpatient department is prospectively 
coded by one of the paediatricians (n = 5). The code 'meningeal signs' applies to 
patients with pain in the neck in history, or with meningeal irritation assessed by 
either the general practitioner or the paediatrician. Meningeal irritation was 
defined as presence of Brudzinski sign I or II, Kernig sign, tripod phenomenon or 
neck stiffness in children > I year, and in children S; I year one of the previous 
signs or irritability during manipulation of head or legs by the paediatrician or a 
bulging fontanelle. 4,13 In children with missing information on some tests, but with 
at least one positive sign, meningeal irritation was considered present. Patients 
with a history of severe neurological disease or ventricular drain were excluded. 
Patients referred from other hospitals were additionally excluded, since in these 
patients treatment may have been initiated already and influenced the clinical 
signs at presentation, Data obtained from patients between 1988 and 1995 were 
used to derive a prediction model (derivation set). This model was evaluated on 
data from patients between 1996 and 1998 (validation set). 
Data from patient history and physical examination were collected by review of 
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the patient charts. The paediatric patient record has a standardised format, 
including general characteristics, the patient's hlstory of the main problem and 
complaints of main organ systems and the findings at physical examination. For 
consciousness four levels were distinguished: alert - reaction to voice - reaction 
to pain - no reaction. Disturbed consciousness was considered in case of reaction 
to pain only, or no reaction at all. Data from laboratory tests of cerebrospinal fluid 
(CSF) , blood, stool and urine specimens were retrieved from the computer-
documented hospital information system. 
The outcome diagnosis was the presence or absence of bacterial meningitis. Its 
presence was defined as a leukocyte count of > 5 cells/~I in CSF, with positive 
bacterial cultures of CSF or blood. 1 Patients with antibiotics used before the 
lumbar puncture were considered to have a pre-treated bacterial meningitis in 
case of an increased CSF leukocyte count with negative bacterial cultures and 
subsequent hospitalisation and treatment with antibiotics for at least 7 days. 14 
Elevated CSF leukocyte count with viral growth in CSF or faeces or positive viral 
serology was considered as a case of viral meningitis and absence of any isolated 
pathogen as a case of aseptic meningitis. 15 Final diagnoses other than meningitis 
were determined by either bacterial cultures of blood, urine, stool, or ear, nose, 
or throat specimens, or based on a consensus diagnosis. 4 
In the derivation set, we first quantified the association between the presence and 
absence of bacterial meningitis and each potential diagnostic determinant using 
univariate logistic regression analyses. Continuous variables were analysed on a 
linear and on a transformed scale (logaritlunic, quadratic, root or exponential), if 
clinically plausible, and the best transformation was used in further analyses. We 
assessed the independent contribution of determinants with univariate 
associations (p-value < 0.15) by multivariate logistic regression analyses. In 
accordance to the chronology in whlch data are documented in clinical practice 9, 
we first included determinants from patient hlstory and physical examination. The 
'cliuical evaluation model' was reduced by excluding predictors from the model 
with p-values > 0.10, since variables with a p-value :": 0.10 were considered to be 
independently related to bacterial meningitis, only. 16 Then, all univariate 
correlates obtained from laboratory tests were added to the reduced 'clinical 
evaluation model'. Laboratory variables with a p-value :": 0.10 were considered to 
additionally contribute to the prediction of bacterial meningitis and thus remained 
in the final modeL Reliability of all models was estimated using the Hosmer & 
Lemeshow test 17, and their ability to discriminate between patients with and 
without bacterial meningitis using the area under the receiver operation 
characteristic curve (ROC-area). Differences in the discriminative value between 
the models were estimated by differences in ROC-area, taking into account the 
correlation between models as they were based on the saxne cases. 18,19 
Since multivariate analysis requires all data to be present in all patients 16, we 
used imputation techniques as available in SOLAS (version 1.1) to fill in missing 
values of some variables by a (theoretical) value, without disturbing the 
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relationship between the variables as observed in the data. This allowed to 
include all patients in the analysis (increased statistical efficiency) and reduced 
bias since missing may not occur at random (e.g. a record of a seriously sick 
patient may be more complete than that of a less sick patient) such that the 
'complete cases' would reflect a selected sample of children with meningeal 
signs. 20 Variables with a high percentage of missing data (> 50%) before 
imputation were excluded from the analysis. To account for uncertainties in 
imputed data 20.21, the imputation was repeated five times (Le. multiple 
imputation), and one prediction model was estimated, as described above, from 
each of the five imputed datasets. Averaging the regression coefficients and 
standard errors of the logistic models estimated of the five datasets resulted in 
one prediction model. 21 
The final model was then transformed into a clinical prediction rule. The 
coefficient of each variable in the model was multiplied by 2.5 and then rounded 
to the nearest (half) integer. By assigning points for each variable present and 
adding the results, a score was obtained for each individual patient. The ROC-
area of this score was estimated. The derived prediction rule was then applied to 
the patients in the validation set, and the performance of the rule (ROC-area) and 
the percentage of correctly predicted patients was compared with the derivation 
set. 
Table 1 General characteristics of derivation and validation set. 
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Male gender 
Age (years)' 
Age :5 6 months 
Age from 6 months to 2 years 
Age from 2 years to 6 years 
Age> 6 years 
Referral pattern 
General practitioner 
Self referral 
Other specialist 
Fever in history 
Body temperature at examination (OC)" 
Pain in the neck in history 
Suspected meningeal signs at referring 
physician 
Meningeal irritation at paediatrician 
Diagnosis 
Bacterial meningitis 
Viral/aseptic meningitis 
Pneumonia 
Other bacterial infectionst 
Self limiting diseases:!: 
"mean (standard deviation) 
Derivation set 
(n=286) 
61% 
3.5 (3.4) 
37 (13%) 
92 (32%) 
98 (34%) 
59 (21 %) 
80% 
12% 
2% 
93% 
39.1 (1.1) 
46% 
56% 
73% 
29% 
12% 
7% 
3% 
49% 
Validation set 
(n=74) 
68% 
4.0 (3.9) 
13 (18%) 
16 (22%) 
26 (35%) 
19 (26%) 
78% 
12% 
4% 
88% 
38.9 (1.1) 
49% 
60% 
65% 
20% 
12% 
11% 
2% 
55% 
t other bacterial infections included septicaemia, urinary tract infections, 
gastro-enteritis 
*self~limiting diseases are upper respiratory tract infections, non~specified 
viral infection and myogenic torticollis 
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Results 
The derivation set comprised 286 consecutive patients, the validation set 74. 
There were no differences between the derivation and validation set (Table I). 
Bacterial meningitis was diagnosed in 29% (95% CI: 24 - 35%) of the patients of 
the derivation set (five pre-treated before lumbar puncture) and in 20% (95% CI: 
12 - 31 %) of the validation set. A lumbar puncture had been performed in 210 
(73%) and 47 (64%) children of the derivation and validation set, respectively. 
None of the 103 children without lumbar puncture developed bacterial meningitis 
during follow-up, which involved an outpatient department visit or telephone call 
by one of the paediatricians (in training) within 14 days after discharge. 
Table 2 Univariate correlates (p < 0.15) of bacterial meningitis (EM) (derivation set, n:;;;;: 286) 
~numbers are :,eercentages. unless stated otherwise ~ 
Variable Number of BMpresent BMabsent 
subjects (n~84) (n~202) 
available ~%) % % 
Patient history 
Male gender 286 (100%) 50 66 
Temperature (highest) measured 212 (74 %) 39.8 (1.3) 39.5 (1.2) 
at homeCC)" 
Fever 283 (99%) 100 91 
Duration offever (days)" 271 (95%) 2.3 (2.0) 1.8 (2.0) 
Duration of the main complaint 276 (97%) 2.1 (1.7) 1.8 (2.4) 
(days)' 
Pain in the neck in history 233 (81 %) 46 57 
Headache 180 (63%) 49 56 
Acute deterioration 276 (97%) 33 9 
Drowsiness 201 (70%) 70 36 
Vomiting 256 (90%) 74 23 
Increased crying 256 (90%) IS 27 
Coughing 212 (74%) 35 43 
ComElex convulsions 286 (100%) 6 I 
Physical examination 
Rectal temperature (OC)§ 279 (98%) 39.4 (0.9) 39.1 (1.2) 
Disturbed consciousness 286 (100%) 63 6 
Impaired peripheral perfusion 210 (73%) 49 20 
Cyanosis 286 (100%) 12 0 
Petechiae or ecchymoses 286 (100%) 21 3 
Enlarged cervicallymphenodes 253 (88%) 32 48 
Throat infection 267 (93%) 23 38 
Rhinitis 257 (90%) 32 42 
Otitis 243 (85%) 0 5 
Meningeal irritation 286 (100%) 100 61 
Focal neurological disorders 286 (100%) 23 10 
Haematologylblood chemistry 
Leukocyte count (x 1 0911)" 264 (92%) 17.0 (8.8) 15.0 (8.0) 
Absolute neutrophil count (x 109/1)'" 213 (74%) 13.1 (8.3) 10.5 (7.3) 
Thrombocyte count (XI09/l)" 255 (89%) 257 (144) 319 (128) 
5erum CRP (mg/l)' 145 (51 %) 166 (94) 69 (82) 
Actual bicarbonate (mrnolll)" 196 (69%) 20.0 (3.9) 21.3 (3.7) 
Base excess ~mrno1ll2" 196 (69%) -3.0 (4.0) -2.1 (3.9) 
"Mean (standard deviation) 
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Univariate correlates (p < 0.15) of bacterial meningitis in the derivation set are 
presented in Table 2. In all children with bacterial meningitis fever in history and 
meningeal irritation assessed by the paediatrician were both present. The age of 
children with bacterial meningitis (3.6 years, 95% CI: 2.8 - 4.3) did not 
significantly differ from children without (3.5 years, 95% CI: 3.0 - 4.0). 
Independent predictors of the presence of bacterial meningitis obtained from 
patient history and physical examination were the duration of the main complaint 
and vomiting in history and meningeal irritation, cyanosis, petechiae and 
disturbed consciousness at physical examination (Table 3). The ROC-area was 
0.92 (95% CI: 0.89 - 0.95). Including age did not improve this model, nor a 
subgroup analysis on children younger and older than I year, separately. Serum 
CRP was the only laboratory predictor with added value beyond the independent 
predictors in the 'clinical evaluation' model and increased the ROC-area to 0.95 
(95% CI: 0.92 - 0.97): an increase of 0.02 (95% CI: 0.01 - 0.04). All models had a 
good fit (p-value > 0.10). 
Table 3 IndeEendent Eredictors for bacterial menin£!!tis 
Variable Clinical Clinical Contribution to 
evaluation model evaluation + score . 
OR (95% CI) laboratory model 
OR (95% C!) 
Patient history 
Duration of the main 1.5 (1.2 - 1.9) 1.5 (1.2 - 1.9) 
complaint (per day)'fI 
Vomiting 2.4 (1.0 - 5.4) 2.3 (0.9 - 5.5) 2 
Physical examination 
Meningeal irritation 25.0 (3.2 - 197.5) 21.1 (2.6 - 172.4) 7.5 
Cyanosis 24.0 (2.0 - 289.4) 13.0 (l.l- 151.3) 6.5 
Petechiae or ecchymoses 7.5 (2.2 - 25.6) 4.9 (1.4 -17.9) 4 
Disturbed consciousness 22.2 (9.4 - 52.4) 21.8 (8.6 - 55.2) 8 
Laboratory tests 
Serum CRP {Eer 10 mg:Il)"I" 1.1 (1.0 -l.l) 0.1 
ROC-area (95% CI) in 0.92 (0.89 - 0.95) 0.95 (0.92 - 0.97) 0.94 (0.91- 0.97) 
derivation set 
ROC-area (95% CI) in 0.92 (0.86 - 0.98) 0.92 (0.86 - 0.98) 0.92 (0.86 - 0.98) 
validation set 
"Based on 'clinical evaluation + laboratory model' 
OR ::;: odds ratio, CI ::;: confidence interval, ROC::;: receiver operating characteristic 
'fIduration of the main complaint rounded off to half days, with a maximum of 7 points 
tpoints assigned to serum CRP: 0.1 point per 10 mgilincrease, thus 0 - 9 mgll: 0 points; 
10 - 19 mgll: 0.1 points; etc, with a maximum of 2 points 
Using the scores assigned to each predictor after transformation of the final model 
(final column of Table 3) the following rule was derived: 
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The total score in our patients in the derivation set ranged from 0.5 to 31.0 points. 
The ROC-area of the score was 0.94 (Table 3). Using the total scores, patients 
were divided into five groups and the frequency of meningitis in each group was 
computed (Table 4). Bacterial meningitis was absent in all patients with a score < 
9.5 and present in almost all patients with a score 2: 20. The threshold value < 9.5 
identified 99 patients without bacterial meningitis (35%; 95% CI: 29 - 40%), 
without missing one case of bacterial meningitis. 
0-4.9 
5.0 - 9.4 
9.5 -14.9 
15.0 -19.9 
> 20.0 
o 
17 (16%) 
24 (63%) 
43 (98%) 
35 (100%) 
88 (84%) 
14 (37%) 
1 (2%) 
o 
3 (15%) 
4 (44%) 
8 (73%) 
14 (100%) 
17 (85%) 
5 (56%) 
3 (21%) 
Both models and the prediction rule were applied to the validation set to estimate 
future performance of the rule. The ROC-areas of all three models were 0.92 (95% 
CI: 0.86 - 0.98) (Table 3), suggesting nearly identical performance compared to 
the derivation set. The threshold value of 9.5 identified 34 (46%; 95% CI: 34 -
58%) of the patients in the validation set without bacterial meningitis. In the 
validation set, 47 lumbar punctures had been performed actually; 36 of these 
were indicated by the prediction rule. Four lumbar punctures were additionally 
indicated by the rule in 27 patients without an actual lumbar puncture. 
Considering the number of lumbar punctures as actually performed, the net 
benefit of the prediction rule would be 7 (47 - (36 + 4)) of 47 lumbar punctures 
(15%; 95% CI: 6 - 28%). 
Discussion 
We have shown that physicians can very well predict the presence or absence of 
bacterial meningitis in children with meningeal signs using a few patient 
characteristics, such as the duration of the main complaint, vomiting, meningeal 
irritation, cyanosis, petechiae, disturbed consciousness and serum CRP. The 
application of this rule in practice decreases the diagnostic burden and risk for 
side effects for the patient, as well as the measurement costs. In particular, with 
this rule a lumbar puncture can correctly be withheld in about 35 % of children 
presenting with meningeal signs, leading to a 15% net reduction of lumbar 
punctures. This net benefit, however, depends on the actual number of lumbar 
punctures currently applied, and will vary among hospitals. 
Most physicians will perform a lumbar puncture in any child with signs of 
meningeal irritation. Indeed, in our model, meningeal irritation appeared to be 
one of the strongest predictors. To distinguish between bacterial and viral / 
aseptic meningitis or other diseases that may present with meningeal signs, 
however, other clinical characteristics as present in our model have added value. 
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The relative importance of a variable on the risk of bacterial meningitis is 
indicated by the value of the score assigned to each predictor. For instance a 
patient with vomiting and meningeal irritation obtains 9.5 points (2 + 7.5) and has 
an estimated probability of bacterial meningitis of 16% (Table 3, score 9.5 - 14.9). 
Additional presence of a disturbed consciousness increases the score to 17.5 (9.5 
+ 8), which is related to a 63% probability of bacterial meningitis. Inclusion of 
serum CRP in our rule suggests that CRP results are necessarily available, before 
drawing conclusions. CRP, however, has a positive score in the rule and thus 
always increases the total score. Therefore, patients with a score above 9.S based 
on clinical variables only (i.e. before knowing serum CRP) will receive an 
indication for lumbar puncture, irrespectively of the CRP level. These patients are 
probably the evident cases of bacterial meningitis, in whom further diagnostic 
tests are quite straightforward. To include serum CRP is valuable in the less 
evident cases (with clinical score < 9.5), in particular. 
We have chosen a threshold value for the total score that will not miss a single 
case of bacterial meningitis. A higher threshold for the risk score may lead to a 
larger reduction in lumbar punctures, but also increases the risk of missing a case 
of bacterial meningitis, which is unacceptable. The defined threshold value of 9.5 
has not missed one case of bacterial meningitis in both the derivation and 
validation set. Since the validation set comprises a random sample of patients to 
whom the prediction rule will be applied in future, this validation reflects the 
future performance of the rule. Nevertheless, the purpose of the prediction rule is 
to guide decisions into practice, and not to replace clinical judgement. 
It may seem controversial that meningeal irritation at physical examination is part 
of our inclusion criteria and included as a predictor in our prediction rule as well. 
Patient inclusion, however, has been based on the presence of either one of the 
three characteristics (pain in the neck, referral for meningeal signs or meningeal 
irritation at physical examination). Presence of meningeal irritation at physical 
examination appears to be independently related to an increased risk of bacterial 
meningitis, in contrast to pain in neck in history or referral because of meningeal 
signs. 
In accordance with clinical practice, the value of diagnostiC tests (i.e. findings of 
clinical examination and laboratory tests) should be assessed in patients with 
disease suspicion, defined by signs and symptoms, as the final diagnosis is still 
unknown at this stage. 11 Therefore, we have studied patients suspected of 
bacterial meningitis, characterised by signs as described above. Because of this 
way of patient selection, we cannot directly compare our results to previous 
reported prediction models, as these studies are based on patients selected on 
their proven presence or absence of meningitis (bacterial, viral or aseptic). 
Furthermore, the characteristics of our study population, such as age and 
pathogen type are determined by the clinical presentation. This selection of 
patients, however, does not affect the applicability of the rule in future patients, as 
long as they are also selected on their clinical presentation of 'meningeal signs'. It 
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should be noted, however, that the diagnostic prediction rule does not apply to all 
patients suspected of meningitis, since patients with a dominance of other 
symptoms of meningitis (such as convulsions, coma, etc.) are not included in our 
study population. 1,5,6 
To further appreciate the present results some aspects need to be discussed. 
First; the study partly includes the period in which bacterial meningitis caused by 
Haemophilus iniluenzae (HIE) was still present, although almost eradicated by 
vaccination nowadays. 22 An analysis with exclusion of the HIE cases (n = 32), 
however, did not alter the results and yielded the same rule. The rule has proven 
to perform well in the validation set, in which no cases of HIE meningitis were 
present. Second; this study has been performed at a paediatric university hospital 
with about 2,500 new patients visiting the paediatric emergency department 
yearly and of whom 90% need basic paediatric care. 23 Therefore we think that 
the derived prediction rule is also applicable for general hospitals. Third; this 
study has been based on routinely documented information, in which not all data 
were available for each patient. Although formal criteria do not exist, we initially 
chose to exclude all diagnostic variables from the analysis with a large proportion 
of missing data, since imputation of variables with 50% missing data or more 
would be too in-stable. Moreover, missing data of such variables may indicate 
that they are difficult to document in clinical practice and therefore are not 
preferred in an easy and widely applicable prediction rule. Finally, in some 
children the reference standard (lumbar puncture) for the outcome bacterial 
meningitis was missing, which may have lead to a certain verification bias. 24 
Bacterial meningitis, however, is a serious and rapidly progressing disease 
without treatment. 1 Since none of the children without a lumbar puncture 
developed bacterial meningitis during follow-up, no cases of bacterial meningitis 
were missed. We may have misdiagnosed some cases of viral or aseptic 
meningitis, since these are not fatal if left untreated. This misclassification, 
however, will not affect our results, since we aimed to distinguish between the 
presence or absence of bacterial meningitis. We presumed that a lumbar 
puncture is performed to detect bacterial meningitis. Hence, by using our rule, a 
lumbar puncture will be withheld in some children with a viral or aseptic 
meningitis (n = 9 out of 44; 20% in this study), such that this diagnosis is missed. 
We believe that this is acceptable, since viral and aseptic meningitis have a fair 
prognosis in children> I month and do not need specific treatment. 25 This point 
of view may change in the future, when antiviral treatment for enteroviral 
meningitis becomes available. Ascertaining the diagnosis viral meningitis may be 
additionally important to inform parents or for epidemiological reasons. 
The predictors of our rule have also been reported by other studies on the clinical 
characteristics of children with meningitis, although the independent contribution 
of serum CRP to the diagnostic accuracy has not been described before. 2,5,7,8,26 It 
may be surprising that in our study presence of fever in history and leukocyte 
count in blood did not contribute to the diagnosis bacterial meningitis, since they 
are known to be predictors for serious bacterial infections. 26,21 We, however, 
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have evaluated whether the predictors could distinct between bacterial 
meningitis and 'non-bacterial meningitis' (the latter including viral/aseptic 
meningitis, other serious bacterial infections and self-limiting diseases). 
Apparently, fever or leukocyte count does not differ between these two. 
Additionally, if we consider laboratory tests separately from the clinical 
evaluation model, also thrombocyte count, glucose level and actual bicarbonate 
concentration in blood are associated with bacterial meningitis. These tests, 
however, have no additional value beyond patient history and physical 
examination and thus can be omitted in the diagnostic process. 9 Furthermore, it 
should be noted that the aim of this study was to derive a prediction rule for 
identifying those patients presenting with meningeal sings in whom a lumbar 
puncture can correctly be withheld for ruling out bacterial meningitis. Hence, we 
did not yet analyse the additional diagnostic value of variables obtained from CSF 
laboratory tests. 
In conclusion, this is the first study on the predictive value of clirical parameters 
to estimate the presence or absence of bacterial meningitis among patients 
consulting the emergency department with meningeal signs. A prediction rule 
including duration of the main complaint and presence of vomiting in history, 
presence of meningeal irritation, cyanosis, petechiae and disturbed 
consciousness at physical examination, and serum CRP concentration, is an easy 
applicable tool for physicians to guide their decision whether or not to perform a 
lumbar puncture in the individual patient. In patients with meningeal signs, a 
lumbar puncture can be withheld in 35% without missing one case of bacterial 
meningitis. 
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Children with meningeal signs: when to start 
empirical antibiotic treatment? 
Abstract 
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Submitted for publication 
We developed a decision rule, including cerebrospinal fluid (CSF) indices and 
clinical characteristics to decide whether or not empirical antibiotic treatment 
should be started in children with meningeal signs. 
In 227 children (aged 1 month to 15 years) visiting the paediatric emergency 
department with meningeal signs, the added value of early obtainable (CSF) 
indices to predict bacterial meningitis was judged using multivariable logistic 
modelling. Bacterial meningitis was defined as CSF leukocyte count > 5 cells/ ~ 
with a positive bacterial culture of CSF or blood. 
Independent predictors of bacterial meningitis from early obtainable CSF 
indices were the CSF polymorphonuclear leukocyte count and the CSF !blood 
glucose ratio. The diagnostic value of this CSF model was 0.93. Applying the 
model together with clinical characteristics, absence of bacterial meningitis was 
early predicted in 69 of the 227 patients (30%), such that treatment could 
correctly be withheld. 
In conclusion, the decision rule including clinical characteristics and CSF 
indices, is a useful tool for decisions on therapeutic interventions in clinical 
practice and will optimise their use. 
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Introduction 
A delayed diagnosis and treatment of bacterial meningitis worsens its prognosis. 
Consequently, physicians have a low threshold to perform a lumbar puncture in 
patients suspected of having meningitis. Moreover, patients with an increased cell 
count in cerebrospinal fluid (CSF) are commonly treated for bacterial meningitis 
until the CSF culture result becomes available (after 48 - 72 hours). 1-3 Patients 
with meningeal signs, however, may still suffer from other diagnoses than 
bacterial meningitis. 4-6 Early discrimination of bacterial meningitis from other 
diseases can prevent unnecessary hospitalisation and potential side effects of 
empirical antibiotic treatment. 
Previous studies have assessed several characteristics from clinical evaluation or 
laboratory tests that may predict bacterial meningitis. 7-10 These studies, however, 
selected their patients on the diagnosis (proven bacterial, viral and! or aseptic 
meningitis) or on the presence of a lumbar puncture. Such a patient selection may 
lead to bias towards the more evident cases of meningitis and thus to an 
overestimation of the diagnostic value of tests that in practice will be applied to all 
patients suspected of having meningitis. 11-13 Moreover, in practice the physician 
is faced with a patient with meningeal signs in whom the diagnosis is not known 
yet. 11 In accordance to clinical practice, we therefore selected in this study 
children by their clinical presentation. 
In a previous study we derived and validated on 360 children with meningeal 
signs a prediction rule based on clinical signs and symptoms, that enables to 
determine the indication for lumbar puncture. 14 The aim of the present study was 
to evaluate in those patients with an indication for lumbar puncture whether early 
available CSF indices can predict the presence or absence of bacterial 
meningitis, before the CSF culture becomes available. Such predictors could then 
be used to determine whether or not empirical antibiotic treatment should be 
started. 
Patients and methods 
Patients 
All patients aged from 1 month up to 15 years, visiting the emergency department 
of the Sophia Children's Hospital in Rotterdam, the Netherlands between 1988 and 
1998 with meningeal signs, were eligible. 'Meningeal signs', as documented by a 
prospective problem oriented patient classification system 15, was defined as 
presence of pain in the neck in medical history, or presence of meningeal 
irritation as assessed by either the general practitioner or the paediatrician. 
Meningeal irritation was defined as presence of Brudzinski sign I or II, Kernig 
sign, tripod phenomenon or neck stiffness in children> 1 year, and in children'; 1 
year one of the previous signs or irritability during manipulation of head or legs 
by the paediatrician or a bulging fontanel. 6.14.16 Patients referred from other 
so 
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hospitals or with a history of severe neurological disease or ventricular drain 
were excluded. 
In a previous study on 360 children with meningeal signs, a prediction rule based 
on clinical signs and symptoms for the presence and absence of bacterial 
meningitis was derived and validated. 14 This rule can be used in practice to early 
determine whether or not a lumbar puncture is indicated, without missing a single 
case of bacterial meningitis. The following rule was defined: 
Score:;;: 1 x duration main problem (days) + 2 x vomiting in history + 7.5 x 
meningeal irritation + 6.S x cyanosis + 4 x petechiae + 
8 x disturbed consciousness + 0.1 x serum CRP (per 10 mgll) 
Using this algorithm, a risk score could be computed for each individual patient 
by assigning points for each variable present. For example, a child with vomiting 
in history, and with meningeal irritation and petechiae at physical examination got 
a total score of 13.5 (2 + 7.5 + 4) points. In all 360 patients, the score ranged from 
0.5 to 31 points. In those with a risk score < 9.5 points (about 35% of the patients), 
bacterial meningitis was always absent and a lumbar puncture could be withheld. 
In the remaining 227 patients (score" 9.5), a lumbar puncture was indicated. In 
these 227 patients, the present study assessed the additional predictive value of 
eSF indices to the presence or absence of bacterial meningitis and their use in the 
decision whether or not to start empirical treatment. 
Datacollection 
By review of the paediatric record, demographic data and presenting signs and 
symptoms were collected. Data from laboratory tests of eSF, blood, stool and 
urine specimens were retrieved from the computer-documented hospital 
information system. The following eSF indices were analysed: the total eSF 
leukocyte count, the percentage polymorphonuclear leukocytes (PMNs) , the 
absolute number PMN s, protein and glucose concentration and the Gram-stained 
smear of eSF specimen. The eSFlblood glucose ratio was computed by dividing 
the eSF glucose level by the serum glucose level (both samples taken at the same 
time) and analysed as a separate variable. 
Diagnostic outcome 
The diagnostic outcome was the presence or absence of bacterial meningitis. Its 
presence was defined as leukocytes > 5 cells/ ~l in eSF and a positive bacterial 
culture of eSF or blood. 2 Patients using antibiotics before the lumbar puncture 
were considered to have a pre-treated bacterial meningitis, if they had an 
increased eSF leukocyte count and a negative bacterial culture but were 
subsequently hospitalised and treated with antibiotics for at least 7 days. 9 Final 
diagnoses other than bacterial meningitis were based on either bacteriologic or 
viral cultures from eSF, blood, urine, stool and ear, nose, or throat specimens or 
based on a consensus diagnosis. 6 In absence of a lumbar puncture, presence or 
absence of bacterial meningitis was assessed by follow-up (outpatient department 
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visit or telephone call by one of the paediatricians (in training) within 14 days 
after presentation). 
Analysis 
The association between the CSF indices and the presence or absence of bacterial 
meningitis was quantified using univariate logistic regression analyses. 
Continuous variables were analysed without categorisation, but various cut-off 
levels and transformations (square root, log) were evaluated. 17 Subsequently, all 
CSF indices univariately associated (p value < 0.15) were included in a 
multivariate logistic regression model to evaluate their independent value in the 
prediction of bacterial meningitis. From this (overall) model, model reduction was 
performed by excluding predictors from the model with p-values > 0.10, since 
variables with a p-value :> 0.10 were considered to be independently related to 
bacterial meningitis, only. 17 Reliability (goodness of fit) of all models was 
estimated using the Hosmer & Lemeshow test IS, and their ability to discriminate 
between patients with and without bacterial meningitis using the area under the 
Receiver Operation Characteristic curve (ROC-area). Differences in the 
discriminative value between the overall and reduced models were estimated 
using the ROC-areas with 95% CI, taking into account the correlation between the 
models as they were based on the same cases. 19,20 
To reduce bias and increase statistical efficiency 21.22 missing values in the data 
were filled in by imputation using SOLAS (version 1.1). SOLAS uses an empirical 
Bayesian algorithm to impute missing data. Missing data may not be missing at 
random (e.g. a record of a seriously sick patient may be more complete than a 
less sick patient) such that the 'complete cases' would reflect a selected sample of 
children with meningeal signs. In order to account for uncertainties in imputed 
data 21.22, the imputation was repeated five times (i.e. multiple imputation) and 
one prediction model was estimated as described above from each of the five 
imputed datasets. 
Next, to validate each model obtained from each dataset and to adjust for too 
optimistic estimates of the predictors' regression coefficients, random 
bootstrapping techniques were used. 17.23 In this way, the discriminative ability of 
each model in future but similar patients was estimated. The five adjusted 
regression coefficients and standard errors (i.e. from each of the five imputed 
datasets) were then averaged according to standard statistical techniques to 
obtain one final (adjusted) model. 22 This adjusted final model was then 
transformed into a CSF prediction rule by rounding the coefficients of the 
included variables to the nearest integer. A total CSF score was computed for 
each individual patient by assigning points for each variable present. The ROC-
area of this score was estimated. Finally, the discriminative ability of the CSF 
prediction rule combined with the previously obtained clinical risk score 14 was 
evaluated. 
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Results 
General characteristics of the 227 included patients are shown in Table L 
Bacterial meningitis was present in 44% (95% CI: 37-50%), among whom were 
five cases of pre-treated meningitis; 186 children were hospitalised (82%). 
Table 1 General characteristics of patients with indication for lumbar puncture (n::::;227). 
(values represent absolute numbers and % in parentheses, unless stated otherwise) 
Age (years)" 3.6 (3.6) 
Male gender 139 (61 %) 
Fever 220 (97%) 
Vomiting 165 (73%) 
Duration main problem (days)* 2.1 (2.0) 
Disturbed consciousness 82 (36%) 
Meningeal irritation 221 (97%) 
Petechiae 37 (16%) 
Cyanosis 10 (4%) 
Bacterial meningitis 99 (44%) 
Hospitalisation 186 (82%) 
"Mean (standard deviation) 
Table 2 presents the univariate analysis of the CSF indices. Mean total CSF cell 
count, percentage PMNs, absolute PMN count and CSF protein concentration were 
significantly higher in patients with bacterial meningitis whereas CSF glucose 
concentration and CSF !blood glucose ratio were significantly lower. Under the 
assumption not to miss a single case of bacterial meningitis since this is clinically 
unacceptable, for none of the CSF variables a threshold value could be found that 
identified a meaningiul number of patients without bacterial meningitis. The 
Gram-stained smear was negative in 29 of the 99 (29%) patients with bacterial 
meningitis and positive in 2 of the 128 (2%) patients without and thus did not fully 
discriminate either. In one of these two false-positive cases S. epiderrnidis was 
identified in the CSF culture, which was considered to be contamination. 
Table 2 Cerebrospinal fluid laboratory findings in 227 patients with and without bacterial 
meningitis (values represent mean and standard deviation in parentheses, unless stated 
otherwise) 
Total leukocyte count /).11 
Absolute PIvrn' count /).11 
% PM:Ns 
Glucose concentration 
(mmol/l) 
BMpresent 
(n = 99) 
4,947 (6,227) 
3,523 (4,825) 
67 (30) 
1.8 (1.3) 
BMabsent 
(n = 128) 
274 (1,073) 
193 (1.002) 
23 (31) 
3.7 (1.0) 
Odds Ratio 
(95% Cn 
4.1 (3.0 _ 5.7) j' 
3.4 (2.6 _ 4.4) t 
1.5 (1.3 - 1.6)' 
0.3 (0.2 - 0.4) 
Protein concentration (gil) 1.93 (1.62) 0.56 (0.56) 5.6 (3.3 - 9.4) 
Glucose ratio CSF/blood 0.29 (0.22) 0.65 (0.21) 0.4 (0.3 - 0.5)' 
Positive Gram-stained smear§ 70 2 144.9 (33.6 - 624.5) 
PIvrn': polymorphonuclear cells; CSP: cerebrospinal fluid; BM: bacterial meningitis; CI: 
confidence interval; tOdds ratio per unit lDJ,og(CSF cell count) (multiplicative), ~:Odds 
ratio per 10% increase (multiplicative), !lpercentage 
Multivariate regression analysis of all CSF indices identified the absolute PMN cell 
count and CSF !blood glucose ratio as independent determinants of presence of 
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bacterial meningitis. The second column of Table 3 shows the contents of this final 
model before bootstrapping. The diagnostic value (ROC-area) of this CSF model 
was 0.93 (95% CI: 0.89-0.96). The third column shows the odds ratios and the 
ROC-area of this model after adjustment for overfitting (bootstrapping). Both 
models had a good fit, i.e. Hosmer & Lemeshow test p-value > 0.10 (data not 
shown). 
Table 3 Odds ratios (95% confidence interval) of the independent CSF variables 
Variables Model Model Risk score" 
(unadjusted) (adjusted) 
eSF absolute PMN 3.0 (2.2 - 4.2) 3.0 (2.1- 4.1) 1.0 
count~ 
eSFlblood glucose ratio 0.6 (0.5 - 0.8) 0.6 (0.5 - 0.8) -0.5 
eSF: fluid; PlVIN: cell count; . receiver operating 
characteristic 
Scoring algorithm: 1.0 x lOlog(absolute CSF PlVIN count) - 0.5 x (CSFlblood glucose ratio) 
"The score per variable is obtained by rounding the regression coefficients (;;::;In(OR)) to 
the nearest fifth decimal 
'lfodds ratio per unit lOlog(plVIN count) (multiplicative); in score coded as a (0--9 PlVINs/f,lI), 
I (10-99 PMNs/~I), 2 (100-999 PMNs/~I). 3 (1,000-9,999 PMNs/~I), and 4 (>10,000 
PMNs/~I). 
'lfin score coded as 0 (ratio <0.10), I (ratio 0.10-0.19), 2 (ratio 0.2-0.29), 3 (ratio 0.3-0.39), 
etc. up to 10 (ratio >1.0) 
From the regression coefficients of the predictors in the adjusted model 
corresponding scores were derived (regression coefficients rounded to the 
nearest fifth decimal), such that a prediction rule was developed (fourth column, 
Table 3). A total score was computed for each patient by assigning 1 point for 
each increase of the l"J.og (absolute PMN count) and -0.5 point for each tenth 
increase of the CSFlblood glucose ratio. For instance, a patient with 1,500 cells/)11 
with 80% PMNs (1,200 PMNs/)11) and a CSF Iblood glucose ratio of 0.2 got 2 points 
(3 - 1). When applied to all patients, the score ranged from -5 to +4. The ROC-
area of this CSF rule was 0.93 (95% CI: 0.89 - 0.96). Table 4 shows the incidence of 
bacterial meningitis and the number of subjects across selected categories of the 
score. The CSF score identified groups with increased probability of true 
bacterial meningitis. No threshold value could be defined for the CSF score, 
however, that selected a substantial group of patients without bacterial meningitis 
in whom treatment could be withheld, without missing one case of bacterial 
meningitis. 
Table 4 Distribution of patients with and without bacterial meningitis according to the CSF score 
CSF score BM+ BM-
-5 to -3.5 1 (4%) 24 (96%) 
-3to-0.5 16 (14%) 97 (86) 
o to 2.5 53 (90%) 6 (10%) 
3 to 4 29 (97%) 1 (3%) 
lill 99 (44%) 128 (56%) 
CSF: cerebrospinal fluid; BM: bacterial meningitis; +: present; -: absent 
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A lumbar puncture is only one step in the diagnostic process and usually 
performed after history taking and physical examination. Therefore, we evaluated 
the CSF model combined with the clinical risk score, as derived previously. 14 
Figure 1 shows that combined use of both rules can very well discriminate 
between patients with and without bacterial meningitis. Again under the 
assumption not to miss any patient with bacterial meningitis, the required 
threshold for the CSF score varied among groups of patients with different clinical 
risk scores. In patients with a clinical score between 9.5 and lOA, a threshold CSF 
score of < 1 identified patients without meningitis. For patients with a clinical 
score of 10.5 to 12.9 and 13 to 19.9, the CSF thresholds were < -2 and < -3, 
respectively. In patients with a very high clinical risk score (2: 20), the CSF score 
could not additionally discriminate the patients with bacterial meningitis from 
those without. Similarly, in patients with a CSF score <: 1, the clinical score could 
not further select patients with and without bacterial meningitis. Using the 
thresholds (Figure 1), in 69 patients (30%, 95% CI: 24 - 36%) empirical treatment 
could correctly be withheld. 
Figure 1 Combination of the clinical risk score with CSF score n = 227 
CSF score Clinical risk score 
9.5 -IDA 10.5 - 12.9 13 -19.9 <: 20 
-S to -3.5 
-3 to -2.5 
-2 to 0.5 
1 to 4 
No indication for treatment 
Indication for treatment 
CSF: cerebrospinal fluid; BM: bacterial meningitis; +: present; -: absent 
Discussion 
The absolute number of PMNs in CSF and the CSF !blood glucose ratio are 
independent predictors of bacterial meningitis in patients with meningeal signs. 
Using these early CSF indices only, bacterial meningitis cannot be predicted, 
without missing a case of bacterial meningitis. Combination of these two CSF 
indices with patient characteristics, such as the duration of the main problem, 
vomiting. meningeal irritation, cyanosis, petechiae, disturbed consciousness and 
serum CRP. however, can very well discriminate between the absence or 
presence of bacterial meningitis such that unnecessary treatment can be 
withheld. Application of this CSF rule in combination with these patient 
characteristics will reduce unnecessary antibiotic treatment and unnecessary side 
effects of this treatment (allergy, gastro-intestinal complaints, infusion problems, 
hospital infections, etc.) and increases clinical efficiency. Hence, empirical 
antibiotic treatment can correctly be withheld in 30% of the children. Of course, 
this reduction in treatment should be considered in view of the actual number of 
treatments in current practice (n = 186). The net reduction of empirical treatment 
as achieved by the decision rule is 28 (16%; 95% CI: 10 - 21 %). This net benefit, 
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however, depends on the actual number of empirical treatment, and will vary 
among hospitals. 
The combined use of the clinical risk score 14 with the CSF rule in predicting 
bacterial meningitis agrees with common practice, where laboratory tests usually 
are evaluated in view of the present clinical signs and symptoms. As illustrated in 
Figure I, in patients with an intermediate clinical risk score or CSF score, both 
scores contribute to the assessment of the risk of bacterial meningitis; therefore 
the decision rule is valuable in this group of patients in particular. In patients with 
a very high clinical risk score (> 20), who are the most obvious cases of bacterial 
meningitis, the CSF score does not contribute to therapeutic decisions and 
empirical treatment will be started anyway; the CSF culture result, however, will 
guide specific antimicrobial treatment. 2.3 Similarly, patients with a very high CSF 
score are evident cases of bacterial meningitis and the clinical profile does not 
contribute much to therapeutic decisions. 
The diagnostic process is a stepwise procedure, with use of diagnostic tests 
subsequent to patient history and physical examination. 11 Following this usual 
order of testing in clinical practice, we have selected patients suspected of 
bacterial meningitis (because of meningeal signs), who had an indication for 
lumbar puncture as defined by a prediction rule based on clinical symptoms. 14 In 
these patients, we have derived a rule to decide whether or not empirical 
treatment is necessary. One may question whether the decision rule including the 
CSF score and the clinical score together may also be applicable In a clinical 
setting where lumbar punctures are performed without using the clinical 
prediction rule. Therefore, we repeated the analyses on all patients who actually 
underwent a lumbar puncture (n = 256). The same CSF and clinical scoring rule 
were found and the same number of patients were selected for empirical 
treatment. This indicates that our CSF rule can both be applied in patient 
undergoing a lumbar puncture as selected by our clinical rule as well as in 
patients undergoing a lumbar puncture based on the paediatrician's decision. 
Nevertheless, it should be noted that in this latter clinical setting more 
unnecessary lumbar punctures will be performed. 
That CSF indices alone cannot very well discriminative between absence or 
presence of bacterial meningitis, has been mentioned previously. 7.24 This 
underlines the diagnostic problem when evaluating a child suspected of bacterial 
meningitis. Given the increased risk of mortality and morbidity in a delayed 
diagnosis and treatment of bacterial meningitis, clinicians preferably treat each 
child with an increased CSF leukocyte count empirically, until the CSF culture 
result is available. 2.3 Although a save strategy, a large group of patients without 
bacterial meningitis will be unnecessarily treated with antibiotics, with 
unnecessary costs and risk for potential side effects of treatment. Our finding of 
total CSF PMN count and the CSF !blood glucose ratio to be independent 
predictors of bacterial meningitis has also been reported by previous studies. 
7,8,10 In contrast to others 7, serum glucose was not an independent predictor in our 
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study, although the CSF Iblood glucose ratio in our rule indirectly includes this 
variable. The diagnostic value of CSF C-reactive protein and lactate concentration 
are not evaluated in this study. Although their diagnostic value has been reported 
25.26, these highiy advanced tests are not available in every hospital emergency 
department. Since our aim was to develop a rule widely applicable in general 
paediatric practice, we have decided not to include these advanced tests in the 
study. The final CSF model also does not contain the Gram-stained CSF smear. Its 
addition to the CSF model with PMN count and CSFlblood glucose ratio only, 
significantly increased the ROC-area from 0.93 to 0.95 (95% CI: 0.92 - 0.98). 
Despite this ROC-area increase, however, the Gram-stain did not improve the 
discrimination of patients without bacterial meningitis such that more urmecessary 
treatments could be withheld. 
To appreciate the present results some aspects need to be discussed. First, our 
study partly includes a time period in which bacterial meningitis caused by 
Haemophilus influenzae (HIE) was still present. Since HIE has almost been 
eradicated by vaccination nowadays ", we have performed an analysis with 
exclusion of these meningitis cases (n = 32), as well. This exclusion, however, did 
not alter the results and yielded the same CSF and clirical scoring rule. Second, 
the CSF rule has been developed in a population of patients with meningeal signs 
as the main problem. It should be noted that this rule does not apply to all patient 
suspected of meningitis, since patients with a prominence of other symptoms of 
meningitis (such as convulsions, coma, etc.) are not included in our study 
population. 2,3,28 To our knowledge, however, this is the first study in a paediatric 
emergency department based on the patient's clinical presentation. Third, in 
some children the reference standard (lumbar puncture) for the outcome 
bacterial meningitis was missing. In these children absence of bacterial 
meningitis has been assessed using follow-up data. Although this could have 
introduced some diagnostic verification bias 29, we think this did not occur in our 
study, since bacterial meningitis is a serious and fatal disease without adequate 
treatment 2 and all children without a lumbar puncture were followed-up and 
recovered uneventfully. We may, however, have misdiagnosed some cases of 
viral or aseptic meningitis. Since we aimed to distinguish between the presence 
or absence of bacterial meningitis, this will not affect our results. Fourth, our study 
has been performed at a paediatric university hospital. Ninety percent of patients 
visiting the emergency department of this hospital, however, requires basic 
paediatric care. 15 Therefore, we think that the derived prediction rule is 
applicable both to academic and general hospitals, Finally, validation of the CSF 
model demonstrated that the rule is robust. Before implementation of this decision 
rule in clirical practice, however, a prospective validation in similar future 
patients is necessary and currently being performed in our hospital. 
In conclusion, this study provides physicians with a rational basis for estimating 
the risk for bacterial meningitis in patients consulting the emergency department 
with meningeal signs, The decision rule is a tool in clirical practice for decisions 
on therapeutic interventions and therefore will optimise their use. 
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Abstract 
Use of an early applicable diagnostic decision rule, as previously derived, could 
improve management of children with meningeal signs, suspected of having 
bacterial meningitis. 
Objectives: To assess the validity of this rule in an external patient population. 
Design: Prospective validation study. 
Setting: Emergency department of four (paediatric) hospitals in the Netherlands 
Subjects: Children (0.1 to IS years) with meningeal signs, suspected of having 
bacterial meningitis 
Interventions: A diagnostic decision rule, including two scoring algorithms to set 
the indication of lumbar punctures and empirical treatment; one algorithm using 
symptoms, signs and serum C-reactive protein and a second one additionally 
using cerebrospinal fluid indices. 
Outcome measures: The discriminative value of both algorithms was estimated 
using the area under the receiver operator characteristic curve (ROC-area), as 
well as the absolute numbers of correctly diagnosed patients, and compared with 
the results from the original population. 
Results: Between November 1999 and November 2000 we included 176 children 
(median 2.2 years), initially presenting themselves with meningeal signs. 
Bacterial meningitis was diagnosed in 20 of them (11.4%). The scoring algorithms 
accurately predicted the frequency of bacterial meningitis. The algorithms' ROC-
areas in this population were similar to those of the original population. 
Conclusions: The previously derived diagnostic rule performed well in a new 
population of children with meningeal signs. It is a valuable tool for the clinician 
in making decisions on the need of a lumbar puncture or on initiating empirical 
treatment in these children. 
Introduction 
Children with meningeal signs offer the physician a diagnostic dilemma, since a 
large proportion of children with bacterial meningitis show meningeal signs 1.2, 
but many children with signs of meningeal irritation have another basis for their 
symptoms. 3,4 Since delayed diagnosis and treatment of bacterial meningitis 
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worsens its prognosis, physicians have a low threshold to perform a lumbar 
puncture in patients with meningeal signs and to start empirical antibiotic 
treatment in those with an increased cell count in cerebrospinal fluid (CSF), 
Hence, lumbar punctures and empirical treatment that are performed in these 
children may, to some extent, be regarded UIlIlecessary in retrospect. To improve 
their management, a diagnostic decision rule was developed in a previous study 
to guide decisions on the performance of a lumbar puncture and on starting 
empirical antibiotic treatment for bacterial meningitis in children with meningeal 
signs, which showed good performance. 5,6 The question remained, however, 
whether this rule could be applied to other clinical settings. 7-9 The aim of this 
study was to evaluate prospectively the performance of the rule in new patients 
with meningeal signs at the paediatric emergency department of four hospitals. 
Methods 
Patients 
The study was performed in the Sophia Children's Hospital Rotterdam (SCH; 
academic paediatric hospital), the Juliana Children's Hospital in The Hague (JCH; 
general paediatric hospital), and at the paediatric department of the Sint 
Fransiscus Hospital, Rotterdam and the Reinier de Graaf Hospital, Delft (both 
general hospitals; GH), The Netherlands. Children, aged from 1 month up to 15 
years, who visited the emergency department with the problem 'meningeal 
signs', without pre-existent neurological diseases were eligible for this study. The 
problem 'meningeal signs', was applied to children with pain in the neck in 
history, or referred by the general practitioner for meningeal signs, or in whom 
the paediatrician has assessed meningeal irritation. 5,6,10 To ensure the enrolment 
of all patients with 'meningeal signs' we checked the emergency department log 
during the study period. Patients were included in the period of November 1999 
to November 2000 (SCH andJCH during 12 months; GH 7 months). 
Decision rule 
The decision rule developed on 360 children suspected of having bacterial 
meningitis as admitted to the SCH between 1988 - 1998 5.6 included two scoring 
algorithms (see Appendix for details). The first algorithm (clinical score) aimed to 
guide decisions on the need of a lumbar puncture and assigned the patient points 
for each of six characteristics: 1 point for each day of complaints before 
presentation, 2 points for vomiting in history; 7.5 points for meningeal irritation at 
examination; 8 points for disturbed consciousness; 6.5 points for cyanosis; 4 
points for petechiae; and 0.5 points for serum CRP per 50 mg/l increase. The 
second algorithm (CSF score) aimed to guide decisions on initiating empirical 
treatment for bacterial meningitis and assigned the patient points for each of two 
cerebrospinal fluid (CSF) indices: 1 point for each IOlog(absolute CSF 
polymorphous cell count) increase and -0.5 points for CSF !blood glucose ratio 
per one-tenth increase. For example, a boy with complaints since half a day, who 
vomits, with meningeal irritation at physical exaruination, a serum CRP of 45 mg/l, 
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150 polymorphous cells in CSF/~l and a CSFlblood glucose ratio of 0.45, gets a 
clinical score of 10 (=0.5 + 2 + 7.5 + 0 + 0 + 0) and a CSF score of 0 (= 2 - 2). In the 
population the rule was derived on (further referred to as 'derivation set' 5.6), a 
threshold value of a clinical score < 9.5 identified patients in whom a lumbar 
puncture could be omitted without missing one case of bacterial meningitis. In 
patients with a clinical score of 9.5 - 10.4, a CSF score of:::: I identified patients in 
whom empirical treatment was indicated; for those with clinical scores between 
10.5 - 12.9 or 13.0 - 19.9 the lower CSF thresholds for empirical treatment were:::: -
2 and :::: -3, respectively. All patients with a clinical score:::: 20 had an indication 
for empirical treatment, irrespective of the CSF score. For further information on 
the derivation and validation of the decision rule we refer to previous 
publications. 5.6 
Data collection 
During the prospective application of the rule, all items of the rule and some 
additional general characteristics, symptoms, signs, and laboratory tests were 
collected. Duration of the main problem was defined as the duration of the 
complaint that was reason for referral (rounded to half days). Vomiting was 
scored positive if mentioned in patient history during the disease period. 
Meningeal irritation was defined as presence of Brudzinski sign I or II, Kernig 
sign, tripod phenomenon or neck stiffness in children older than one year and in 
children younger than one year as the presence of one of these signs or irritability 
during manipulation of head or legs or a bulging fontanel. 10 For consciousness 
four levels were distinghuised: alert - reaction to voice - reaction to pain - no 
reaction; disturbed consciousness was considered in case of reaction to pain only, 
or worse. Petechiae or ecchymoses were defined present if documented at 
presentation, not causally explained by excessive cough, crying or manipulation. 
Cyanosis was based on clinical judgement. 
The outcome diagnosis was the presence of bacterial meningitis, defined as the 
presence of elevated leukocyte count (> 5 cells!~l) in cerebrospinal fluid (CSF) of 
a non-traumatic puncture and a positive bacterial culture of CSF or blood. 2 
Elevated CSF leukocyte count with viral growth in CSF or faeces or positive viral 
serology was considered as a case of viral meningitis and absence of any isolated 
pathogen as a case of aseptic meningitis. 11 Final diagnoses other than meningitis 
were determined by either bacteriologic cultures of blood, urine, stool and ear, 
nose, or throat specimens or based on a consensus diagnosis, including a one-
week outpatient follow-up. 10 To the latter aim, data on recovery of non-
hospitalised patients were collected at their control visit or by telephone call 
within 3 - 7 days after first admission by one of the paediatricians (in training) or 
the research fellow. 
Before applying the rule, the paediatrician was asked whether or not he or she 
would perform a lumbar puncture in the patient. Subsequently, the treating 
physician estimated the clinical score for each patient. The true decision to 
perform a lumbar puncture, however, was still left to the physician's opinion, as 
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the aim of this study was not to implement the rule but first to validate its 
performance in other patient populations. The same procedure was followed for 
the CSF score. 
Analysis 
The two scoring algorithms included in the decision rule were evaluated 
separately. First. the discriminative value of the clinical algorithm was assessed in 
the new population (further referred to as 'validation set') using the area under 
the receiver operator characteristic curve (ROC-area) and compared with results 
of the derivation study. 12 As in the derivation study, we also defined a lower 
threshold below which no case of meningitis occurred. Then, on all patients with a 
clinical score higher than this threshold, i.e. with an indication of lumbar 
puncture, the CSF scoring algorithm was validated using the ROC-area. As ROC-
areas are not directly interpretable in terms of absolute patients numbers 13, we 
finally estimated the number of correctly diagnosed patients across categories of 
both scoring algorithms and compared these numbers with the derivation set. 
Results 
The validation population comprised 176 patients: 103 of]CH; 59 of SCH; and 14 of 
GH. A lumbar puncture had been performed in 108 (61 %) children (Figure 1). 
~ 
Lumbar puncturo 
n"108 
"-... Outpatlont follow-up 
S61:5 
SLD: 29 
\ / 
No lumb~r 
-
Outpn~()rrt follow-up 
S81:3 Duncturo. n"68 SLD: 50 
~ 
Figure 1 Flow chart of applied management to the 176 children with meningeal signs 
BM: bacterial meningitis; SBI: serious bacterial infections (other than BM); 
SLD: self-limiting diseases 
Eighty-seven children with early discharge (with or without lumbar puncture, 34 
and 53, respectively) recovered uneventfully, as documented during the 
outpatient department visit or telephone call. Eight children lacked follow-up. The 
patients' main characteristics are presented in Table 1 and compared with those 
of the derivation set. Patients in the validation set presented less frequently with 
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petechiae or a disturbed consciousness and were less frequently hospitalised 
than those in the derivation set. Although children were rather equally referred 
with meningeal signs by the general practitioner, the paediatrician confirmed 
presence of meningeal irritation less frequently in the validation set (56 of I II; 
50%) than in the derivation set (133 of 203; 66%). The frequency of bacterial 
meningitis in the validation set was substantially lower than in the original 
population (II % and 28%, respectively). 
Table 1 General characteristics of deriVation and validation set. 
Characteristic Derivation set 
Male gender 
Age (years) § 
Referral General practitioner 
Self referral 
Other 
Neck stiffness in patient history 
Referred with meningeal irritation by 
general practitioner 
Meningeal irritation assessed by 
paediatrician 
Fever in history 
Vomiting in history 
Duration main problem (days) § 
Body temperature at examination (OC) " 
Petechiae at examination 
Disturbed consciousness 
Cyanosis 
Serum CRP (rngll)' 
Hospitalisation 
Diagnosis Bacterial meningitis 
Serious other bacterial 
infection i· 
(n=360) 
225 (63%) 
2.4 (0.8 - 5.3) 
286 (79%) 
42 (12%) 
9 (3%) 
168 (47%) 
203 (56%) 
256 (71 %) 
330 (92%) 
182 (51 %) 
1 (1 - 2) 
39.2 (Ll) 
39 (11 %) 
83 (23%) 
10 (3%) 
54 (14-151) 
218 (61 %) 
99 (28%) 
36 (10%) 
Validation set 
(n=176) 
118 (67%) 
2.2 (0.5 - 6.0) 
132 (75%) 
34 (19%) 
9 (5%) 
79 (45%) 
111 (63%) 
102 (58%) 
161 (92%) 
89 (51 %) 
1 (1- 2) 
38.9 (Ll) 
24 (14%) 
14 (8%) 
2 (1%) 
18 (8-71) 
79 (45%) 
20 (11 %) 
40 (23%) 
Viral/aseptic meningitis 44 (12%) 21 (12%) 
Other self-limiting disease* 181 (50%) 95 (54%) 
§median (25th and 75th percentiles); "mean (standard deviation) 
tincluding septicaemia, pneumonia, urinary tract infection and bacterial gastro-enteritis 
*including upper respiratory tract infections, viral syndromes 
The ROC-area of the clinical score was 0.86 (95% CI: 0.81 - 0.94), which was little 
lower than in the original data set (ROC-area 0.94; 95% CI: 0.91 - 0.96).5 Table 2 
presents the observed frequency of bacterial meningitis in the validation set in 
categories of the clinical score and the expected number using the probability as 
predicted by the logistic model underlying the clinical score. No large 
differences were found between the observed and predicted number of patients 
with bacterial meningitis within categories of the clinical score. 
The validation of the CSF scoring algorithm was performed on all children with an 
indication of a lumbar puncture, based on their clinical score. Since bacterial 
meningitis was absent in all patients with a score < 8.5, we used this threshold for 
selecting patients in need of a lumbar puncture (n = 99; Table 2). The ROC area of 
the CSF score was 0.95 (95% CI: 0.89 - LO), which is similar to the ROC area in the 
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derivation set (0.93; 95% CI: 0.89 - 0.97). 6 Table 3 presents the observed 
frequency of bacterial meningitis in the validation set according to the CSF score 
and the expected number using the probability as predicted by the logistic model 
underlying the CSF score. In the third category of the CSF score (score -1.5 to -
0.5), the expected number was higher than the observed (7 versus 2, 
respectively) . 
Table 2 Validation of the clinical score 
Number of patients 
Observed prevalence of 
EM, n (%) 
Expected prevalence of 
EM, n (predicted 
probability" in %) 
0-4.9 
61 
0(0) 
0(0.3) 
5.0 - S.4 
16 
0(0) 
0(0.2) 
Clinical score 
S.5 - 14.9 
78 
10 (12.S) 
9 (11.6) 
BM: bacterial meningitis; n: number of patients with EM 
"Predicted probability as estimated by the logistic model 
15.0 - 19.9 > 20.0 
16 5 
6 (37.5) 4 (So.o) 
9 (5S.7) 4 (90.9) 
We validated the threshold values of the clirical and CSF score for the indication 
of a lumbar puncture and for empirical treatment, as defined in the derivation set, 
in the new population. The lowest clirical score observed in children with 
bacterial meningitis in the validation population was 8.5, somewhat lower than the 
one observed in the derivation population. In Figure 2, the adjusted threshold 
values for the clirical and CSF score are presented, to set the need for a lumbar 
puncture or empirical treatment, such that no case of bacterial meningitis would 
be missed in the validation set. A clirical score threshold value of 8.5 selected 77 
children (44%) with a clirical score < 8.5, in whom a lumbar puncture could be 
withheld, and increased the prior probability of bacterial meningitis in all 176 
children with meningeal signs (201176: 11 %) to 20% (20/99) in those selected for 
a lumbar puncture (clirical score 2 8.5). Additional use of the CSF score further 
improved patient management by correctly withholding empirical antibiotic 
treatment in 48 of the 99 patients selected for lumbar puncture (48%), without 
missing one case of bacterial meningitis. 
Table 3 Validation of the CSF score in patients with a clinical score> 8.5 (n-99) 
CSFscore 
66 
<~3 ~3to-1.0 -1.5to~0.5 >0 
Number of patients" 12 25 20 16 
Observed prevalence of 0 (0) 1 (4.0) 2 (10.0) 13 (S1.3) 
EM, n (%) 
Expected prevalence of 0 (2.6) 2 (S.7) 7 (33.3) 12 (75.3) 
EM, n (predicted 
probabilityt in %) 
BM: bacterial meningitis 
"n=73, since cases with missing values (n=26) are excluded 
t Predicted probability computed by mean of probabilities as predicted by the logistic 
model 
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Discussion 
The principle aim of diagnostic protocols is to apply them in clinical practice and 
to improve patient management. Clinical prediction rules may, however, not 
perform as well in new settings, as they had had in the settings in which they were 
developed. 8.14.15 Therefore, prospective validation of a rule should inform about 
whether the rule reflects true associations rather than the play of chance or 
statistical 'overfitting' and whether they can be applied appropriately in practice. 
In this present study, we have validated a diagnostic decision rule, as previously 
derived, to guide two questions in children presenting with meningeal signs, i.e. 
when to perform a lumbar puncture, and when to start empirical antibiotic 
treatment, without missing a single case of bacterial meningitis. In a new group of 
176 children visiting the emergency department with meningeal signs, the 
scoring algorithms of this rule using symptoms and signs at presentation and 
early available laboratory tests from blood and cerebrospinal fluid appears to be 
valid. 
In 26 patients (of whom three with bacterial meningitis) the CSF score could not 
be computed due to missing values for either the CSF cell count, or glucose 
concentration in CSF or serum for laboratory techuical reasons. These patients 
were excluded from further analysis, which may explain part of the difference 
between the observed and expected number of cases (Table 3). 
In the validation set two children with bacterial meningitis had a clinical score of 
8.5, and would have been missed using a threshold value of 9.5 (as defined on the 
derivation set) for performing a lumbar puncture. One was a 34-days old boy, 
prematurely born, and thus at the borderline of the age criteria of our rule 
(patients aged from one month up to 15 years). He had a one-day history of 
complaints, meningeal irritation at physical examination, and a serum CRP of 2 
mg/l. CSF contained 11,310 cells/~I (90% polymorphonuclear cells) and the 
CSFlblood glucose ratio was 0.49. E. coli was isolated from CSF. The other was a 
6-month old bOY, with complaints since half a day and a generalised seizure of 10 
minutes. During examination, he developed a second generalised seizure. Serum 
CRP was 68 mg/l, and CSF contained 2,700 cells/~I (polymorphonuclear cells 
only); CSFlblood glucose ratio was 0.61. S. pneumoniae was isolated from CSF 
and blood. Obvious, the combination of seizures and meningeal signs is very 
indicative of bacterial meningitis. In a population of children with meningeal signs 
as the main symptom, however, seizures occur too infrequently to be included in 
a diagnostic prediction rule. Hence, based on these findings in the validation 
study, we have adjusted the former threshold values for the clinical and CSF 
score, such that no children with bacterial meningitis will be missed in future use 
of the rule. 
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Figure 2 Distribution with and without bacterial meningitis across categories of both 
BM- = 77 BM- =48 
Neither indication for lumbar uncture nor treatment 
Indication for lumbar uncture, but no indication for treatment 
Indication for lumbar uncture and for treatment 
Some comments on the use of the rule and its generalisability need to be made. 
First, in this validation study, the prevalence of bacterial meningitis in children 
with meningeal signs has reduced substantially, compared to the population the 
rule was derived on. This may be due to the routine Haemophilus type B-
vaccination of infants, as introduced in the Netherlands since 1996. 16,17 Since the 
value of a prediction rule may be affected by differences in disease prevalence in 
different populations 18-20, we estimated the performance of both the clinical and 
CSF algorithm, after adjusting for this difference in prevalence, i.e. adjusting the 
intercepts of the two original logistic regression models 5,6, from which the 
scoring rules in the appendix were derived, These adjusted models, however, 
yielded similar ROC-areas as the (unadjusted) scoring rules in the appendix, In 
addition, the adjustment did also not improve the predictive accuracy in terms of 
absolute number of patients. Therefore, we think that an adjustment for 
differences in disease-prevalence does not necessarily have to be included in the 
scoring algorithms of the appendix. Second, the derivation of the rule was based 
on retrospectively collected data, but data were prospectively collected during 
validation. The rule, however, performed similar in the validation set compared to 
the derivation data. Therefore, we think that the rule including the symptoms and 
signs as we defined, is well applicable in practice, Third, since the rule aims to 
guide the diagnostic process before the diagnosis is known (conform practice), 
we selected patients by their clinical presentation, i.e. patients visiting the 
emergency department with meningeal signs. It should be noted that this rule 
does not apply to all patient suspected of having meningitis, since patients with a 
prominence of other symptoms of meningitis (such as coma, convulsions, etc. 1,2) 
are not included in our study population. Finally, the rule was derived in an 
academic paediatric hospital (receiving about 90% basic paediatric care 21) but 
validated in four hospitals, including three non-academic ones, with their 
particular patient populations. Since the rule performed well in all hospitals, we 
state that the rule is applicable to paediatric emergency departments in general, 
In conclusion, a diagnostic decision rule for children with meningeal signs proved 
to perform well in a newly selected group of patients. Using this rule, patients can 
be classified in groups of increased probability of bacterial meningitis. This 
diagnostic decision rule can be used as a tool for the clinician to guide decisions 
on the performance of a lumbar puncture or initiating empirical treatment in 
children with meningeal signs in order to improve their management. 
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APPENDIX Contents of the diagnostic decision rule 
la Clinical scoring algorithm 
Characteristic 
Duration main problem in history 
Vomiting in history 
Meningeal irritation at physical 
examination 
Cyanosis at physical 
examination 
Petechiae at physical 
examination 
Disturbed consciousness at 
physical examination 
Serum CRP (mgll) 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
<SO 
50-99 
100 -149 
ISO - 199 
>200 
Total clinical risk score (sum of scores) 
Points assigned if 
characteristic 
present 
I per day (max 10) 
2 
a 
7.5 
a 
6.5 
a 
4 
a 
8 
a 
a 
0.5 
1.0 
1.5 
2.0 
Patient 
score 
Ib Cel'ebrospinal fluid (CSF) scoring algorithm. 
Characteristic 
CSF polymorphous cell count 
(per ~I) 
CSF !blood glucose ratio 
Total CSF score (sum of scores) 
< 10 
10 - 99 
lOa - 999 
1000 - 9999 
> 10.000 
< 0.1 
0.1 - 0.19 
0.2 - 0.29 
0.3 - 0.39 
0.4 - 0.49 
0.5 - 0.59 
0.6 - 0.69 
0.7 - 0.79 
0.8 - 0.89 
0.9 - 0.99 
> 1.0 
Points assigned if Patient 
characteristic score 
present 
a 
I 
2 
3 
4 
a 
-0.5 
-1.0 
-1.5 
-2.0 
-2.5 
-3.0 
-3.5 
-4.0 
-4.5 
-5.0 
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Abstract 
In this study we evaluated retrospectively the neurological outcome of bacterial 
meningitis in children initially presenting with meningeal signs. 
Data were collected from 103 patients, aged from one month up to 15 years, 
who initially visited the emergency department of a paediatric hospital in the 
Netherlands with meningeal signs and in whom bacterial meningitis had been 
diagnosed. 
We found a 2% mortality in children with bacterial meningitis, and a 13% 
morbidity among survivors: 7% hearing impairment and 6% neurological 
sequelae. The worst prognosis was associated with S. pneumoniae and the 
presence of acute focal neurological symptoms. A substantial decrease in 
meningitis was found after the introduction of the H. influenzae vaccination, but the 
relative occurrence of sequelae remained the same. N. meningitis was the 
dominant pathogen of meningitis. 
An adverse outcome was observed in 15 % of children with bacterial 
meningitis, mainly depending on the pathogen type. Due to different pathogen 
occurrence frequencies, however, pathogens contributed in similar proportions 
to the absolute numbers of sequelae. 
Introduction 
Bacterial meningitis has a large impact on health care in childhood, since it still 
causes substantial mortality and morbidity, in spite of adequate treatment. 1 
Similar to other countries z, inclusion of the vaccination for H. Influenzae (HIB) in 
the standard vaccination programme in the Netherlands since July 1993, has lead 
to a substantial decrease of the incidence of meningitis. 3.4 Its effect on the 
mortality and morbidity after childhood bacterial meningitis, however, remains to 
be evaluated. Alterations of the pathogen spectrum may influence the prognosis 
of bacterial meningitis, since the pathogen is known to be related to the 
occurrence frequency of sequelae. 1.5 
In this study we evaluated the frequency, type and combinations of sequelae after 
bacterial meningitis in children presenting with meningeal signs in relation to 
pathogen type and the introduction of HIE vaccination. 
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Methods 
This study was executed as part of large study on the diagnosis and prognosis of 
367 children, aged one month to 15 years, visiting the paediatric emergency 
department of the Sophia Children's Hospital between 1988 - 1998 with meningeal 
signs. 6.7 In this study we evaluated 103 cases of bacterial meningitis. We 
collected clinical characteristics and results from laboratory tests at presentation, 
during hospitalisation and from follow-up visits in the first year after diagnosis. 
Children with severe pre-existent neurological diseases were excluded. Bacterial 
meningitis was defined as bacterial growth in cerebrospinal fluid (CSF) or blood 
with > 5 leukocytes/~l in CSF. 5.7 If antibiotics were used before performing a 
lumbar puncture, patients with an increased CSF leukocyte count and a negative 
bacterial culture were considered to have pre-treated bacterial meningitis if they 
were subsequently hospitalised and treated with antibiotics for at least seven 
days. 7.8 Presence or absence of neurological sequelae was determined based on 
neurological examination as documented in the patient record during follow-up 
visits. Hearing function was assessed during follow-up using conventional 
behavioural pure tone or brainstem electric response audiometry. The following 
sequelae of bacterial meningitis persistent after 6 months after diagnosis were 
distinguished: 1) Hearing loss: unilateral or bilateral retrocochlar or cochlear 
hearing loss" 30 decibels (severe loss: bilateral loss " 70 decibels), 2) Locomotor 
deficits assessed by neurologist, 3) Abducens or ocu10motorius nerve palsy, 4) 
Epilepsy: indication for anti-epileptic drugs after a first seizure or repeated 
seizures without fever after hospitalisation and 5) Retardation: delay >6 months in 
psychomotor and mental development. 1 
Frequencies of sequelae and death after bacterial meningitis were computed with 
95% confidence intervals (95% CI). In order to evaluate the effect of vaccination 
to H. influenzae, an analysis was performed for the pathogen types separately, and 
on the periods from 1988 up to June 1993 and from July 1993 up to 1998, 
separately. 
Results 
Results were based on 103 children with bacterial meningitis: 51 boys (50%), 
median age 2.5 years (inter quartile range 1.0 - 5.1 years). N. meningitidis (NM) 
was identified in 51 (50%; 95% CI: 40 - 59%), S. pneumoniae (SP) andH. influenzae 
(HlB) in 10 (10%; 95% CI: 5 - 17%) and 34 (33%; 95% CI: 24 - 42%), respectively. 
Other pathogen types (n = 8, 8%; 95% CI: 3 - 15%) included six pre-treated cases 
of bacterial meningitis, one with Streptococcus sanguis and one with Streptococcus 
group B. Acute focal neurological symptoms (abducens nerve palsy, limb paresis, 
pathologic Babinsky sign, fixed head position) were present in 12 children (12%), 
and seizures in 14 (14%): six before hospital adruission only, six upon 
presentation and in two occurring within the first 24 hours in hospital. The median 
duration of hospitalisation was 12 days (interquartile range 10 - 15 days) and 46 
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children (45%) were admitted to the intensive care unit. The empirical antibiotic 
treatment consisted of a third generation cephalosporin in all patients (either or 
not combined with amoxicillin), except for four patients receiving amoxicillin with 
chloramphenicol. Dexamethason treatment was not given to any patient. Two 
children died during the acute phase of bacterial meningitis (one from acute 
neurological complications, one from multi-organ failure). The median duration of 
follow-up of survivors as available from the patient records was 6.7 months 
(interquartile range 3.1 - 12.2 months). In 13 patients persistent neurological 
sequelae were assessed during follow-up. Sequelae included deafness in one 
child (1%), mild hearing loss in six (6%), mental retardation in five (5%), 
persistent palsy of the abducens nerve in three (3%), locomotor deficits in three 
(3 %) and epilepsy in one (1 %). A description of the type of sequelae in individual 
patients is presented in Table 1. 
Table I Frequency of neurological and audiological sequelae among survivors 
of bacterial meningitis (n::::;lOl) 
Description of sequelae 
Deafness 
Mild hearing loss 
Mild mental retardation 
Palsy of nervus abducens 
Mild hearing loss and mild mental retardation 
Severe mental retardation and locomotor disorders with 
either epilepsy or palsy of nervus abducens 
Nurnberof 
patients 
(%; 95% CI) 
1 (1%;0-5%) 
5 (5%; 2-11%) 
2 (2%; 0-7%) 
2 (2%; 0-7%) 
1 (1%; 0-5%) 
2(2%;0-7%) 
In Table 2 the occurrence of mortality and morbidity of bacterial meningitis is 
presented for the pathogens separately. S. pneumoniae was related to the highest 
mortality and morbidity. In the period from January 1988 up to June 1993, 78 cases 
of bacterial meningitis occurred (NM: 31; SP: 7; HIB: 32; other: 8), from June 1993 
up to December 1998 only 25 cases (NM: 20; SP: 3, HIB: 2). The frequencies of 
sequelae for these periods were 13% (95 CI: 6 - 22%) and 20% (95% CI: 7 - 41 %), 
respectively. Although N. meningitidis had the lowest mortality and morbidity 
rate, it substantially contributed to the total morbidity and mortality in absolute 
numbers of patients, due to its frequent occurrence. 
Table 2 Mortality and morbidity after bacterial meningitis related to the pathogen. 
Pathogen Mortality Hearing loss Neurological Total sequelae 
N (%/ffi N (%):[: sequelae; N (%):[: N (%; 95% CI)* 
N. meningitidis 1 (2%) 1 (2%) 2 (4%) 3 (6%; 1-17%) 
(n = 51) 
S. pneumoniae 1 (10%) 2 (22%) 3 (33%) 5 (56%; 21-86%) 
(n = 10) 
H. infIuenzae 0 3 (9%) 1 (3%) 4 (12%; 3-28%) 
(n = 34) 
Other (n::::; 8) 0 1 (11 %) 1 (11 %) 1 (11 %; 0-48%) 
All (n - 103) 2 7 6 13 
(2%; 0 -7%) (7%; 3 -14%) (6%; 2 -13%) (13%; 6 -19%) 
!3percentage among all 
*percentage among survivors 
'lrdeath causes: acute neurological complications and multi-organ failure. 
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In children with focal neurological symptoms or seizures in the acute phase (n = 
26), four had neurological sequelae in follow-up and four hearing loss (n = 8; 31 %; 
95% CI: 14 - 51 %). No differences in frequencies of sequelae were found between 
those with acute focal neurological symptoms and those with seizures. In children 
without focal neurological symptoms or seizures in the acute phase (n = 77) two 
children died during hospitalisation (2.6%; 95% CI: 0 - 9%), two had neurological 
sequelae in follow-up and three hearing loss (n = 5; 7%; 95% CI: 2 - 15%). 
The median duration of complaints before the presentation was 1.0 day 
(interquartile range: 0.5 - 3.0) in patients with neurological sequelae or hearing 
loss and 1.0 days (interquartile range: 1.0 and 3.0) in those without. Duration of 
fever before presentation was also similar in patients with and without sequelae: 
1.5 days (interquartile range: 0.5 - 4.0) and 1.5 (interquartile range: 1.0 - 3.0), 
respectively. 
Discussion 
In children with bacterial meningitis who initially presented themselves with 
meningeal signs, we found 2% mortality and 13% sequelae among survivors, 
including in 7% hearing impairment and 6% neurological sequelae. Neurological 
sequelae often occurred combined with each other, whereas hearing impairment 
was mainly present as isolated sequelae. Patients with focal neurological 
symptoms or seizures in the acute phase tended to have sequelae in follow-up 
more often than those without. S. pneumoniae was related to the highest 
occurrence frequency of sequelae. In absolute numbers, however, N. meningitidis 
contributed to a similar number of sequelae. Therefore, follow-up strategies of 
children with bacterial meningitis should include all cases, and not children with 
known risk factors only. 
A substantial decrease in meningitis was found in our hospital after the 
introduction of the HIB-vaccination (25 versus 78 patients, both in a 5.5 years 
period). The relative frequency of sequelae, however, remained similar. Since in 
this study patients were treated similarly, we think that the incidence of sequelae 
is not influenced by changes in treatment over time. 
Although this study is based on small numbers, most findings in this study agree 
with previous reports. 1,9~12 We could not confinn an association between the 
duration of complaints or fever and mortality and morbidity. In literature 
controversial results are present on this association. 10,13,14 The mortality rate in 
this study is somewhat lower compared to others. This may result from our 
inclusion criteria, i.e. patients initially presenting themselves with meningeal 
signs. Subsequently, other presentations such as the predominance of seizures or 
coma, which are known to be related to a worse outcome, are not included. 5,10 
The overall occurrence of hearing impairment in our study is also lower 
compared to others. This may be the effect of the decrease in HIB-meningitis, 
76 
Prognostic aspects of bacterial meningitis 
which is relatively more frequently related to audiological than neurological 
sequelae. 1 Although neurological sequelae are known to occur concomitantly in 
patients after bacterial meningitis, most reports on occurrence of sequelae after 
meningitis report occurrence rates per type of sequelae. 1.15.16 Quantification of 
outcome after meningitis in terms of health related quality-of-life, as is necessary 
in cost-effectiveness analyses, requires specific descriptions of combinations of 
sequelae and their frequency of occurrence in patients. Although based on small 
numbers, the results of Table 1 may be of value for this aim. In this study, minor 
sequelae such as behaviour problems and mild learning or attention disorders 
were not addressed. Information on these mild sequelae is much less precisely 
documented routinely in the patients' record, in contrast to the neurological 
examination and hearing test results. As we used retrospectively collected data, 
these mild sequelae are more likely to be missed. 
In conclusion, we found a 2% mortality rate in children with bacterial meningitis, 
initially presenting with meningeal signs, and a 13% morbidity rate among 
survivors. The worst prognosis seems to be associated with S. Pneumoniae and the 
presence of acute focal neurological symptoms. A substantial decrease in 
meningitis was found after the HIB-vaccination, but the relative occurrence of 
sequelae remained the same. N. Meningitis is the dominant pathogen since the 
introduction of HIE-vaccination and substantially contributed to the absolute 
number of patients with sequelae. Therefore, follow-up strategies of children with 
bacterial meningitis should include all cases, and not children with known risk 
factors only. 
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Abstract 
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In this study, we determined independent predictors of the occurrence of 
permanent neurological sequelae or death after the onset of childhood bacterial 
meningitis, 
Data were used from a large study on children (I month up to 15 years), 
initially presenting themselves with meningeal irritation, A nested case-control 
study was performed on children with (n = 23) and without (n = 70) permanent 
neurological sequelae (hearing impairment, locomotor dysfunction, mental 
retardation or epilepsy) or death after bacterial meningitis, Predictors obtained 
from clinical evaluation and laboratory tests at presentation and during the 
clinical course were identified by multivariate logistic regression analysis and 
Receiver Operating Characteristic (ROC) curve analyses. 
The study population comprised 23 cases and 70 controls: 52% boys, median 
age 2.8 years. Independent predictors for an adverse outcome after bacterial 
meningitis were male gender, atypical convulsions in history, low body 
temperature at admission and the pathogen S. pneumoniae. The area under the 
ROC-curve of this rule was 0.87 (95% CI: 0.78 - 0.96), which was not improved by 
adding other characteristics. A scoring formula including these independent 
predictors could classify patients into categories with increased risk for an 
adverse outcome. 
Permanent neurological sequelae or death after bacterial meningitis in 
childhood can be predicted based on clinical characteristics available early in the 
clinical course. The pathogen type is the main prognostic determinant of 
childhood bacterial meningitis. 
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Introduction 
In spite of optimal intensive care facilities and antibiotic treatment, childhood 
bacterial meningitis still causes mortality and persistent neurological sequelae in 
about 5% and 10 - 20%, respectively. 1 Early prediction of an adverse outcome 
may help to determine which children require more intensive or longer follow-up. 
Furthermore, early prediction may provide the physician with a rationale for 
parental counselling about the prognosis of their child in an early phase of the 
disease. Prognostic outcome of individual patients can be estimated by the use of 
prediction rules that calculate the probability of occurrence of an adverse 
outcome as a function of (various) prognostic factors. 2 Although many studies 
have been performed on prognostic characteristics of children with bacterial 
meningitis 3-1\ their conclusions are different and sometimes contradicting. In 
addition, only few studies evaluated the independent value of predictors using 
multivariate analysis. Finally, most studies on prognosis include a substantial 
number of patients with meningitis caused by Haemophilus influenzae (RIB), which 
pathogen has nearly been eradicated since the introduction of routine 
immunisation of infants. 15 
The aim of this study was to determine independent predictors of neurological 
sequelae or death after childhood bacterial meningitis. With these predictors a 
prediction rule was derived for early classification of increased risk for 
neurological sequelae or death. 
Methods 
Patients 
The present study was executed as part of a large study on the diagnosis and 
prognosis of bacterial meningitis in children (aged from 1 month till 15 years) 
presenting with meningeal signs, who initially visited the emergency department 
of the Sophia Children's Hospital in Rotterdam or Juliana Children's Hospital in 
The Hague, The Netherlands, between 1988 and 1998. 16 From this population a 
cohort of all children who suffered from bacterial meningitis, was selected (n = 
170) , which formed the basis for the present nested case-control study. Bacterial 
meningitis was defined as presence of leukocytes > 5 cells/ ~l in cerebrospinal 
fluid (CSF) after a non-traumatic puncture, with a positive bacterial culture of CSF 
or blood. 16,17 If antibiotics were used before performing a lumbar puncture, 
patients with an increased CSF leukocyte count and a negative bacterial culture 
were considered to have (pre-treated) bacterial meningitis, if they were 
subsequently hospitalised and treated with antibiotics for at least 7 days. 16 
Meningitis cases caused by H. influenzae and patients with pre-existent 
neurological diseases were excluded from the study. 
For the present study, cases were defined as patients with neurological sequelae 
persisting for more than 6 months or who died after bacterial meningitis. The 
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following neurological sequelae were distinguished: 1) deafness (bilateral 
hearing loss> 70 dB), 2) mild hearing loss (hearing loss unilateral or bilateral > 
30 dB), 3) severe mental retardation with locomotor deficits 4) epilepsy (repeated 
seizures without fever or indication for anti-epileptic treatment after first afebrile 
seizure), 5) mild locomotor deficits as documented by the neurologist, 6) mild 
mental retardation and 7) a combination of these latter three. Patients were 
classified to one of the seven described sequelae, 'death' or 'complete health' by 
two independent paediatricians, using the available information from the patient 
record, radiological imaging and functional tests (EEG, hearing tests). Discordant 
classifications by the two paediatricians were judged by an independent third, in 
order to reach a final consensus on the prognostic outcome classification. Within 
the total cohort of 170 patients, 23 cases with neurological sequelae or death 
occurred. Seventy healthy recoveries (controls) were sampled from the 
remainder of the cohort (case control ratio 1:3; sample fraction 0.48). 
Potential predictors 
By review of the patient record and the computer documented hospital 
information system three categories of potential prognostic factors were obtained: 
I) data from patient history and physical examination obtained at admission, such 
as demographic data and presenting signs and symptoms; 2) data from laboratory 
tests of CSF, blood, stool and urine specimens available at admission and 3) 
clinical findings and laboratory data obtained during the hospital stay. In order to 
reduce the amount of potential predictors to be evaluated in this study, we only 
selected those that were previously reported to be prognostic determinants in 
childhood bacterial meningitis in the literature. 19 Since we were interested in 
prognostic predictors of childhood bacterial meningitis after introduction of the 
RIB only, studies among adults and on HIB-meningitis were excluded from this 
literature search. 
Data analyses 
The association between the presence and absence of neurological sequelae or 
death and each potential prognostic determinant was quantified using univariate 
logistic regression analyses. Subsequently, predictors that were univariately 
associated with the outcome (odds ratio with a p-value < 0.15) were included in a 
multivariate logistic regression model to evaluate their independent value in the 
prediction of outcome. 20 The multivariate analyses followed the order in which 
data are obtained in practice. 21 Model reduction was performed by excluding 
predictors from the model with p-values > 0.10, such that a reduced model was 
derived, including independent predictors of neurological sequelae or death. 
Reliability (goodness of fit) of the all models was estimated using the Hosmer & 
Lemeshow test 22, and their prognostic ability to discriminate between patients 
with and without adverse outcome using the area under the Receiver Operation 
Characteristic curve (ROC-area). Difference in prognostic ability between models 
was estimated by difference in ROC-area with 95% confidence intervals (95% CI), 
taking into account the correlation between models as they were based on the 
same cases. 23,24 
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To reduce bias and increase statistical efficiency and to account for uncertainties 
in imputed data, multiple imputation was used for missing values in the data. 25,26 
To estimate the prognostic ability of the final model in future but similar patients, 
the model was validated by random bootstrapping techniques. 20,27 The final 
model was then transformed into a scoring rule by dividing the regression 
coefficients of the included predictors by the smallest one and rounding them 
subsequently to the nearest integer. A total risk score was computed for each 
individual patient by assigning points for each predictor present. Next, patients 
were classified according to their risk score and the absolute numbers of 
mortality and morbidity among categories of risk scores were evaluated. 
Results 
The general characteristics of all 93 children presenting with meningeal signs are 
presented in Table 1. The number of cases with neurological sequelae or death in 
the total cohort (n = 170) was 23: a prevalence of 14% (95% CI: 8 -19%). Of the 23 
cases, two died (8.7%), six were deaf (26.1 %), eight children had mild hearing 
loss (34.7%), four had severe retardation (17.4%) and three had epilepsy, mild 
locomotor deficits or mild mental retardation (13.0%). 
Table 1 General characteristics (n = 93) 
Characteristic Number(%) * 
Age (years)"t 
Male gender 
Admission to intensive care unit 
Pathogen type 
S. pneumoniae 
N. meningitidis 
Other~ 
Duration follow-up (years)"t 
Outcome 
Complete recovery 
Deafness 
Mild hearing loss 
Epilepsy. mild locomotor deficits and/or mild 
mental retardation 
Severe mental retardation and tetraplegia 
Dead 
2.8 (0.9 - 5.8) 
48 (52%) 
50 (54%) 
16 (17%) 
64 (69%) 
13 (14%) 
0.6 (0.02 - 3.3) 
70 
6 
8 
3 
4 
2 
*'Values represent absolute numbers with % between parentheses; otherwise if stated. 
tMedian (range) 
:I: Other include group B Streptococcus (n = 2), Salmonella (n = 1), 
Streptococcus sanguis (n = 1) and pre-treated bacterial meningitis (n ::::; 9) 
Table 2 presents the results of our literature search from 1984 till 1999 on potential 
prognostic determinants of childhood bacterial meningitis predictors (excluding 
HIB-meningitis). Not all prognostic determinants were included in all studies, and 
the results were partially contradicting. The studies differed in their selection of 
the study population (defined by e.g. age, pathogen type or disease severity) and 
in the definition of the final outcome. 
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Overview of prognostic predictors after childhood bacterial meningitis from literature 
(1984 - 1999). 
Characteristic Associated Not associated 
with adverse with adverse 
outcome outcome 
Male gender 3,4 5,6,7,8 
Young age 5,9*.10 3,6,7,8,13 
Seizures before presentation 5,6,8,9* 4,7,10,14 
Longer duration of complaints 3,5,6,9 7,8, 11, 13 
Low body temperature 6,14 4,9* 
Coma! disturbed consciousness 7,9*,13 4,5,6, 10 
Shock 7,9,10 
Focal neurological deficits 3,5,9 8,13 
Petechiae 3 9* 
Meningeal signs/irritability 3,4 7 
Absence of meningeal signs 9 
Decreased serum sodium 5 6 
Low peripheral blood WEC 4 
High peripheral blood WEC 3, 13 
Low blood thrombocyte count 3 6 
Low CSF glucose 3,7,8 5,6, 10, 13 
High CSF protein 4,6,7,8, 13 
LowCSFWBC 3,6,7 4,5,8,10,13 
Low glucose ratio CSF /blood 7, 13 
Pathogen type 4 3,5,8 
Fever pattern in clinical course 14 5,12 
Duration of meningeal signs 14 
Seizures> 72 hrs 5 
WEC: white blood cell count; CSF: cerebrospinal fluid 
Numbers refer to studies as numbered in the reference list. 
Independent 
prognostic 
predictors in 
Eresent study 
Yes 
No 
Yes 
No 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
Yes 
No 
Yes 
No 
Studies concern all pathogens (except for ref. 7 and 13: S. pneumoniae cases only), on 
children from one month up to fifteen years (except for ref. 7: < 18 yrs; ref. 5 and 14: 
three months up to fifteen yrs; ref 4 and 11: children without age specification), with 
outcome including death and neurological sequelae (except for ref. 7, 9 (if marked with 
*),8,12 and 13: sequelae only; ref. 4: hearing loss only). 
In Table 3 the univariate significant correlates with neurological sequelae or 
death as found in this present study are presented (p < 0.15). Significant 
predictors from patient history were gender and the occurrence of atypical 
convulsions before admission (i.e. duration> 15 minutes, non-generalised jerks, 
incomplete recovery, or multiple convulsions within 24 hours). If age was 
dichotomised, the odds ratio for an adverse outcome in children younger than 
one year was 2.5 (p = 0.09) with reference to those older than one year. Duration 
of the disease or fever duration before admission were not related. At physical 
examination, significant correlates were body temperature, the presence of 
petechiae and focal neurological signs. Disturbed consciousness (reaction on 
pain ouly, or no reaction) was not related. From laboratory tests available at 
admission, ouly the protein concentration in cerebrospinal fluid (CSF) was 
associated with the outcome. Blood leukocyte or thrombocyte count, the CSF total 
polymorphonuclear cell count (PMN) or CSF !blood glucose ratio were not 
correlated. Significant correlates among data that come available after admission 
were pathogen type and insufficient respiration during clinical course, 
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convulsions MO days after admission, meningeal signs still present after three 
days of admission and time to the first afebrile day. Repeated laboratory tests, 
such as leukocyte count or absolute polymorphonuclear leukocyte count in blood 
or serum CRP concentration at the third or fifth day were not correlated with the 
outcome. 
Table 3 Univariate correlates (p < 0.15) with presence or absence of neurological sequelae or 
death 
Variable 
Patient history 
Male gender 
Age (years) t 
Atypical convulsions 
Physical examination 
Body temperature t 
Petechiae/ecchymoses 
Focal neurological signs 
Initial laboratory tests 
C5F protein (gil) t 
Pathogen 
S. pneumoniae 
N. meningitidis 
Other 
Clinical com:se 
Mechanical ventilation 
Anti-epileptica > 2 days 
Meningeal signs > 3 days 
Time to first afebrile day 
(daysy" 
Number 
of 
subjects* 
93 
93 
93 
92 
93 
93 
81 
93 
93 
91 
80 
74 
Sequelae 
present 
(n - 23) 
74% 
3.5 (4.2) 
30% 
38.2 (1.4) 
26% 
35% 
2.5 (1.6) 
43% 
48% 
9% 
35% 
35% 
30% 
2.6 (1.9) 
Sequelae 
absent 
(n -70) 
44% 
4.3 (3.9) 
7% 
39.2 (1.0) 
49% 
14% 
1.9 (1.7) 
9% 
76% 
15% 
4% 
1% 
9% 
3.3 (1.9) 
Odds 
ratio 
3.5 
0.9 
5.7 
0.5 
0.4 
3.2 
1.2 
9.1 
l.l 
RC 
11.9 
36.8 
4.7 
0.8 
p-value 
0.02 
0.40 
0.01 
0.01 
0.05 
0.03 
0.03 
0.01 
0.01 
0.01 
0.01 
0.14 
CSF: cerebrospinal fluid; RC: reference category; values represent percentages, 
otherwise if stated 
., number of subjects for whom the variable was obtained 
t mean and standard deviation between parentheses 
After stepwise multivariate analysis of univariate correlates according to the 
sequence they are obtained clinical practice, the independent predictors for an 
adverse outcome were male gender, presence of atypical convulsions in history, 
a lower body temperature at physical examination and the pathogen S. 
pneumoniae. The odds ratios and regression coefficients of these independent 
predictors after bootstrapping are presented in Table 4. Pathogen type was 
categorised in three groups (i.e. S. pneumoniae (SP) , N. meningitidis (NM) and 
others) and was included in the model as two indicator variables with the 
category 'other' as the reference. The ROC-area of this model was 0.87 (95% CI: 
0.78 - 0.96). 
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Table 4 Independent predictors of neurological sequelae or death after bacterial meningitis 
Odds ratio Regression Contribution 
(95% en" coefficient 4 to score * 
Male gender 4.4 (0.9 - 20.7) 1.48 2 
Atypical convulsions 9.7 (1.0 - 98.5) 2.27 3 
Body temperature (oG)' 0.5 (0.2 - 0.9) -0.75 -I 
Pathogen SP 22.6 (1.3 - 393.8) 3.12 4 
NM 4.4(0.5-41.7) 1.48 2 
ROG-area (95% GI) 0.87 (0.78 - 0.96) 
SP: Streptococcus pneumoniae, NM: Neissenoa meningitidis 
" Odds ratios and regression coefficients adjusted for overoptimism by bootstrapping 
tRegression coefficient::::: In(OR) 
t Risk score computed by dividing the regression coefficient by the smallest one 
(Leo body temperature; 0.15) and rounded to nearest integer. 
§ Odds ratio per u.n.it of °C (multiplicative), in total score -1 point is 'added' to the total 
score for each degree above 35.0 °e. 
Based on the regression coefficients (thlrd column in Table 4), a risk score was 
derived (fourth column in Table 4). By assigning points for each variable present, 
a total score was computed for each individual patient using the following 
formula: 
Score;;;;; 4 + 2 x male gender + 3 x convulsions - 1 x (body temperature - 35) + 4 x SP + 2 x NM 
In our population, the score ranged from 0.5 to !l.S and the ROC-area of this 
score was 0.87 (95% CI: 0.78 - 0.96). To obtain an estimate of the absolute 
incidence of sequelae across categories of the score in the total cohort, all control 
subjects were given a weight which was the inverse of the sampling fraction 
(weight = 2.1). 28 Hence, a new dataset was created which included all 23 cases 
and the weighted control group resembling the entire cohort (n = 170). Table 5 
shows the incidence of neurological sequelae or death for the cohort and the 
nuruber of subjects across selected categories of the score. Reading the table in a 
horizontal way, one can derive the predictive value for an adverse outcome per 
score category. For example, in none of the children with a score < 2.5 (15% of all 
subjects), neurological sequelae or death occurred (predictive value = 0%). In 
those with a score > 5.5, sequelae or death occurred in 44% (15/34). The 
sensitivity and specificity at different score thresholds can be derived by reading 
Table 5 vertically. E.g. a threshold score < 2.5 predicted 17% of all healthy 
recoveries (i.e. specificity of 17%), without missing one case with sequelae or 
death (i.e. sensitivity of 100%). Using a threshold score> 5.5, the sensitivity was 
65% with 13% false positives (specificity 87%). 
Table 5 Number of patients (%) with and without neurological sequelae or death 
in the original cohort across categories of the risk score. 
Risk score N* Patients with Healthy 
sequelae 
< 2.5 25 (15%) 0 
2.5 to 4.5 78 (46%) 2 (9%) 
5.0 to 5.5 33 (19%) 6 (26%) 
> 5.5 34 (20%) 15 (65%) 
Total 170 (100%) 23 (100%) 
"N - number of subjects per score category 
recoveries 
25 (17%) 
76 (52%) 
27 (18%) 
19 (13%) 
147 (100%) 
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Table 6 presents the frequency of the type of sequelae among categories of the 
risk score. The most severe sequelae and death occurred in patients with the 
highest predicted risk group. The rule, however, could not clearly differentiate 
between the different types of sequelae. 
Table 6 Risk stratification :eer type of se~elae 
Score Healthy" Deaf MIlL" Mild Severe Dead'" 
deficits* retardation'" 
<2.5 25 
2.5 to 4.5 76 2 
5.0 to 5.5 27 1 4 1 
>5.5 19 3 4 2 4 2 
Total 147 6 8 3 4 2 
:rv:tHL: mild hearing loss; Mild deficits: epilepsy, mild mental retardation or 
locomotor deficits 
"Values represent absolute numbers of patients per risk score category. 
Discussion 
We identified independent predictors of death or neurological sequelae after 
bacterial meningitis in childhood. A prediction rule based on male gender, 
atypical convulsions in history, body temperature at admission and the pathogen 
type could classify patients with an increased risk of sequelae or death. Early 
assessment of the prognosis by this rule may help the physician in parental 
counselling and defining the duration of follow-up in case of a predicted fair 
prognosis. In addition, the prediction rule allows for classification of patients with 
a similar risk of sequelae, as a function of various prognostic factors. For instance, 
a male subject without convulsions, with a body temperature of 39°C and N. 
meningitidis meningitis receives a score of 5 (= 5 + 2 + 0 + -4 + 2; Table 4), 
corresponding with a 18% risk for sequelae (6/33; Table 5), whereas a similar 
patient, but with convulsions and S. pneumoniae meningitis receives a score of 10 
(= 5 + 2 + 3 + -4 + 4), corresponding with a higher risk of 44% (15/33). 
Unfortunately, the type of sequelae could not be predicted by the rule. This 
probably results from the fact that the model was derived to predict a 
dichotomous outcome, including all types of sequelae and death together. Model 
derivation to predict an ordinal outcome, i.e. for different sequelae types 
separately, may lead to a better discrimination of types of sequelae. 29 Due to the 
limited number of patients with sequelae, however, this was not possible in the 
present study. 
The outcome of our prediction model combined neurological sequelae and death 
such that specific determinants of sequelae after survival of bacterial meningitis 
may not have been identified in this study. We therefore performed a sub-
analysis on survivors after bacterial meningitis only. This analysis yielded the 
same predictors, although determinants available later in the clinical course, such 
as the duration of meningeal signs for three days or more (OR = 4.1, p-value = 
0.09), seemed to be of additional importance. This modified prediction rule, 
however, neither improved the discrimination of patients with and without 
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sequelae (ROC-area = 0.87), nor the prediction of the type of sequelae, compared 
to the model (Table 4) derived on the outcome including death. 
We recognise that the classification of patients with increased risk of death and 
neurological sequelae by the rule is not optimal, since in the highest risk category 
complete recovery still occurs in 56%. Differentiating between an 18% and 44% 
risk on sequelae may be of limited value in clinical practice. In a few patients, 
however, the risk of sequelae can be ruled out by the prediction rule. Although all 
children with bacterial meningitis require careful follow-up by hearing tests and 
neurological examinations, in these children with a very low risk on sequelae, 
follow-up can be shorter if initial hearing tests or neurological examination are 
normal. 
Validation of the model by bootstrapping techniques demonstrated that the 
prediction rule is robust. Before implementation of the model in clinical practice, 
however, the actual performance of this scoring rule should be proven by using 
this rule in a new group of children with bacterial meningitis. 27,30 A future study is 
planned to validate this scoring rule in similar children with bacterial meningitis, 
initially presenting with meningeal signs. 
We observed substantial differences in the results of previous studies on 
prognostic characteristics of children with bacterial meningitis (Table 2). This 
may result from the differences in study population (defined by e.g. age, 
pathogen type or disease severity), from the potential predictors included in the 
analysis, and from different statistical methods (uni- or multivariate, or stratified 
analysis). Since the number of patients with sequelae in the study population is 
often limited, the power of a particular study to select important predictors is 
rather limited. In order to overcome this problem in our study, we combined the 
information available from the literature with our study results. As shown in the 
final column of Table 2, our results concord with previous studies. The fact that we 
did not find an association between age and outcome, in contrast to others 2,5,9,10, 
may be the result of the small age range in our study population (50% younger 
than 2.8 years). Another explanation may be that clinical signs correlated with age 
are included in our model, and therefore age itself does not contribute additional 
to these variables. Similar to previous reports 14, we did not find independent 
associations of repeated laboratory tests, such as blood leukocyte count or serum 
CRP at 3 or 5 days after admission with the prognosis. Although in practice these 
laboratory tests are repeatedly performed during the convalescent period, they 
do not have prognostic value. In this study we identified the pathogen type as one 
of the most important predictors for the prognosis after bacterial meningitis in 
childhood. The vaccination of HIB and subsequent decrease of meningitis caused 
by this pathogen, will lead to a relatively higher proportion of S. pneumoniae and 
thus to a subsequent higher risk of mortality and morbidity after meningitis. 
To appreciate the results of this study, some topics need to be further discussed. 
First, in this study, cases of HIB were excluded because of the decreasing 
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importance of this pathogen after the introduction or routine vaccination in infants. 
Most previous studies on prognosis included cases of HIB. Since the various 
clinical signs and symptoms may be related to a particular pathogen type, other 
studies with mixed pathogens may have revealed other associations. Second, this 
study was based on patients with bacterial meningitis who initially presented with 
meningeal signs. Cases of bacterial meningitis with a predominance of coma or 
convulsions, which may be associated with higher frequencies of morbidity and 
mortality 6-8, were not included. This inclusion criterion may explain the relative 
low base-line risk of sequelae and mortality (14%) as found in this study. Third, in 
this study we did not include sequelae such as amputations and scarring, which 
may occur in patients with meningococcal septicaemia with concomitant 
meningitis. These patients, however, present themselves with a predominance of 
septicaemia and petechiae, but not with meningeal signs. In addition, these 
sequelae have a different cause and therefore are related to other prognostic 
factors. 31 Fourth, the present study followed a nested case-control design for 
efficiency reasons. Hence, the baseline risk of a neurological sequelae or death 
(i.e. the intercept of the model) could not be directly estimated in contrast to the 
odds ratios (regression coefficients) of the predictors which are correct estimates. 
22 Therefore, we reported in Table 4 a transformed scoring rule which does not 
use the intercept (as it is equal for each subject anyway), but still enables 
classification of subjects according to their absolute risk of sequelae, based on 
differences in their risk profile (risk score). Moreover, the scoring rule is easier to 
apply in practice. The nuruber of points assigned to each predictor, if present, 
indicates its relative importance on the prognosis. Finally, minor sequelae, such 
as behaviour problems and mild learning or attention disorders were not 
included in the outcome in this study. This is because information about mild or 
subjective sequelae is much less precisely documented routinely in the patient 
record, in contrast to the neurological examination and hearing test results. The 
chlldren in our study (median age = 2.8 years) are much younger than school-
going age and therefore small deficits may not have been detected till the chlld 
started at school. 5 
In conclusion, permanent neurological sequelae or death after bacterial 
meningitis in chlldhood can be predicted using clinical characteristics available 
early in the clinical course. The pathogen type is the most important prognostic 
determinant of bacterial meningitis. Additional independent predictors of an 
adverse outcome are male gender, atypical convulsion in history, and body 
temperature at physical examination. Clinical characteristics or laboratory tests 
from the reconvalescent period do not improve the prediction of sequelae. 
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Abstract 
This study evaluated the preference scores ('utilities') for permanent sequelae 
after childhood bacterial meningitis, obtained with two different instruments: the 
EQ-SD and Health Utilities Index (HUI). 
Seven standardised case descriptions of patients with permanent sequelae 
after bacterial meningitis were classified on the EQ-SD and HUI classification 
system, respectively, by a panel of 28 paediatricians. Preference scores for each 
classification were calculated using the EQ-SD and HUI standard scoring 
algorithms. 
HUI Mark 3 preference scores were substantially lower than the EQ-SD for all 
case descriptions (mean difference 0.11; 9S% CI: 0.08 - 0.14). Mean Kendall W for 
agreement of the ranking order between EQ-SD and HUI Mark 3 was 0.90. For 
both methods, the procedure as a whole was sufficiently reliable. The EQ-SD and 
HUI resulted in different absolute preference scores, in particular for states 
associated with 'deafness' and 'mental retardation'. 
In studies focussed on 'sensation' (hearing, vision, speech) and / or 'cognition', 
the HUI may be preferable to EQ-SD. Furthermore, sensitivity analysis to 
preference scores is recommended. 
Introduction 
The call for evidence-based medicine requires quantification of health outcomes 
of diagnostic and therapeutic interventions in (cost-)effectiveness analysis. Health 
outcomes are commonly defined by two components, i.e. duration of life and 
health-related quality-of-life (or, in short, health status). The assessment of 
duration of life is technically straightforward. To take health status into account in 
effectiveness analysis, composite health outcome measures such as quality-
adjusted-life-years (QALYs) have been developed, combining the outcomes in 
terms of duration of life and health status using 'time' as the common 
denominator. In QALYs, years lived in an optimal health state count as 1.0, and 
years not-lived due to mortality as O. Years lived with a specified disability are 
combined with a preference score ('utility'), reflecting the relative severity of the 
disabled health state. 1.2 
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Currently two widely applied instruments are available to obtain such preference 
scores: the EQ-SD, developed by the EuroQol Group, and the Health Utilities 
Index (HUI), developed at the McMaster University in Hamilton, Canada, 3-5 Both 
provide 1) a patient questionnaire that classifies health status of patients through a 
multi-dimensional classification system, resulting in composite standardised 
health state descriptions and 2) a scoring algorithm based on external valuations 
to obtain a preference score (utility) associated with each particular health state 
description. 1.2,6 The scoring algorithms for both EQ-SD and HUI are based on 
valuations of subsets of health states by the general public. 
In a current study on children suspected for bacterial meningitis at the 
emergency department of a large paediatric hospital in the Netherlands, a 
diagnostic prediction rule for bacterial meningitis has been developed in order to 
reduce the amount of diagnostic procedures. 1 The cost-effectiveness of this 
diagnostic prediction rule from a societal perspective is being evaluated using 
decision tree analysis. Bacterial meningitis with adequate treatment still carries a 
mortality risk of 3 - 4% and a risk of 9 - 14% for neurological sequelae (about two 
thirds hearing impairment). These percentages are even lUgher in cases of 
delayed treatment. 8.9 The sequelae vary from complete deafness, localised 
neurological disabilities such as paresis or epilepsy, to severe mental retardation 
and tetraplegia. 10,11 To include the distal consequences of the diagnostiC 
prediction rule, in terms of an increase or a decrease of adverse outcomes in the 
decision tree, preference scores for permanent disabling sequelae after bacterial 
meningitis were needed. Both the EQ-SD and the HUI seemed potentially useful 
for thls aim and their particular strengths or weaknesses did not convince us in 
advance to prefer one above the other in deriving these preference scores. 12,13 
Although the short EQ-SD patient questionnaire is known to be completed easily, 
the HUI-1SQ appears to generate only little more effort (about S - 10 minutes 
completion time), and may result into a more comprehensive description of health 
status. 6 The effect of differences in the dimensional contents of the EQ-SD and the 
HOI on the resulting preference scores for health states at interest is not latown. 
We therefore conducted an empirical study including expert evaluation of 
representative narrative health-state descriptions by using both the EQ-SD and 
the HUI with the following aims: 1) empirical comparison of EQ-SD and HUI 
preference scores, and 2) obtaining preference scores for health states associated 
with neurological sequelae after bacterial meningitis. 
Methods 
Health-status measures 
The EO-SD includes a S-dimensional classification system, with three ordered 
levels of severity for each dimension (Appendix 1). The patient questionnaire 
consists of S questions that lead to a direct classification with regard to these 
dimensions. In total, 243 different health-state descriptions are possible. The S-
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item classification data can be converted to a preference score (utility) by a 
scoring algorithm. The standard scoring algorithm (the so-called York Al tariff) 
was derived from data of the York 'Measurement and Valuation of Health' study, 
in which 42 composite EQ-5D health states were empirically valued by 2,997 
persons using time-trade-off (TTO) as the valuation method, and subsequent 
linear regression modelling after a transformation of the TTO valuations. The 
scoring formula yields preference scores ranging from -0.594 (the worst 
imaginable health state) to 1.0. Anchor points are 'Healthy' (valued as '1.0') and 
'Dead' (valued as '0'). 3 
The Health Utilities Index Mark 2 version (HUl-2) consists of a descriptive system 
with six dimensions, i.e. sensation, mobility, emotion, cognition, self-care and 
pain with four to five levels for each attribute. The fertility dimension is optional. 
HUl-2 was originally developed for assessing the quality-of-life in childhood 
cancer. 5 The 6-dimensional HUl-2 classification allows for 24,000 different health-
state descriptions. A more recently developed system, complementary to the 
Mark 2 version, is the Mark 3 version (HUl-3), consisting of eight attributes with 
five to six ordered levels for each attribute (Appendix 2). HUl-3 allows for 972,000 
different health states. 4.14 The patient (or parent) HUl-15Q questionnaire consists 
of 15 questions. Completion of this questionnaire leads to classification of the 
patient (child) on both the HUl-2 and the HUl-3, that can be directly converted into 
a preference score by a scoring algorithm. Both HUl-2 and HUl-3 scoring 
algorithms are based on standard gamble and visual analogue scale scores 
obtained from a random sample of parents or children older than 16 years from 
the general population. For HUl-2, one scoring algorithm has been derived, with 
anchor points 'Healthy' (preference score '1.0') and 'Dead' (preference score '0'), 
allowing for negative valuation of health states worse than 'Dead' (minimum value 
-0.03). For the HUl-3, two algorithms are provided: the first (further referred to as 
HUl-3A) with anchor points 'Healthy' (preference score' 1.0') and the health state 
having the lowest level on each of the 8 attributes (named 'Pits', preference score 
'0'), with 'Dead' valued in between (0.22); the second (further referred to as HUl-
3B) with anchor points 'Healthy (preference score '1.0') and 'Dead' (preference 
score '0'), allowing for negative valuation of health states worse than 'Dead' with a 
minimum value of -0.36. 4.5 
Case descriptions 
Descriptions of the health states in narrative style were focussed on seven types of 
permanent sequelae after bacterial meningitis, selected on the basis of 
frequency, severity, and the availability of diagnostic criteria (i.e., excluding 
relatively 'vague' sequelae such as mild learning problems). The case 
descriptions were associated with: 1) deafness; 2) mild hearing loss; 3) epilepsy; 
4) mild mental retardation; 5) severe mental retardation combined with 
tetraplegia, 6) paresis of the leg, and 7) mild mental retardation combined with 
epilepsy and paresis of the leg. An additional description of a 'normal' child was 
provided as a reference case. All descriptions had a similar structure, and 
contained (in about 200 words) information on the domains mobility, self-care, 
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dally activities (school, hobbies, social activities), emotional state, and pain or 
other symptoms for a 6-year old child, based on literature and expert opinions. 
10,11,15,16 All case descriptions were judged on their consistency of structure and 
information on all domains, and followed by a detalled notification of their 
accuracy by experts (ear-nose and throat-physician, neurologist, one physician in 
a rehabilitation centre and one in a centre for mentally and/or physically 
handicapped children). An example of one case description is given in Figure I. 
A child, aged 6, suffers from total deafness after bacterial meningitis two 
years before. Despite a hearing-aid, his hearing function is minimal. He 
attends a special school for hearing-disabled children. At this school, he 
performs well. His vocabulary is adequate. Additionally, he has learned 
how to express himself through sign language, that he can use in 
conversations with relatives. He can vvrite his name, read and write simple 
words, count up to 20 and perform easy computations. Because he attends a 
special school. most of his school-mates live far from home, but he has 
some friends in the neighbourhood. He has troubles with playing games 
with his friends, because he does not hear them well and does not 
understand what they are talking about. He plays in the local football team 
weekly. He does not always understand the instructions given by the 
trainer, but then he imitates his team-mates. Apart from his hearing 
disability. he does not have other physical symptoms. Walking and running 
go without problems. He can wash and dress himself properly, knows how 
to tie his shoelaces and how to button up his shirt. In general he is a 
cheerful child. Sometimes. when he is understood wrongly by strangers 
because of his deafness, he feels angry. 
Figure 1 Case description (example) 
Respondents 
A convenience sample of 36 general paediatricians with several years of working 
experience was asked to participate in the expert panel. The paediatricians were 
working in one of the 7 academic teaching hospitals of the Netherlands, or in a 
general hospital from the adherence area of the Sophia children's University 
Hospital in Rotterdam. The paediatricians were asked to use the case descriptions 
to generally imagine a child with the specified sequelae as described in each 
case description and to complete the EO-5D and the HUI-150 questionnaires for 
each case description. Utility estimates were derived from their completed 
questionnaires using the standard population-based scoring algorithms for both 
the EO-5D and HUI. General information like age, gender and years of practical 
experience from the panel members was collected. Panellists were invited to 
comment on the items of the patient questionnaires. 
Analysis 
The primary comparison involved the preference scores generated by the EO-5D 
and HUI. Additionally we evaluated some aspects of feasibility of the patient 
questionnaires and the reliability of the preference scores. 
Feasibility of the patient questionnaires We assessed the missing value rates and 
used the written comments of the respondents on vagueness and ambiguities in 
the item phrasings. 
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Descriptive precision We assessed the number of different health states used by 
experts to classify each case description for the three classification systems and 
the percentage included in the modus. 
Preference scores The preference scores for the health state classifications were 
computed using the standard EQ-5D, HUI-2 and HUI-3 (both types) algorithms 
respectively. 3-5 Mean preference scores with their standard deviations (SD) for all 
case descriptions were computed and displayed graphically. Differences and 
similarities between the mean preference scores per case description were 
interpreted quantitatively by F-test. Significant differences (p-value < 0.05) were 
interpreted qualitatively on the basis of the dimensional contents of the case 
descriptions in relation to the contents of the classification systems. 
Ranking order of case descriptions The case descriptions were ranked by their 
preference score per respondent and the level of agreement per respondent for 
the ranking order as assessed by the EQ-5D, HUI-2 and HUI-3 was determined 
(Kendall's coefficients for concordance W). In addition, the mean rank was 
computed for each case description. We evaluated to what extent differences in 
ranking order could be explained by the contents of the classification systems. 
Profile analysis Using MANOVA, a profile analysis (comparing EQ-5D, HUI-2, HUI-
3A and HUI-3B) was performed, to test whether 1) the four different preference 
scores were equal for each of the seven health states (,coincident profiles'), 2) the 
four different preference scores differed by a constant level at each of the seven 
health states ('parallel profiles'), and 3) the seven case descriptions all obtained 
the same average preference score ('flatness'). 17 Since profile analysis requires 
equal units of measurement, method specific z-scores were used instead of the 
raw preference scores. 
Measurement error of preference scores We analysed the relative contribution of 
different sources of variance (measures, respondents, health states) at interval 
level using Generalisability Theory. G-theory is a specific application of analysis 
of variance. 18 The G-study was performed twice, i.e. each with EQ-5D, HUI-2 and 
one of the HUI-3 variants. The relative contribution (variance components) of the 
different factors in this study (facets), i.e. 'health states' (H; 7 levels), 'methods' 
(M; EQ-5D, HUI-2, HUI-3, so 3 levels) and 'respondents' (R; n = 28), their first-
order interaction terms (HXM, HxR, MxR) and one second order interaction 
(HXMXR), including (by definition) all the unexplained error variance, were 
estimated separately. Since this G-study requires complete data, missing values 
in the HUI-15Q and the EQ-5D questionnaires were imputed by the modal answer 
for that question per case description among the other respondents. 
Reliability of preference scores G-theory was also used to estimate reliability 
coefficients for the separate classification methods. The variance component 
computed in a G-study for health states can be interpreted as a reliability 
coefficient among participants in their valuation of the different health states. 
All analysis were conducted with SPSS, release 8.0 19, except for the G-study 
which was conducted in SAS, version 6.11. 20 
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Results 
Twenty-eight paediatricians were willing to co-operate: 16 male and 12 female 
with mean age 45.8 years (SD = 6.5). They had average 13.8 year (SD = 6.4) of 
practical experience. 
Feasibility of patient questionnaires For EQ-5D and HUI questionnaires two and 
nine answers, respectively, were missing, all concerning the questions about 
pain/discomfort. These missing answers led to two missing preference scores for 
EQ-5D (I % on a total number of 7x28=196), and five (3%) for both the HUI-2 and 
HUI-3. The respondents most frequently reported problems on items combining 
two issues in some questions or their response categories ('double-barrelled' 
items 18), e.g. the use of 'discomfort' and 'pain' in the same question although their 
meaning is not equivalent. In particular, the non-consistent use of double-
barrelled items through all response categories in the HUI-15Q led to problems 
for the respondents. For example, the first response category of question 7 in HUI-
15Q contains 'happiness and interest in life', whereas the other answering 
categories include 'happiness' only. 
Table 1 Number of health states per case description for EQ-SD classification and 
HUI-3 classification 
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Case description 
EQ-5D' 
1 Deafness 
2 Mild hearing loss 
3 Epilepsy 
4 MR 
5 s:rvm and tetraplegia 
6 Leg paresis 
7 Epilepsy, :rvm and 
leg paresis 
HUI-3t 
1 Deafness 
2 Mild hearing loss 
3 Epilepsy 
4 MR 
5 S:rvm and tetraplegia 
6 Leg paresis 
7 Epilepsy, MR and 
leg paresis 
No. of unique health Modal health Frequency (%) 
state classifications state of the modal 
7 
6 
6 
8 
7 
6 
6 
23 
21 
19 
26 
16 
14 
24 
classification health state 
classification 
11211 11 (39.3%) 
11211 14 (50%) 
11212 10 (35.7%) 
12212 7 (25%) 
33322 10 (35.7%) 
22211 22 (78.6%) 
22212 15 (53.6%) 
15313211 / 
15414211 / 
16313111/ 
16414311 
13111111 / 
13212111 
11123211 
11343311 
66565266 
11113124 
11244334 
2 (7.1 %)' 
3 (10.7%)' 
4 (14.3%) 
2 (7.1 %) 
5 (17.9%) 
8 (28.6%) 
3 (10.7%) 
:rvm - mild mental retardation, S:rvm - severe mental retardation 
* number of possible unique classifications: 243 
t number of possible unique classifications: 972,000 
* all modal classifications are provided lino unique modus present, e.g. four health state 
classifications each used by 2 experts 
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Descriptive precision The number of different classifications used by the experts to 
classify each case description for EQ-5D and HlTI-3, respectively and the 
percentage included in the modus is shown in Table 1. For presentational reasons 
HlTI-2 data are not shown in the Table. The HlTI-3 led to unique classifications per 
respondent for almost each health state description. The modus included 
maximally 79% of the respondents for the EQ-5D, 67% for the HlTI-2 and 29% for 
the HlTI-3. With respect to the number of total possible classifications for each 
method, the EQ-5D used about 1/35 and the HlTI-3 1/50,000 of the possible 
classifications (243 and 972,000 in total, respectively) for each case description. 
Table 2 Mean index-scores (standard deviation) per case description for EQ-SD, 
HUI-Z. and HUI-3 
Case description EQ-SD HUI-Z HUI-3A' HUI-3B' 
1 Deafness 0.81 (0.15) 0.79 (0.06) 0.47 (0.10) 0.Z8 (0.14) 
2 Mild hearing loss 0.91 (0.08) 0.84 (0.07) 0.74 (O.ll) 0.65 (0.14) 
3 Epilepsy 0.83 (0.08) 0.88 (0.06) 0.78 (O.ll) 0.70 (0.14) 
4 Mild mental retardation 0.62 (0.11) 0.55 (0.08) 0.44 (0.14) 0.24 (0.18) 
(MR) 
5 Severe retardation and -0.15 (0.13) 0.12 (0.03) 0.02 (0.02) -0.33 (0.02) 
tetraplegia 
6 Leg paresis 0.67 (0.12) 0.80 (0.10) 0.64 (0.10) 0.51 (0.14) 
7 Epilepsy, MR and leg 0.47 (0.25) 0.46 (0.07) 0.28 (0.10) 0.02 (0.14) 
paresis 
§ HUI-3A - index scores of HUI Mark 3 computed by the algorithm with anchor points 
'Pits' and 'Healthy' 
'lfHOI-3B ::::: index scores of HUI Mark 3 computed by the algorithm with anchor points 
'Dead' and 'Healthy' 
Preference scores In Table 2 and Figure 2 mean preference scores for each case 
description are presented for the three methods (EQ-5D, HlTI-2 and HlTI-3). For 
the HlTI-3, the preference scores resulting from both scoring algorithms are 
presented. HlTI-3B preference scores were all significantly lower than EQ-5D, 
HlTI-2 and HlTI-3A preference scores (p < 0.05). Because of this systematical 
difference, we focussed the comparison of the preference scores on the latter 
three. The HlTI-3A preference scores were significantly lower than HlTI-2 
preference scores for all case descriptions. HUI-3A preference scores were also 
significantly lower than the EQ-5D preference scores, except for 'paresis of the 
leg', which was scored almost equally by HlTI-3A and EQ-5D and except for 
'severe mental retardation with tetraplegia' which was scored significantly lower 
by EQ-5D than by HlTI-3A. The largest difference between EQ-5D and HlTI-3A was 
found for 'deafness'. Comparing the preference scores as generated by HlTI-2 and 
EQ-5D resulted in no differences for the case description 'deafness' and 'mild 
mental retardation with epilepsy and leg paresis'. The HlTI-2 preference scores 
for 'mild hearing loss' and 'mild mental retardation' were significantly lower and 
the others significantly higher than those generated by EQ-5D. 
Ranking order of case descriptions The HlTI-2 and HlTI-3 (A and B) resulted in 
identical ranking orders. An inverse ranking order was present for 'Epilepsy' and 
'Mild hearing loss' by EQ-5D, occurring as first and second in ranking on the HlTI-
scales. Similarly, the EQ-5D inverted the ranking order of 'Paresis of a leg' and 
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'Severe deafness', ranked 3,d and 4th on the HUI-scales. Since all HUI-scales (HUI-
2, HUI-3 A, and B) resulted in the same ranking order, the level of agreement in 
ranking order per respondent was determined for EQ-5D with HUI-3 only. The 
mean Kendall's coefficient for concordance W of all respondents was 0.90 (SD: 
0.057). 
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Figure 2 Mean index scores with 95% confidence intervals per health state description for each 
health state measure method. Case descriptions on x-axis are sequenced according to 
the ranking order by HUI-3. 
Profile analysis The comparability of the preference scores of all four health state 
measures for each case description was evaluated by profile analysis in more 
detail. The assumptions of 'coincidence', 'parallelism' and 'flatness' were all 
rejected (p < 0.001). Thus the value of preference scores cliffered among the four 
methods (absence of 'coincidence') and clifferences in preference scores of the 
four methods were not constant over the seven case descriptions (absence of 
'parallelism'). The latter is also visualised by one line crossing another in Figure 
2. Absence of 'flatness' indicates that there was a substantial clifference in the 
average preference scores obtained for the seven case descriptions. In particular, 
there was a reliable clifference between the four measures in the preference 
scores obtained for the case descriptions 'Deafness', 'Epilepsy', 'Severe mental 
retardation and tetraplegia' and 'Leg paresis'. 
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G-studies Table 3 shows the results of the G-studies. First, the G-study was 
conducted on raw preference scores. In the G-study including EQ-5D, HUI-2 and 
HUI-3A, the largest proportion of variance could be attributed to 'health states' 
(79%), leaving 7% for the first order interaction 'health states x methods' 
(meaning that some health states are valued differently by some methods), 5% 
error variance, 4% for 'methods' as main effect and very low percentages for the 
other facets. In the G-study on EQ-5D, HUI-2 and HUI-3B, the facet 'method' took 
20% of variance, as expected since the HUI-3B scores were so much deviant from 
the others Oine of HUI-3B much lower than the others in Figure 4), leaving 65% for 
'health states', 5% for the first order interaction 'health states x methods', 6% 
error and small percentages for the other variance components. In an additional 
analysis we investigated whether the relative differences between EQ-5D, HUI-2 
and HUI-3 were similar. Therefore, the absolute difference between the methods 
was eliminated by transforming individual values for the health state descriptions 
to method-specific z-values, yielding by definition zero variance for the facet 
'method'. The result of this analysis on EQ-5D, HUI-2 and HUI-3A was similar to the 
one including HUI-3B. The percentage of variance uniquely attributable to the 
health states increased to 84%, and the first order interaction 'health states x 
method' was 5%. 
Table 3 Variance components (percentages) of health states (7) x respondents (28) 
x methods (3) 
Source of 
variation 
Variance components (%) 
Raw index scores Transformed 
EQ-5DIHUl-21HUl-3A EQ-SDIHUl- z-scores 
21HUl-3B 
Respondent (R) 1 1 1 
Health State (II) 79 65 84 
Method (M) 4 20 ° 
RxH 2 I 2 
RxM 2 2 2 
HxM 7 5 5 
Residual (RxHxM) 5 6 6 
* analysis on transformed z-scores yielded similar results for EQ-5D, HU1-2 and each of 
the HU1-3 variants (A and B); transformed z-score for 'Method' per definition zero. 
Reliability of preference scores The results of the G-study for each method 
separately are shown in Table 4. The variance components for the health states 
can be regarded as (standard) reliability coefficients. The HUI-2 showed the 
highest reliability (0.94), but the reliability of the other methods (0.86-0.87) was 
sufficiently high. 
Respondent (R) 
Health State (H) 
RxH 
3 
86 
11 
I 
94 
5 
(j?its=O, healthy=l) 
3 
87 
10 
(death=O, healthy=l) 
3 
87 
10 
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Discussion 
In this study we compared three methods (EQ-5D and two versions of the Health 
Utilities Index) for the classification and valuation of health states, primarily 
regarding the preference scores they generated for the seven case descriptions, 
and additionally regarding aspects of feasibility and reliability. Such an empirical 
head-to-head comparison may help in decisions about which instrument is 
preferable to use in particular disease contexts. Furthermore, this study offers 
preference scores for health states potentially helpful for investigating the 
sequelae after bacterial meningitis. 
Feasibility of health state classification The number of missing classifications was 
similar for all methods. The panellists frequently commented on the use of 
'double-barrelled' items in questions (mostly 'pain/discomfort'), which is 
generally considered as 'wrong' in devising questionnaire items 18, and this may 
hopefully be taken into account if the original authors of EQ-5D and the HUI 
decide about developing an improved version of the patients questionnaires. 
Descriptive precision As expected from the larger numbers of attributes and 
levels, the HUI-3 classification resulted in many more different health state 
classifications per case description than the EQ-5D. This illustrates that the HUI 
classification is more detailed than the EQ-5D, and therefore gives more 
opportunity to represent variability in functioning. At the descriptive level, the 
HUI-3 can be more precise than the rather crude EQ-5D. 
Preference scores Variations in preference scores observed for the same health 
states may have different sources. The first source may be the health concept of a 
particular classification system (e.g. one concept may cover aspects that are 
ignored by another concept). The EQ-5D and HUI-2 and HUI-3 were developed 
with a similar application in mind, i.e. for use to classify patients in various illness 
groups with the opportunity to provide every health-state description with a 
preference score, but their health concepts are different. The HUI focuses on 
'disability' as defined by the WHO 21, representing difficulty in performing 
activities due to functional limitations. The EQ-5D additionally focuses on aspects 
of 'handicap' incorporating the consequences of the disability on the social 
activities. 6 Furthermore, the dimensional content of the three measures is 
different. EQ-5D does not contain 'cognition' in contrast to HUI-3, which may 
explain the large differences between the HUI-3 and EQ-5D found for the three 
health states with mental retardation. This illustrates one of the disadvantages of 
the EQ-5D for populations characterised (in part) by cognitive dysfunction (e.g. 
dementia, intellectual disability, etc). 22 The EQ-5D also does not include a 
specific dimension for 'sensation', so that the effect of hearing impairment on 
health-related quality-of-life can only be covered by its effect on functional 
domains, such as 'usual activities' or 'anxiety/discomfort'. These latter domains, 
however, are not well correlated with hearing function. 13 The fact that the 
preference scores for 'Mild hearing loss' and 'Deafness' as generated by the EQ-
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SD in our study were higher (closer to the value for optimal health) than for 
'Epilepsy' and 'Paresis', respectively, is probably caused by the lack of a sensory 
domain, subsequently resulting in an inverse ranking order compared to both HUI 
methods, 3-5 The difference between HUI-2 and HUI-3 for 'deafness' can be 
explained by the fact that HUI-2 has just one climension 'sensation' while in HUI-3 
this dimension is split into three separate dimensions, i.e. hearing, vision and 
speech_ All four measures result in a different pattern of low and high preference 
scores, as illustrated by the profile analysis results. 
The second possible source of variation in preference scores from different 
measures is the scoring attitude towards the fixed endpoints of the scales (anchor 
points) and the position and handling of 'dead' by the classification method. The 
differences in preference scores between HUI-3A (anchor points 'Pits' and 
'Healthy') and HUI-3B (anchor points 'Death' and 'Healthy') are largely attributed 
to the difference in anchor points. 
Another source of differences in preference scores may be the elicitation 
valuation method used for valuing health states in the empirical study. Standard 
gamble (HUI) and time-trade-off (EQ-SD), however, yield almost identical values 
in the same experimental setting. 12-23 Therefore in the results of the present study 
this source of differences was considered negligible. 
The final source of variation in preference scores may be the method of analysis 
for estimation the prediction model of the classification system (linear regression 
after several transformations for EQ-SD, multiplicative modelling for HUI-2 and 
HUI-3. 3-S Since this is part of the development of the measurement method, and 
since we aimed at a comparison of the methods 'off-the-shelf, this source of 
differences was not explored in the present study. 
Error components of preference scores Most of the variance of the preference 
scores was attributable to the health state descriptions themselves, i.e. 79% and 
6S% in case of evaluating EQ-SD, HUI-2 and HUI-3A or HUI-3B, respectively. 
Partly, this was to be expected, since the case descriptions as used in this study 
were more or less covering the whole range between complete health and dead. 
Obviously, a G-study on very similar health states would result in a smaller 
variance component for the health states. The general effect of the facet 'method' 
was relatively small. The first order interaction HxM, however, was substantial (S -
7%)_ This should be interpreted as that some health states obtain a different 
preference score for some of the methods. This interaction between the health 
state measures and the health states is also illustrated by the absence of 
'parallelism' in the profile analysis, as described before. This is further evidence 
for the hypothesis that differences in climensional contents cause the main 
differences in preference scores generated by the different methods. 6 
Reliability of classification and preference scores The reliability of the whole 
procedure of derivation of the preference scores was similar for all methods 
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(> 0.85). It should be noted, however, that the respondents were all paediatricians 
and that the reliability of the classification may be lower in a less homogenous 
population of respondents. 
The fact that experts (paediatricians) served as respondents for the classification 
of the patient case descriptions in the current study may impress as peculiar and 
deserves further attention. First, it is important to distinguish, in a general sense, 
classification from valuation. Preference scores as generated by the standard EQ-
5D and HUI methodology are derived following a two-step procedure essentially 
involving two different groups of respondents. The first step is classification of 
patients' health status by completion of patient questionnaires. The second step 
involves the linking of the result to a preference score using a scoring algorithm 
based on valuations of composite health state descriptions from the general 
public. Preference scores thus derived are regarded to reflect preferences from 
the societal viewpoint, and hence applicable in cost-effectiveness studies 
conducted from this viewpoint. 24 Application of utilities in decision analysis at the 
individual patient level is quite another issue; in such a case, both description and 
valuation should be elicited from the individual patient himself. Note that the 
panel members in the current study did not take part in the estimation of the 
utilities associated with the case descriptions. The utility estimates were derived 
using the standard population-based scoring algorithms for bot the EQ-5D and 
HUI. However, also in the generation of 'societal' preference scores, the 
classification of patients should corne preferably from the patients, or parents in 
the case of young children, themselves. In the current study, the comparison of 
the preference scores generated by the three measures will not be affected by 
the use of experts instead of parents, since this potential bias 25-26 is consistently 
present across the three methods. But we also had a positive argument for 
choosing experts for the classification step. The EQ-5D and HUI patient 
questionnaires both are in the current standard format not applicable to young 
children, since they contain questions about school, reading and self-care. 1.6 
Children at risk for meningitis in general are much younger than school-going 
age, and use of the questionnaires in this population requires either years of 
follow-up or extrapolation of the child's functioning to the age of at least 6 years. 
Experts (paediatricians) could, because of their professional experience, be 
asked to imagine what a child aged six with permanent sequelae after meningitis 
at age one or two would be like. 
From the literature, there are a few examples of utility assessment for adverse 
outcomes associated with meningitis. 27·28 The results of these studies are only to a 
very limited extent comparable to the results of the present study, due to 
differences in the subjects who performed the valuation task, descriptions of the 
states that were valued, and valuation methods. 
Given the availability of two standard instruments for utility estimations, the 
situation would have been easy if both measures resulted in the same preference 
scores estimates. With regard to the practicallty of the classification 
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questiormaires, and the agreement and reliability of the measures, we did not find 
decisive differences between the measures. The relative performance of the 
measure is related to the dimensional contents of the methods, which may be the 
best foundation for a choice. Although this intuitively may be thought upon on 
beforehand, it is now supported by empirical evidence. In this study we needed 
preference scores for health states associated with neurological sequelae after 
bacterial meningitis. Since hearing impairment and cognitive disabilities are the 
most frequent sequelae for this disease 8, we decided to prefer the preference 
scores obtained by the HUI-3. Finally, since the estimation of preference scores 
depends on the classification system that has been used and are not so absolute 
as thought, the sensitivity to differences in the preference scores estimates 
included must be an integral part of any study using such values. 
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Appendix I EQ-5D 
Attribute Level Description 
Mobility 
Self-care 
Usual 
Activities 
Pain/ 
Discomfort 
Anxiety / 
Depression 
I 
2 
3 
I 
2 
3 
2 
3 
I 
2 
3 
I 
2 
3 
No problems walking about 
Some problems walking about 
Confined to bed 
No problems with self-care 
Some problems washing or dressing self 
Unable to wash or dress self 
No problems with performing usual activities 
(e.g. work, study, housework, family or leisure activities) 
Some problems with perlorming usual activities 
Unable to perfonn usual activities. 
No pain or discomfort 
Moderate pain or discomfort 
Extreme pain or discomfort 
Not anxious or depressed 
Moderately anxious or depressed 
Extremely anxious or depressed 
Appendix Z Health utilities Index. version Mark 3. 
Attribute Level 
Vision I 
2 
3 
4 
5 
6 
Hearing I 
2 
3 
4 
5 
6 
Description 
Able to see well enough to read orclinary newsprint and recognise a friend on 
the other side of the street, without glasses or contact lenses 
Able to see well enough to read ordinary newsprint and recognise a friend on 
the other side of the street, but with glasses 
Able to see well enough to read ordinary newsprint with or without glasses but 
unable to recognise a friend on the other side of the street, even with glasses 
Able to see well enough to recognise a friend on the other side of the street with 
or without glasses but unable to read ordinary newsprint, even with glasses 
Unable to read ordinary newsprint and unable to recognise a friend on the other 
side of the street, even with glasses 
Unable to see at all 
Able to hear what is said in a gl'oup conversation with at least three other 
people, without a hearing aid. 
Able to hear what is said in a conversation with one other person in a quiet room 
without a hearing aid, but requires a hearing aid to hear what is said in a group 
conversation with at least three other people 
Able to hear what is said in a conversation with one other person in a quiet room 
with a hearing aid and able to hear what is said in a gl'oup conversation with at 
least three other people 
Able to hear what is said in a conversation with one other person in a quiet room 
without a hearing aid, but unable to hear what is said in a group conversation 
with at least three other people even with a hearing aid 
Able to hear what is said in a conversation with one other person in a quiet room 
with a hearing aid, but unable to hear what is said in a group conversation with 
at least three other people even with a hearing aid 
Unable to hear at all 
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Appendix 2 Health utilities Index. version Mark 3 ( cont' d) 
Speech 1 Able to be understood completely when speaking with strangers or friends. 
Dexterity 
Ambu-
lation 
Emotion 
Cognition 
Pain 
106 
2 Able to be understood partially when speaking with strangers but able to be 
understood completely when speaking with people who know me well 
3 Able to be understood partially when speaking with strangers or people who 
know me well 
4 Unable to be understood partially when speaking with strangers but able to 
be understood completely when speaking with people who know me well 
5 Unable to be understood when speaking to other people (or unable to speak 
at all) 
1 
2 
3 
4 
5 
6 
2 
3 
4 
5 
Full use of two hands and ten fingers. 
Limitations in the use of hands or fingers, but does not require special tools or 
help of another person 
Limitations in the use of hands or fingers, is independent with use of special 
tools (does not require the help of another person) 
Limitations in the use of hands or fingers, requires the help of another person 
for some tasks (not independent even with use of special tools 
Limitations in the use of hands or fingers, requires the help of another person 
for most tasks (not independent even with use of special tools) 
Limitations in the use of hands or fingers, requires the help of another person 
for all tasks (not independent even with use of special tools) 
Able to walk around the neighbourhood without difficulty. and without walking 
equipment 
Able to walk around the neighbourhood with difficulty; but does not require 
walking equipment or the help of another person 
Able to walk around the neighbourhood with walking equipment, but without 
the help of another person 
Able to walk around the neighbourhood with walking equipment, and 
requires a wheelchair to get around the neighbourhood 
Unable to walk alone, even 'With walking equipment. Able to walk: short 
distances with. the help of another person. and requires a wheelchair to get 
around the neighbourhood 
6 Cannot walk at all 
I Happy and interested in life 
2 Somewhat happy 
3 Somewhat unhappy 
4 Very unhappy 
5 So unhappy that life is not worthwhile 
I Able to remember most thighs, think clearly and solve day to day problems 
2 Able to remember most things, but have a little difficulty when trying to think 
and solve day to day problems 
3 Somewhat forgetful, but able to think clearly and solve day to day problems 
4 Somewhat forgetful, and have a little difficulty when trying to think or solve 
day to day problems 
5 Very forgetful, and have great difficulty when trying to think or solve day to 
day problems 
6 Unable to remember anything at all, and unable to think or solve day to day 
problems 
1 Free of pain and discomfort 
2 Mild to moderate pain that prevents no activities 
3 Moderate pain that prevents a few activities 
4 Moderate to severe pain that prevents some activities 
5 Severe pain that prevents most activities 
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Abstract 
Background: Decision rules may provide the physician a rationale to decide on the 
use of diagnostic and therapeutic procedures and improve the quality and cost-
effectiveness of medical care. Recently, we developed a diagnostic rule to decide 
when to perform a lumbar puncture and to initiate empirical antibiotic treatment 
in a child with meningeal signs. In this study we estimated cost savings of the rule 
compared to current practice. 
Methods: Data were used of 360 children visiting the emergency department of 
the Sophia Children's Hospital with meningeal signs between 1988 and 1998, who 
followed routine care. Costs of diagnostic and therapeutic procedures were 
estimated using financial accounts of an academic and a general paediatric 
hospital. The number of performed procedures actually performed and as 
expected when using the decision rule and total costs (Le. unit costs x consumer 
frequency) were estimated and compared. 
Results: The population of children with meningeal signs comprised 99 with 
bacterial meningitis (27%), 36 with another serious bacterial infection (10%) and 
225 with a self-limiting disease (63%). Application of the rule would have led to a 
net reduction of 30 lumbar punctures and 33 hospitalisations for empirical 
treatment with the same diagnostic accuracy as current practice. The rule would 
save € 292 per patient (relative reduction 10%); € 33 by diagnostic procedures 
and € 259 by therapeutic interventions. Cost savings were mainly achieved in 
children with self-limiting diseases. Cost savings were most sensitive to inpatient 
nursery costs and the a priori probability of bacterial meningitis in the population. 
Conclusion: A diagnostic decision rule for children with meningeal signs has the 
potential to improve the appropriate use of medial resources, to be cost-effective 
and to early ascertain the absence of bacterial meningitis. 
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Introduction 
The critical evaluation of diagnostic tests and therapeutic strategies has lead to 
the development of decision rules. These rules may provide physicians a more 
rational basis for decisions on the use of diagnostic and therapeutic procedures 
and may improve quality and the cost-effectiveness of medical care. 
In previous reports, we assessed the value of diagnostic and therapeutic 
procedures in management of children with bacterial meningitis visiting the 
emergency department with meningeal signs. 1.2 Since delayed diagnosis and 
treatment of bacterial meningitis worsens its prognosis, physicians have a low 
threshold to perform a lumbar puncture in patients with meningeal signs. 
Moreover, patients with an increased cell count in cerebrospinal fluid (CSF) will 
immediately get empirical antibiotic treatment for bacterial meningitis until the 
CSF bacterial culture result is available (after 48 - 72 hours). 3.4 Although a safe 
strategy, thls results in a large group of patients without bacterial meningitis that 
unnecessarily undergoes a lumbar puncture and is treated with antibiotics. In 
order to safely reduce the number of lumbar punctures and empirical treatments 
in patients without true bacterial meningitis, a diagnostic decision rule for the 
indication of a lumbar puncture and empirical treatment for bacterial meningitis 
has been developed. 1.2 This rule has yet only been evaluated on its diagnostic 
accuracy. 
The aim of the present study was to estimate possible cost savings that could be 
achieved by a rule predicting bacterial meningitis in children with meningeal 
signs compared to current practice. To extrapolate these results to other clinical 
settings, we also investigated key-parameters that mainly determined the cost 
savings after introduction of the diagnostic decision rule. 
Methods 
Patients 
This study used data from a large ongoing diagnostic study in children with 
meningeal signs, which has been described previously. 1.2 In brief, 360 children 
(aged from 1 month up to 15 years) visiting the emergency department of the 
Sophia Children's Hospital, Rotterdam, The Netherlands, with meningeal signs 
between 1988 and 1998 were included. Demographic data, presenting signs and 
symptoms on admission as recorded in the standardised paediatric patient 
record, and clinical findings during hospitalisation or outpatient follow-up were 
documented. In addition, data from all other diagnostic procedures such as 
laboratory tests of cerebrospinal fluid (CSF), blood, stool and urine specimens 
and radiographic tests at admission and during hospitalisation, were retrieved 
from the computer-documented hospital information system. 
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Decision rule 
The developed diagnostic decision rule included two scoring algorithms: one 
using characteristics from patient history (duration of the complaints and 
presence of vomiting), physical examination (presence of meningeal signs, 
petechiae, disturbed consciousness and cyanosis) and serum C-reactive protein 
(CRP), to guide decisions on the need of a lumbar puncture, and a second one, 
using cerebrospinal fluid (CSF) indices (CSF !blood glucose ratio and the absolute 
polymorphonuclear cell count), to decide upon initiating empirical treatment. 1.2 
Total scores can be computed by assigning points for each factor present in the 
individual patient and may guide decisions on the performance of a lumbar 
puncture or the use of empirical treatment in practice as presented in Appendix I. 
For example a boy with complaints since half a day, who vomits, with meningeal 
irritation at physical examination, a serum CRP of 45 mg/l, ISO 
polymorphonuclear cells in CSF/~ and a CSF!blood glucose ratio of 0.45, gets a 
clinical score of 10 (= 0.5 + 2 + 7.5 + 0 + 0 + 0) and a CSF score of 0 (= 2 - 2). In all 
patients with a clinical score < 9.5 points bacterial meningitis was absent, such 
that a lumbar puncture and empirical treatment could safely be withheld in these 
patients. In patients with a clinical score of 9.5 - 10.4, a CSF score of 2:1 identified 
patients in whom empirical treatment was indicated; for those with clinical scores 
between 10.5 - 12.9 or 13.0 - 19.9 the lower CSF thresholds for empirical 
treatment were 2: -2 and 2: -3, respectively, without missing a single case of 
bacterial meningitis. All patients with a clinical score 2: 20 had an indication for 
empirical treatment, irrespective of the CSF score. For further information on the 
derivation and validation of the decision rule we refer to previous publications. 1.2 
Resource use 
During the diagnostic phase the following resources were distinguished: 
emergency department visit, lumbar puncture procedure, laboratory tests 
(including haematology, blood chemistry, urinalysis, CSF cytology and 
biochemical analysis and microbiology of blood and urine and CSF), and chest 
radiography. Resources during the therapeutic course included hospitalisation 
(days on a intensive care unit, isolation or paediatric ward), consultations by the 
paediatric specialist, laboratory and radiographic tests additional to those 
performed during the diagnostic phase, and prescription of medication use either 
in hospital or during outpatient treatment (such as antibiotics, anti-epileptics, 
procedure of intravenous treatment). The actual resource use was based on the 
frequencies of resources in current practice as documented in the database. To 
estimate the expected resource use after applying the diagnostic decision rule, 
we simulated the consequences of all possible scenarios that could follow from 
applying the decision rule. In Figure I the eleven possible scenarios are outlined, 
with the expected number of patients per scenario when applying the rule on the 
database of children with meningeal signs. Three groups of diagnoses were 
distinguished, according to their need of therapeutic interventions: I) patients 
with bacterial meningitis (BM), 2) patients with serious bacterial infections other 
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than meningitis (SBI; i.e. septicaemia, pneumonia, urinary tract infection or 
bacterial gastro-enteritis) and 3) patients with viral or aseptic meningitis or with 
other self-limiting diseases (SLD; i.e. upper respiratory tract infections, non-
specified viral infections, myalgia). To estimate the resource use of each scenario, 
various assumptions were made. We assumed that some diagnostic tests not part 
of the decision rule or not indicated by the decision thresholds, would be 
performed in some patients anyway for differential diagnosis or for therapeutic 
purposes. 5 Similarly, we assumed that hospitalisation could be indicated in a 
patient by disease severity also. To determine patients that were actually 
hospitalised for illness severity or for empirical treatment in case of suspicion of 
bacterial meningitis, we checked the patients' discharge letters. Hospitalised 
patients who did not actually undergo a lumbar puncture or those who continued 
treatment even after the results of CSF cultures were considered negative, were 
assumed to be hospitalised even though the decision rule would indicate 
otherwise. Finally, since the decision rule aimed not to miss any patient with 
bacterial meningitis, we assumed that all patients were correctly treated after 
applying the decision rule and had a similar risk of mortality and morbidity as in 
c=ent practice. These assumptions had the following consequences: 
I. The diagnostic decision rule would not change actual resource use of the 
diagnostic and treatment course in patients with true bacterial meningitis. 
Diagnostic tests actually performed, but not part of the decision rule would still 
be performed in these patients (e.g. for therapeutic purposes). 
2. In patients with true SBI the decision rule would not lead to another diagnostic 
strategy as actually applied except for the use of lumbar punctures. 
3. In SBI patients actually hospitalised for other reasons than for presumed 
bacterial meningitis (scenario 4 and 8) the hospitalisation frequency and the 
use of therapeutic interventions would remain unchanged. 
4. In SLD patients, diagnostic tests of the diagnostic decision rule would be 
required only to rule out bacterial meningitis. Since other tests may still be 
required to rule out the presence of other severe bacterial infections, some 
additional diagnostic tests might be used anyway. We assumed this would 
occur in a same number of patients with SLD as those with SBI. 
5. In SLD patients actually hospitalised for other reasons than for presumed 
bacterial meningitis (scenario 5 and 9), the hospitalisation frequency and the 
use of therapeutic interventions would not change. 
Unit costs 
Average unit prices of diagnostic tests and therapeutic interventions were 
estimated in Euro (€ I = $ 0.946, January 2001) using financial accounts of the 
Sophia Children's Hospital, Rotterdam of 1996 and time-estimates of procedures 
by experts. Unit costs of an emergency department visit included personnel costs 
of the paediatrician, a resident (45 minutes per visit each) and nurse (15 min). Unit 
costs of a lumbar puncture included costs of a paediatrician (15 min), nurses (2 
nurses, summed time 45 min) and material costs. Unit costs of laboratory tests 
were calculated by dividing the annual laboratory costs by the weighted number 
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of annual tests. Costs of radiographic tests included the time spent by the 
radiologist, materials and radiographic equipment. Costs of medication were 
based on actual purchase prices enlarged with an allowance for chemists' costs. 
inpatient nursing costs were based on mean costs of the Sophia Children's 
hospital (academic hospital) and the Juliana Children's Hospital, The Hague (a 
large general paediatric hospital). Unit costs of inpatient nursing days included 
costs of a paediatrician and residents, and nursery, material and hotel costs. All 
unit costs were enlarged with the costs of general equipment, buildings and 
overhead expenses by using direct allocation. 6 
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Figure 1 Clinical scenarios expected following the application of the decision rule 
Costs estimated in Buros (€ 1 ::::; $ 0.946) 
Number of patients per scenario is the expected number of patients per scenario when 
applying the rule on the database of 360 children with meningeal signs. BM: bacterial 
meningitis; SBI: serious other bacterial infection; SLD: self~lim.iting disease; DX: 
diagnostic procedures; RX: treatment; PH: patient history; PB: physical examination; D 1: 
decision using the clinical scoring algorithm; D2: decision using the CSF formula. 
Analysis 
Total costs were estimated in Euro per patient by multiplying the unit costs per 
resource with the diagnostic and therapeutic resource use as actually performed 
and as expected when applying the decision rule (given the above assumptions 
on resource use). in a cost-minimisation analysis the possible cost savings by the 
introduction of the diagnostiC decision rule compared to current practice were 
estimated. Since costs of treaiment (hospitalisation in particular) were much 
higher than costs of diagnostic tests, we compared the cost savings achieved in 
the diagnostic and therapeutic phase separately. The impact of changes in base-
case estimates of unit costs and frequencies of diagnoses and OUI assumptions on 
resource use was evaluated by sensitivity analysis. inpatient nursing costs were 
varied by 20%, which is a plausible variation of inpatient nursing costs between 
an academic hospital and a general hospital. 7 The frequency of bacterial 
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meningitis was reduced by 50%, with a proportional increase of the other two 
diagnostic categories (SBI and SLD). The impact of the previous assumptions on 
resource use was assessed by an analysis under the assumption that all diagnostic 
tests and interventions other than indicated by the decision rule (e.g. for a 
differential diagnosis or for therapeutic purposes), indeed were saved in all 
patients. Therefore, in this analysis we included costs of determining serum CRP 
and glucose, CSF cell count, glucose and bacterial cultures, and costs of treatment 
as indicated in patients by the rule, only. Finally, we estimated the possible cost 
reduction by the rule, using data from a general paediatric hospital with a lower 
frequency of bacterial meningitis and lower inpatient nursing costs. 
Results 
General characteristics of the 360 included children are presented in Table 1. 
Bacterial meningitis was diagnosed in 99 children (28%). A lumbar puncture had 
actually been performed in 256 children (71%) and 217 children hospitalised 
(60%). Table 2 presents the unit costs in Euro of the main diagnostic tests and 
therapeutic interventions, as used in the cost analysis. The unit cost of a lumbar 
puncture was estimated to be € 49. Inpatient nursing costs varied from € 343 per 
day on a paediatric ward to € 480 per day on an isolation ward and to € 832 per 
day on an intensive care unit. 
Table 1 General patient characteristics 
Characteristic 
Male gender 
Age (years)' 
Referral pattern 
General practitioner 
Self referral 
Other specialist 
Fever in history 
Body temperature at examination (OC)$ 
Pain in the neck in history 
Referred with meningeal signs 
Meningeal irritation assessed by the paediatrician 
Diagnosis 
Bacterial meningitis 
Viral/aseptic meningitis 
Pneumonia 
Other bacterial infecti.onst 
Self limiting diseases* 
Lumbar puncture performed 
Hospitalisation 
''Median (25th - 75th percentile) 
$Mean (standard deviation) 
Number (%) 
225 (62.5%) 
2.4 (0.8·5.3) 
286 (79%) 
42 (12%) 
9 (3%) 
330 (92%) 
39.2 (1) 
168 (47%) 
203 (56%) 
256 (71 %) 
99 (28%) 
44 (12%) 
28 (8%) 
S (2%) 
181 (50%) 
256 (71 %) 
217 (60%) 
tOther bacterial infections included septicaemia, urinary tract infections, gastro-enteritis 
*Self-limiting diseases are upper respiratory tract infections or non-specified viral 
infection 
In patients with SBI and SLD 26 and 132 lumbar punctures had actually been 
performed, respectively. After using the decision rule this would be 25 (Figure 1, 
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sum of patients in scenario 2, 4 and 6) and 103 (Figure 1, sum of patients in 
scenario 3, 5 and 7), respectively. 'IWenty-five SBI patients and 93 SLD patients 
had actually been hospitalised; this would be 25 (Figure 1, sum of scenario's 2, 4 
and 8) and 55 (Figure 1, sum of scenario's 3, 5 and 9), respectively when using the 
decision rule. The actual hospitalisation rate in SLD patients decreased from 41 % 
to 24% by the diagnostic decision rule (40% reduction). By multiplying the 
estimated resource use per patient in each scenario with fixed unit costs, the 
mean costs per patient in each scenario were calculated (Figure 1). In particular, 
large differences in therapeutic costs were found between the scenarios, due to 
relative high inpatient nursing costs. 
Table 2 Unit costs of resources in diagnostic and therapeutic strategy 
Type of resource Unit cost (€"') 
Visits 
Emergency department 90 
Inpatient nursing consultation to paediatric specialist 46 
Outpatient consultation to paediatric specialist 13 
Laboratory tests 
Haematologyt 10 
SerumCRP 2 
Acid-base balance 4 
Serum glucose 2 
Lumbar puncture:j; 49 
Bacteriologic cultures$ 20 
Virology' 35 
Chest radiography 35 
Antibiotic treatment (per day)'!f 
3Id generation cefalosporine 13 
Amoxicillin 1 
Benzylpenicillin 4 
Inpatient nursing costs (per day) 
Intensive care unit 832 
Isolation ward 480 
Paediatric ward 343 
• € 1 - $ 0.946 aanuary 2001) 
1lncluding hemoglobin, and leukocyte, thrombocyte and differential count 
*Including the costs of the puncture and cerebrospinal fluid cytology and chemistry 
$Specimens of blood, urine, cerebrospinal fluid or faeces 
1l'Price of daily dose for a child aged 2.5 years with a weight of 15 kg 
Total costs and costs per diagnostic group as actually observed and as expected 
by the decision rule are presented in Table 3. The decision rule would reduce 
total costs by € 292 per patient (10%); € 33 in the diagnostic phase (11 % of total 
reduction) and € 259 in the therapeutic course (89%). The largest cost reduction 
would be achieved in patients with SLD (33 % reduction of total costs), as shown 
by the ratio of cost reduction per diagnosis category. The proportional 
contribution to the total costs shows that BM patients accounted for 62% of the 
total costs in current practice (Table 3). Since we assumed that the decision rule 
would not lead to a change in costs in BM patients, the maximum reduction in 
costs could be 38% of total costs. The decision rule would achieve 10% reduction 
of total costs of this maximum. 
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Table 3 Mean costs in Euro ~€ 1 = $ O.946~ Eer ;eatient Eer dia~osis 9!0u;e 
Number Costs Proportional Costs Cost Proportional 
of current contI'ibutionto decision savings cost savings'" 
patients practice costs of current rule 
Eractice 
Diagnostic phase 
BM 99 387 0.36t 387 0 0 
SBI 36 353 0.12 351 2 0.01 
SLD 225 252 0.53 199 53 0.21 
Total 360 299 1.00 266 33 0.11 
Therapeutic course 
BM 99 6,367 0.65 6,367 0 0 
SBI 36 2,650 0.10 2,460 190 0.07 
SID 225 1,057 0.25 673 384 0.36 
Total 360 2,677 1.00 2,418 259 0.10 
Total (diagnostic and therapeutic) 
BM 99 6,754 0.62 6,754 0 0 
SBI 36 3,003 0.10 2,811 192 0.06 
SID 22S 1,309 0.28 872 437 0.33 
Total 360 2,976 1.00 2,684 292 0.10 
BM: bacterial meningitis; SBI: serious bacterial infection; SID: self-limiting disease. 
*' Computed by cost savings/ costs current strategy 
t E.g. computed by number BM patients x costs/number all patients x costs: 
(99 x 387)/(360 x 299) 
Table 4 presents the results of the sensitivity analysis compared to the base-case 
analysis (Table 3) with a mean saving of € 292 per patient (relative reduction of 
10%). A 20% decrease or increase of inpatient nursing costs would save € 243 and 
€ 341, respectively (a relative cost saving of 10% in both cases, similar to the 
base-case analysis). A 50% decline in the frequency of bacterial meningitis saved 
€ 347, increasing the relative cost saving from 10% (base-case analysis) to 15%. 
Under the assumption that all diagnostic tests and therapeutic interventions other 
than those indicated by the diagnostic decision rule indeed would not be 
performed anymore, € 824 would be saved (relative reduction 32%). Using the 
rule in a general paediatric hospital with a relative lower frequency of bacterial 
meningitis and lower inpatient nursing costs, would result in a similar absolute 
cost saving compared to the base-case analysis (€ 283), but in higher relative cost 
savings (14%). 
Discussion 
In this study we estimated the possible cost reduction following the introduction of 
a diagnostic decision rule predicting the absence of bacterial meningitis in 
children with meningeal signs. Ruling out bacterial meningitis early in the 
diagnostic phase prevents unnecessary lumbar punctures and hospitalisations for 
empirical antibiotic treatment. The use of a diagnostic decision rule to guide the 
decisions when to perform a lumbar puncture and when to start empirical 
antibiotic treatment, will reduce total costs by 10% compared to current practice. 
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Savings of therapeutic costs mainly contribute to the total cost reduction (89%); 
diagnostic cost savings only with II %. The cost reduction is inversely related to 
the frequency of bacterial meningitis in the population, since cost savings are 
attained particularly by reducing the resource use in patients with self limiting 
diseases. The absolute cost reduction is linearly related to inpatient nursing costs. 
Table 4 Sensitivi!i analysis: mean costs EerEatient in Euro ~€ 1 :::; $ 0.9462 
Current Decision Cost- Relative cost-
strategy rule savin9! savin9! 
Base~case analysis 2,976 2,684 292 10% 
Effect of inpatient nursing costs 
80% of base-case estimate 2,475 2,232 243 10% 
120% of base-case estimate 3,477 3,135 341 10% 
BM frequency 14% 2,268 1,921 347 15% 
(50% decline ofBM prevalence) 
Analysis without assumptions about 2,976 2,152 824 32% 
impact of patients' clinical 
presentation on resource use 
Analysis using data of a general 1,994 1,711 283 14% 
children's ho~ital" 
BM: bacterial meningitis 
... Input data derived from Juliana Children's Hospital, The Hague, 1998: 17% BM, 9% SBr 
and 74% SLD among children with meningeal signs; inpatient nursery costs 80% of base-
case input 
The cost reduction in thls study is the difference in (diagnostic and therapeutic) 
resource use between current practice in the Sophia Children's Hospital and as 
estimated after using the diagnostic decision rule, In order to extrapolate these 
results to other hospitals, main influencing factors on cost savings, according to 
the sensitivity analysis should be taken into account. The cost savings mainly 
depend on the inpatient nursing costs, the frequency of SLD patients among 
patients with meningeal signs and their hospitalisation rate. Under the assumption 
that a 40% reduction in hospitalisations for empirical treatment will be achieved 
in patients with SLD by the diagnostic decision rule (as was achieved in our 
analysis), a crude calculation of the cost savings per year can be computed by: 
Number of patients with meningeal Signs per year x % SLD patients x 
hospitalisation rate x 0.4 x length of hospital stay for empirical treatment x daily 
inpatient nursing costs 
It should be noted that additional cost savings due to the reduction in diagnostic 
tests and empirical antibiotic use and those costs savings in patients with serious 
bacterial infections, etc. are not included in this crude estimate. 
To appreciate the results of thls study some topics need to be discussed. First, in 
our base-case estimate of costs of patient management following the use of our 
diagnostic decision rule, we took into account that patient management by the 
physician is influenced by the patients' clinical presentation. Neglecting this 
impact would grossly overestimate the cost-reduction: € 824 cost saving (32%) 
versus € 292 (10%) in the base-case analysis (Table 4). The assumptions on future 
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resource use per scenario, however, are based on current practice and are not 
evaluated further in this study. Evidence whether all these tests are indeed 
necessary to set a differential diagnosis after bacterial meningitis has been ruled 
out or for therapeutic management is lacking. Second, we distinguished three 
patient groups according to their true diagnosis, disease severity and necessity of 
treatment. The group of self-limiting diseases also included the aseptic and viral 
meningitis cases, since treatment of these patients is mainly symptomatic. 8 This 
assumption may need modification in future if antiviral treatment for enteroviral 
meningitis becomes available. Third, in this cost-minimisation study, our point of 
view was a similar effectiveness of the decision rule compared to current practice 
in terms of mortality and morbidity. In particular, the thresholds in Appendix I 
have been chosen in such a way, that applying our rule would miss no case of 
bacterial meningitis. One could, however, choose higher thresholds in the 
decision rule than those presented in Appendix I for the indication of a lumbar 
puncture or empirical treatment. These modified thresholds will change the initial 
diagnostic and treatment costs but will misdiagnose some cases of bacterial 
meningitis cases, as well. The extra diagnostic cost savings realised by varying 
these thresholds should be evaluated in view of the increased mortality and 
morbidity following misclassification of bacterial meningitis cases, incorporating 
the long-term costs and quality-adjusted-life-years lived in a particular health 
state associated with neurological sequelae after bacterial meningitis. 9 Such a 
cost-utility analysis, however, was beyond the scope of this study. Finally, cost 
savings by the rule were mainly determined by inpatient nursing costs and hardly 
affected by cost savings in the diagnostic phase. Therefore, it seems that using 
more diagnostic tests in order to prevent unnecessary hospitalisations results in a 
larger cost-effectiveness. More diagnostic tests, however, may lead to more false-
positive diagnoses of bacterial meningitis, resulting in an increase of unnecessary 
treatments and, therefore, in a decrease in cost-effectiveness. 10,11 For this reason, 
we believe that the economic evaluation of any diagnostic rule should include the 
consequences of the rule on both the diagnostic and therapeutic management. 
In conclusion, a diagnostic decision rule for children with meningeal signs at the 
emergency department will safely achieve a substantial cost reduction of 
diagnostic and therapeutic procedures. The largest cost reduction will be achieved 
in the therapeutic course. The amount of cost reduction in a particular setting 
mainly depends on the frequency of bacterial meningitis in the patient population 
to whom the rule is applied, the costs of inpatient nursing days and the frequency 
in which diagnostic and therapeutic procedures are actually used in the hospital. 
The relative contribution of these main determinants of cost savings may help to 
define key parameters in future economic studies of paediatric care. 
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Appendix 1 Diagnostic decision rule 
Scoring algorithm of the clinical score 
Characteristic 
Duration main problem in history 
Vomiting in history yes 
no 
Meningeal irritation at physical yes 
exanrination no 
Cyanosis at physical examination yes 
no 
Petechiae at physical 
examination 
Disturbed consciousness at 
physical examination 
SerumCRP (rogll) 
yes 
no 
yes 
no 
<50 
50 - 99 
100 - 149 
150 - 199 
~ 200 
Total clinical risk score (sum of scores) 
Points assigned if 
characteristic 
present 
I per day (max 10) 
2 
o 
7.5 
o 
6.5 
o 
4 
o 
8 
o 
o 
0.5 
1.0 
1.5 
2.0 
Scoring algorithm of the cerebrospinal fluid (CSF) score 
Characteristic Points assigned if 
CSF polymorphonuclear cell 
count (per fll) 
CSF !blood glucose ratio 
Total CSF score (sum of scores) 
< 10 
10 - 99 
100 - 999 
1000 - 9999 
> 10.000 
< 0.1 
0.1- 0.19 
0.2 - 0.29 
0.3 - 0.39 
0.4 - 0.49 
0.5 -0.59 
0.6 - 0.69 
0.7 - 0.79 
0.8 - 0.89 
0.9 - 0.99 
> 1.0 
CSF Clinical risk score 
characteristic 
present 
o 
I 
2 
3 
4 
o 
-0.5 
-1.0 
-1.5 
-2.0 
-2.5 
-3.0 
-3.5 
-4.0 
-4.5 
-5.0 
score <9.5 9.5 -10.4 10.5 -12.9 13 - 19.9 
<-3 
-3 to -2.5 
-2 to 0.5 
~1 
Neither indication for lumbar puncture nor for treatment 
Indication for lumbar puncture, but not for treatment 
Indication for lumbar puncture and for treatment 
Patient 
score 
Patient 
score 
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Abstract 
Objectives: We designed a model to determine the consequences for the society 
of adequate diagnosis and treatment in patients with meningeal signs in terms of 
quality-adjusted life-years (QALYs) and costs, 
Study design: Data were used from 360 children with meningeal signs (0,1 - 15 
years), visiting the paediatric emergency department of the Sophia Children's 
Hospital Rotterdam, The Netherlands (l988 - 1998), Model inputs included 
probabilities of meningitis and adverse outcome, preference scores for years 
lived with long-term sequelae, and costs of tests and treatments, We estimated 
costs and effects of diagnostic and therapeutic interventions in children suspected 
of bacterial meningitis, we defined key determinants of the model outcomes, and 
evaluated alternative diagnostic strategies and two vaccination programmes in a 
cost-utility analysis, 
Results: The population comprised 99 children with bacterial meningitis (adverse 
outcome in 10), 36 with serious other bacterial infections and 225 with self-limiting 
diseases, Key determinants of costs and health effects were the risk of bacterial 
meningitis or sequelae, costs of treatment and long-term morbidity. Minimising 
lumbar punctures and empirical treatments by use of a diagnostic decision rule, 
without missing a single case of meningitis, was a dominant strategy to actual 
practice. Vaccination strategies of S. pneumoniae and N. meningitidis resulted in 
our model in incremental cost-utility ratios of 401,965 €/QALY and 22,635 €/QALY, 
respectively. 
Conclusions: Costs of long-term morbidity of bacterial meningitis largely 
outweigh diagnostic and treatment costs. Modelling interventions in children at 
risk of bacterial meningitis should include long-term consequences in terms of 
costs and QAL Y s. 
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Introduction 
The presence of bacterial meningitis is suspected in a child with meningeal signs. 
Because of the severity of this illness, physicians have a low threshold to perform 
diagnostic tests and to start treatment. In about 60% of children with meningeal 
signs, however, no bacterial meningitis, but other (often self-limiting) diseases 
are diagnosed. 1.2 In spite of adequate diagnosis and treatment, bacterial 
meningitis is still associated with a 5% mortality and 10 - 15% morbidity. 3 The 
prognosis has not changed much by improvements in therapy. 4 Prevention of 
meningitis seems to be more promising. Haemophilus influenzae (HIB) vaccination 
has reduced the incidence of bacterial meningitis in young children considerably. 
5-8 Research on S. pneumoniae and N. meningitidis vaccination is in progress. 9,10 
The largest benefit of such interventions is probably to be found in the reduction 
of mortality and the long-term morbidity of bacterial meningitis and associated 
costs. 
This study built on our earlier work in which we developed a diagnostic decision 
rule for the diagnosis and treatment of children with meningeal signs. 11.12 This 
decision rule aimed to reduce diagnostic and therapeutic procedures in children 
suspected of having bacterial meningitis, using predictors from clinical evaluation 
and early available laboratory tests of blood and cerebrospinal fluid for the 
absence or presence of bacterial meningitis. In the current study we modelled the 
consequences of adequate diagnosis and treatment in patients with meningeal 
signs in terms of quality-of-life and costs. The model takes into account the entire 
path of diagnosis, treatment and management of long-term sequelae from a 
societal perspective. By using this model, we could assess the impact of the 
decision rule on the costs of diagnosis and treatment of patients with meningeal 
signs and the consequences of misdiagnosis. Furthermore, by taking into account 
the long-term consequences of bacterial meningitis, we estimated the effect of 
vaccination programmes on total costs of care. 
Methods 
Diagnostic decision rule 
In a large diagnostic study on children presenting with meningeal signs, a 
diagnostic decision rule was developed, to predict the presence or absence of 
bacterial meningitis. 11.12 This decision rule included two scoring algorithms: one 
to guide decisions on the need of a lumbar puncture, using characteristics from 
patient history (duration of the complaints and presence of vomiting), physical 
examination (presence of meningeal signs, petechiae, disturbed consciousness 
and cyanosis) and serum C-reactive protein (CRP), and a second one, to decide 
upon initiating empirical treatment, using cerebrospinal fluid (CSF) indices 
(CSFlblood glucose ratio and the absolute polymorphonuclear cell count). Hence, 
this decision rule allowed for classifying patients in groups of increased 
probability of bacterial meningitis at several steps in the diagnostic path, i.e. after 
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clinical evaluation and after performing a lumbar puncture. In its use, threshold 
values were introduced for the scores in order to reduce the number of lumbar 
punctures and empirical treatments in such a way that no single case of bacterial 
meningitis was misdiagnosed. For details on the rule we refer to previous 
publications. Ll2 
PH, PC, CRP 
" 
O>.o.,.t 
:-.;;.;;; ..................... "--j 1(1 
Cocomotor d.~clt. 
",11d m",,:al ,.",Id.tlon IMRI 
ColI.po". Locomotor d.~cl'o. MR 
I j :llJ7 
'-----............................. ....: 
Cmol<lGllI RX for BM 
'"' :110 
"M 
BM N1 ••••••••••••••••••• ____ •• _ .. _ •••••••••• ..;~ 
10 h<»oltolRX S~I 
M 
~,.7 
BM N1 ................. _ .. ____ ._ •••••• < 
:101 
"" SlO 
,M 
~1 .................................................. ~ 
'nl><»;oltoIRX 
12 GlO 
lJ ~M N' __ ................................ __ ~ 
omb"""orv RX 14 CO, 
=" 
,~ 
:l4.17 
m 
~ 
,., 
7}7 1flD 
Figure 1 Decision tree of the management of patients with meningeal signs 
n 
" 
" 
~ 
PH: patient history; PE: physical examination; CRP: serum C-reactive protein; LP: lumbar 
puncture; BM: bacterial meningitis; SBI: other serious bacterial infection; SLD: self-
limiting disease; DX: diagnostic; RX.: treatment; N: number of patients per branch as 
observed in the data; Dl: decision node 1; D2: decision node 2. Dashed lines indicate 
that similar outcomes occurs as after probability node 1 (Nl); Numbers in italic refer to 
branch numbers as cited in text 
Model design [or cost-effectiveness analysis 
We designed a decision tree, including the main possible diagnostic and 
therapeutic strategies in children presenting with meningeal signs (Figure 1). In 
the diagnostic course, physicians first need to decide whether or not a lumbar 
puncture is indicated as guided by the first part of our rule, using patient history, 
physical examination and serum CRP (D 1 in Figure 1). Subsequently, based on the 
additional CSF analysis results, empirical antibiotic treatment may be started 
because of suspected bacterial meningitis, or other treatment because of 
suspected other diagnoses (D2). Accordingly, after node 2, patients with bacterial 
meningitis are correctly diagnosed and treated (branch 1 in Figure 1) or initially 
misdiagnosed and therefore, receive delayed treatment (branch 4, 7, 10 or 13). 
Any patient with bacterial meningitis may recover uneventfully, die or survive 
with long-term neurological sequelae, in frequencies related to adequate or 
delayed treatment. 3.13.14 Patients with meningeal signs, suffering from other 
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diagnoses than bacterial meningitis (EM) were divided into two distinctive 
categories, according to their need for therapeutic interventions: one with serious 
bacterial diseases (other than BM) and one with self-limiting diseases. Patients 
without bacterial meningitis could be diagnosed and treated (in hospital or 
ambulatory) correctly from presentation onwards, either or not undergoing a 
lumbar puncture, or empirically treated for suspected BM for three days on 
average (at that moment bacterial culture results are available 15; branch 2 and 3 
in Figure I). In the model were included I) the proportion of patients in each 
branch 2) costs of diagnosis and treatment per branch, 3) probabilities of 
mortality and sequelae after bacterial meningitis, 4) quality-adjusted life-years for 
patients' years lived in a particular health state with (and without) sequelae, and 
5) costs of long-term sequelae. The time-horizon of the model was 15 years. Costs 
and life-years were discounted by 4% per year. 16 Discounting is based on the 
idea that a person prefers to enjoy benefits at the present rather than in the future 
(time-preference). 17 Hence, future costs and effects are valued lower than those 
that occur in the near future. 
The proportion of patients in each branch was based on empirical data of the 360 
children with meningeal signs (aged from I month up to 15 years) visiting the 
paediatric emergency department of the Sophia Children's hospital, Rotterdam, 
The Netherlands between 1988 and 1998 with meningeal signs as the reason for 
encounter. 
The costs of diagnosis and treatment per branch were estimated by multiplying the 
resource use of each patient (using the empirical data) with the estimated average 
unit prices of diagnostic tests and therapeutic interventions. 18 Resource use 
included the emergency department visit, diagnostic tests performed at 
admission (laboratory and radiographic tests) or during clinical course, and in-
hospital or ambulatory treatment (nursing days, attendance by paediatrician, and 
prescription of medication use). 19 Unit cost calculations in Euro (€ 1= $ 0.946; 
January 2001) were based on the financial accounts of the Sophia Children's 
Hospital, Rotterdam of 1996. 
Probabilities of neurological sequelae after proper and delayed treated bacterial 
meningitis were derived from literature data. 3,13,14 
Preference scores for long-term health outcomes. Apart from perfect health and 
death, we distinguished in the model permanent health states associated with 
deafness, mild hearing loss, epilepsy, mild mental retardation, mild locomotor 
deficits, a combination of epilepsy, mild mental retardation and locomotor deficits 
and severe mental retardation with tetraplegia following bacterial meningitis. 
Health states associated with particular sequelae were valued by preference 
scores to express the relative severity of the sub-optimal health state with 
reference to perfect health (value 1.0) or death (value 0). These preference scores 
were derived from a study, in which vignettes describing these health states were 
classified by 28 paediatricians using a quality-of-life questionnaire (Health 
Utilities Index Mark 3; HUI-3). 20 Years lived in a particular health state were 
adjusted for quality-of-life in the model (OALYs) using these preference scores. 
Treatment of 'false-positives' (i.e. treating non-bacterial meningitis patients as if 
they had bacterial meningitis) was assumed not to have any long-lasting effect in 
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terms of mortality or morbidity compared to correct treatment. 
Long-term costs of sequelae included inpatient and outpatient institutional care, 
special school attendance, medical supports (such as wheelchair, crutches, 
hearing aid), and supportive treatment by paediatrician, neurologist, 
physiotherapist, ergo-therapist. Cost-estimations were obtained from literature 
21,22 and expert interviews. Costs of institutional care were derived from the 
financial account of a health care centre for mentally and physically disabled 
children and one for hearing disabled children in The Netherlands. 
Analysis 
First, the costs and effects of the diagnostic and therapeutic course were 
estimated for the 360 observed patients. Calculations of costs and quality-
adjusted-life-years (OALYs) were performed using values for the inputs in the 
model as presented in Figure I and Table 2 (base-case values). Subsequently, we 
assessed in a sensitivity analysis the main determinants of the model'S outcome 
by varying base-case values of model inputs over plausible ranges. Costs of 
procedures (of diagnostic and therapeutic course and in the long term) and 
probabilities of sequelae were varied by 20% of the base-case values. Sensitivity 
analysis of the preference scores included values obtained by parents valuing 
health states of children with bacteraemia 23, instead of those derived from 
questionnaire responses of paediatricians as used in the base-case analysis. The 
discount rate was varied from 0% to 8% and the time-horizon from 10 to 20 years. 
Then, costs and benefits of different management strategies of children with 
meningeal signs were estimated. Finally, as an example of the use of our model, 
we performed a cost-utility analysis on the effect of reducing the incidence of 
bacterial meningitis by introducing new vaccination strategies. Model outcomes 
were expressed in mean costs and OALYs per patient. Comparative results of two 
strategies were expressed in incremental cost-utility ratios with the cost 
difference as the numerator and the difference in quality-adjusted life-years as the 
denominator. 
Results 
Table I presents the general characteristics of the 360 children, initially 
presenting themselves with meningeal signs at the emergency department. 
Bacterial meningitis was diagnosed in 99 patients (28%), of whom two (2%) died, 
five (5%) were hearing disabled, one (l %) had severe retardation and 
tetraplegia, and two (2%) suffered from mild mental retardation, epilepsy, or 
locomotor deficits. 
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Table I 
Age (yeaxs)' 
Outcome 
Bacterial meningitis 
Other bacterial infections t 
Self limiting diseases* 
Lumbar puncture perfonned 
Hospitalisation 
Intensive care hospitalisation 
*Mean (standard deviation) 
2.4 (0.8 - 5.3) 
99 (28%) 
36(10%) 
225 (62%) 
256 (71 %) 
217 (60%) 
53 (15%) 
tOther bacterial infections included septicaemia, urinary tract infections, 
pneumonia and bacterial gastro-enteritis 
*Self-limiting diseases included viral/aseptic meningitis (n::: 45), upper 
respiratory tract infections (n::: 94) and non-specified viral infections (n ::: 86) 
Figure 1 presents the costs of the diagnostic and therapeutic course and the 
number of patients following a particular diagnostic and therapeutic strategy, as 
actually observed. Table 2 presents the estimated probabilities, preference 
scores and long-term costs associated with each possible outcome: perfect health, 
death and morbidity, as applied in the model. Application of the model on actual 
practice of the 360 children with meningeal signs resulted in mean total costs of € 
8,393 per patient. Sixty-five percent of total costs were associated with long-term 
sequelae and 31 % with therapy. Costs of the diagnostic course contributed to 4% 
of total costs, only. The mean QALYs without discounting was 14.5 on a time-
horizon of 15 years. This means that the original time-horizon of 15 years was 
reduced by 0.5 QALYs due to mortality and morbidity. Discounting of the years 
lived in future compared to those lived in present further reduced the number of 
QALYs to 11.2. 
Table 2 Model inputs for permanent sequelae and death after bacterial meningitis (EM) 
Outcome Probability after Probability after Preference 
correct treatment delayed treatment scores" 
ofBMll ofBMt 
Death 4.5% 26.0% 0.0 
Perfect health after 84.4% 22.1% 1.0 
survival 
Deaf 5.1% 35.0% 0.47 
Mild hearing loss 5.4% NA 0.74 
Epilepsy 0.5% 3.9% 0.78 
Mild mental 1.5% 11.7% 0.44 
retardation (MR) 
Mild locomotor deficits 0.5% 3.9% 0.68 
Mild :MR, epilepsy and 1.0% 7.8% 0.28 
locomotor deficits 
Severe :MR and 2.0% 15.6% 0.03 
tetraplegia 
NA: not available 
11 Baraff et al. 1993 3 
tLebel et al. 1989 13 
estimated by Health Utilities Index Mark 3 
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Sensitivity analysis 
The model outcomes were particularly sensitive to variations in the prior risk of 
bacterial meningitis in all patients with meningeal signs (i.e. the prevalence of 
bacterial meningitis in the population). the risk of sequelae after bacterial 
meningitis. costs of treatment and long-term follow-up, the time-horizon and to 
variation in the discount rate. In a comparison of management strategies (see 
below), however, variation of the latter two (time-horizon and discount rate) 
affected both strategies, such that the difference in costs or QAL Y s hardly 
changed. A 20% increase or decrease of the prior risk of bacterial meningitis in 
patients with meningeal signs, increased or decreased costs with 17%, 
respectively. Similarly, it decreased and increased the QALYs by 1%, 
respectively. A 20% increase or decrease of the risk of sequelae resulted in a 
12% change of total costs and a I % inverse change of total QALYs. A 20% 
variation in cost of treatment and long-term follow-up influenced total costs by 
13% and 20%, respectively. The model was not sensitive to variation in diagnostic 
costs or to the use of other preference scores of long-term health outcomes. 
Evaluation of different diagnostic strategies 
The impact of different (diagnostic and therapeutic) management strategies that 
could be applied to children with meningeal signs on costs and QAL Y s is 
presented in Figure 2. Strategy 2 in the figure reflects actual practice in the study 
period, i.e. the application of a lumbar puncture and empirical treatment as 
observed in the actual practice. Strategy 3 reflects the results after using the 
above-described diagnostic decision rule, i.e. such that lumbar punctures and 
empirical treatment are minimised, without missing one case of bacterial 
meningitis. For comparison, we considered three additional hypothetical 
management strategies. Strategy I in the figure presents the results when every 
child with meningeal signs would undergo a lumbar puncture and empirical 
treatment until bacterial cultures are conclusive. Strategy 4 implies empirical 
treatment to be initiated in patients with a 5% probability of bacterial meningitis 
or higher only, as predicted by the decision rule. Following this strategy, 13% of 
children with bacterial meningitis would be misdiagnosed and treated with delay. 
In strategy 5 empirical treatment is never unnecessarily applied in patients 
without bacterial meningitis, resulting in misdiagnosis and delayed treatment in 
56% of the children with bacterial meningitis. Total costs and QALYs and costs of 
the diagnostic and therapeutic course and in the long term, separately were 
computed for these five strategies, which range from very conservative to very 
reluctant management. Strategy 3 led to the lowest total costs (€ 8,094) and 
highest QALYs (11.19). More conservative strategies (strategy I and 2) were 
related to higher costs (increase of € 1,243 and € 299, respectively), but achieved 
a same number of QALYs. Less conservative strategies (strategy 4 and 5) were 
related to higher costs (increase of € 845 and € 11,069, respectively) and a 
reduction of QALYs (0.08 and 0.86 QALYs, respectively) due to increased 
mortality and morbidity after misdiagnosed and delayed treated bacterial 
meningitis. 
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Figure 2 Costs of different management strategies in children with meningeal signs 
1 Lumbar puncture and empirical treatment in all 
2 Lumbar punctures and empirical treatment as observed in data 
3 Minimal use of lumbar punctures and empirical treatment, without missing one case of 
bacterial meningitis 
4 No empirical treatment in patients with a predicted risk of bacterial meningitis < 5%. 
5 No empirical treatment in any patient without bacterial meningitis 
Effect of new vaccination strategies 
In this section we will illustrate how the model can be used in evaluating the 
potential long-tenn effects of S. pneumonia (SP) or N, Meningitidis (NM) 
vaccination. The results are summarised in Table 3. In the Netherlands nearly 450 
cases of bacterial meningitis (EM) annually occur in children < 15 years. 24 
Assuming that 'meningeal signs' is the main presenting symptom in 50% of 
patients with BM 2,25 and that BM is present in 20% of patients with meningeal 
signs, as observed in our study after the use of routine HIB-vaccination of infants 
11, about 1,125 children annually visit the emergency department with meningeal 
signs in the Netherlands, By using our decision model described above, total 
costs and QALYs in these 1,125 patients with meningeal signs, of whom 225 
having true bacterial meningitis (20%), would be € 7,342,875 and 12,701 QALYs, 
respectively (Table 3; base-case), 
To estimate effects of SP-vaccination, we estimated that routine SP-vaccination 
(including 3 doses) in the Netherlands would cost € 9,591,701, annually (195,749 
infants), and could achieve a 51 % reduction of SP-meningitis (data obtained from 
the Dutch National Institute of Public Health 26). Assuming a sintilar pathogen 
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distribution in children with meningeal signs as observed in our data (77% NM, 
12% SP and 11 % other pathogens), SP-vaccination with a 51 % effectiveness would 
prevent 14 patients with SP-meningitis in this population each year (225 x 0.12 x 
0.51). Mean model outcomes then were € 6,996,375 and 12,724 QALYs (Table 3). 
Taking into account the costs of vaccination (€ 9,591,701), SP-vaccination led to a 
net cost increase of 9,245,201 and a QALY increase of 23 years: incremental cost-
utility ratio 401,965 €lQALY. 
To estimate the effects of NM-vaccination, we assumed that routine NM-
vaccination (including 4 doses) would cost € 6,068,219, annually, and achieved a 
64% reduction of NM-meningitis. 26 NM-vaccination would then prevent 111 
patients with NM-meningitis in the population each year (225 x 0.77 x 0.64). Using 
our model this resulted in € 4,581,000 and 12,859 QALYs (Table 3). Taking into 
account the costs of vaccination, the incremental cost-utility ratio was 22,635 
€!QALY. 
Table 3 Effects of new vaccination strategies 
Costs (€) Incremental Q.ALYs Incremental 
costs (€);' QAL Ys ;, 
Base~case (1125 children with 7,342,875 
meningeal signs, 20% BM) 
SP vaccination effects 
12,701 
Model outcome 
Costs of vaccination 
Total 
6,996.375 12,724 
9.591,701 
16,588,076 9,245,201 
NM vaccination effects 
Model outcome 4,581,000 
Costs of vaccination 6,068,219 12,859 
23 
Total 10,919.219 3,576.344 158 
"Costs and QALYs incremental to the base case costs and QALYs 
Discussion 
To determine the impact of adequate management of children with meningeal 
signs in terms of survival, quality-of-life and total costs of care, we have designed 
a model incorporating the entire management path including diagnosis, treatment 
and management of long-term prognosis. The total costs are mainly determined 
by the costs associated with long-term morbidity after bacterial meningitis. The 
model is most sensitive to the prior probability (prevalence) of bacterial 
meningitis in patients with meningeal signs, the risk of neurological sequelae 
after meningitis, and the costs associated with long-term neurological sequelae. 
This model allows to assess the impact of different management strategies on total 
costs and QALYs. More conservative use of diagnostic and therapeutic 
interventions increases total costs only slightly. These strategies, however, do not 
improve the outcome and increase the patient burden by unnecessarily 
undergoing a lumbar puncture and hospitalisation. Less conservative approaches, 
that may lead to delayed diagnosis and treatment of bacterial meningitis, have a 
large impact on costs and QALYs associated with long-term sequelae, These costs 
largely overrule the small savings in the diagnostic and therapeutic course. 
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In diagnostic and therapeutic management of a patient with meningeal signs, the 
physician implicitly considers the trade-offs to administer or to withhold therapy, 
or to order additional tests. 27 If the consequences of missing a diagnosis are 
serious, as is the case in children suspected of bacterial meningitis, physicians 
have a low threshold to perform additional tests. 28.29 Diagnostic tests aim to 
discriminate between diagnoses. As a consequence, they will influence choices 
on therapeutic strategies and outcome. 30,31 This study has explicitly shown from a 
cost perspective that it is not worth running the risk of missing one case of 
bacterial meningitis by reducing diagnostic tests. Furthermore, we showed that a 
change in diagnostic strategies particularly influences the therapeutic strategy 
and prognostic outcome and their associated costs and QALYs. This underlines 
the importance of including these long-term effects in the evaluation of diagnostic 
strategies, Previous studies evaluating the costs and outcome following different 
diagnostic strategies of children at risk of bacterial meningitis 32,33, have not 
incorporated the long-term consequences in terms of QALYs and costs, both. 
Key determinants of the model outcome are the prior probability of bacterial 
meningitis, the risk of sequelae after bacterial meningitis, and the costs of 
treatment and long-term follow-up, Although uncertainties may exist in estimates 
of the latter, we think that variation in their estimates will not lead to materially 
different conclusions. The risk of sequelae after meningitis could be derived with 
adequate certainty from literature data. 3,13.14 Since the risk of mortality and 
morbidity is related to pathogen type 3, this aspect should be taken into account 
when applying the model to populations with very different pathogen 
distributions. The sensitivity of the model to the prior probability of bacterial 
meningitis allowed us to use the model for evaluation the impact of new 
vaccination strategies on the outcome, as will be discussed below. The fact that 
the model was mainly sensitive to long-term costs and less to diagnostic and 
therapeutic costs (which may vary among hospitals), increases the 
generalisability of the model. The frequency of health states associated with low 
preference scores in patients with meningeal signs was relatively low. As a 
consequence, the model outcome in terms of QALYs was hardly sensitive to small 
variations of model inputs. 
Guidelines for economic evaluations recommend to use a time-horizon that allows 
inclusion of all relevant costs and effects. 16 Instead of using the life expectancy of 
the study population, we restricted the time-hori2on in the current study to 15 
years. The main reason for this was the uncertainty around the long-term costs 
and preference scores. Costs and quality-of-life not only depend on the severity 
of sequelae, but also on other situation-specific factors. 34,35 For instance, whether 
a child lives in institutional care or at home highly depends on the care-givers' 
social and financial capacity and on facilities available in the situation the patient 
lives in. This increases the uncertainty of costs and quality-of-life estimates. We do 
not think, however, that the inclusion of a longer time-hori2on would substantially 
have affected the outcomes of the model. First, the model aims at incremental 
analyses comparing two different management strategies. Hence, differences in 
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costs and effects are important rather than the absolute values of one strategy. 
Secondly, due to discounting, the effect of future costs and QALYs is limited 
compared to the effect of these variables in more recent years. 
To illustrate further applications of the model, we estimated the long-term effect of 
the introduction of S. pneumoniae (SP) and N. meningitidis (NM) vaccination. It 
should be noted that this example concerns children initially presenting with 
meningeal signs, only, and does not include all patients with meningitis. 
Furthermore, our simplified example does not consider all consequences of 
vaccination thoroughly. First, the risk of an adverse outcome was assumed to 
remain stable in the model, although SP is known to carry a higher risk of 
sequelae than NM. 3 Second, we did not consider the reduction of other invasive 
infections by vaccination, such as pneumonia and otitis due to SP 22 or 
meningococcal septicaemia and their subsequent mortality or morbidity. 
Consequently, overall cost savings and gain in QALYs are underestimated. Third, 
side effects of vaccination and associated costs were not included. Finally, in 
contrast to the costs of the vaccination program, that are occurring in the present, 
the benefits of vaccination (reduction of long-term morbidity and related costs) 
will occur in future. Since the model included a discount rate of costs and benefits 
in future, the beneficial effects of vaccination are valued relatively less than their 
present costs. Estimation of effects of vaccination programmes in a model without 
discounting the benefits resulted in lower cost-utility ratios of 271 ,918 €/QAL Yand 
18,724 €/QALY for pneumococcal and meningococcal vaccination, respectively (a 
32% and 17% decrease of the cost-utility ratios, respectively). Although 
discounting costs is generally accepted by the investment argument, it is 
questionable to discount the future benefits of preventive measures. 36 Our model, 
however, shows how to assess the cost-effectiveness of vaccination programmes 
including the long-term consequences on survival, morbidity and associated 
quality-of-life following from bacterial meningitis. According to our model, 
vaccination against SP and NM would gain QALYs in future at certain costs in 
present. Of course, it remains to be discussed whether the gain in QALYs is worth 
the additional costs. Some authors have proposed criteria when to recommend a 
technology to be introduced. Strong evidence for adoption would exist for 
technologies with incremental cost-utility ratios of 20,000 €/QALY or less, and a 
moderate evidence for those with incremental cost-utility ratios of 100,000 
€/QALY or less. 37 Decisions on whether or not to introduce a new technology, 
however, may be influenced by other considerations than the economic aspects, 
such as ethical or political reasons, or personal preferences, as well. 
In conclusion, costs of long-term morbidity of bacterial meningitis largely 
outweigh the costs of initial diagnosis and treatment of children suspected of 
bacterial meningitis. In a model for accurate evaluation of preventive, diagnostic 
or therapeutic interventions in children at risk of bacterial meningitis, these long-
term costs and QAL Ys should be considered. 
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Diagnostic practice is a sequential process starting with a patient with a particular 
set of signs and symptoms. In diagnostic research, the issue is to determine the 
added value of a diagnostic test to the information already available. Electronic 
patient files including data from routine patient care receive increased attention 
in medical science, and are supposed to facilitate scientific research and 
evaluation of routine care. Various problems arise, however, using routine care 
databases in diagnostic research. First; most databases do not label patients by 
their symptoms or signs but by their final diagnosis. Second; in routine care the 
diagnostic work-up of a patient is by definition determined by previous 
diagnostic (test) results. Therefore, routinely documented data are subject to so-
called work-up bias. Third; the reference test is in practice always interpreted 
with knowledge of the preceding test information, such that in scientific studies 
the diagnostic value of a test under evaluation is commonly overestimated. 
Fourth; routinely documented databases are likely to contain missing data. In this 
paper we will elaborate on these four problems in diagnostic research using 
routine care data and discuss whether and how they can be overcome. 
Introduction 
Diagnostic practice is a sequential, stepwise process starting with a patient with a 
particular set of signs and symptoms. In order to ascertain or rule out a diagnosis, 
the physician decides upon additional tests based on his findings in previous 
steps, to increase or decrease the probability of a particular disease (target 
disease). Hence, to serve practice, diagnostic research should follow the 
sequential process of making a diagnosis in practice and quantify the added value 
of a diagnostic test to information already available. 1.2 Although this is recognised 
by various authors 2.1l, most prevailing diagnostic research still focus on the value 
of a single test (so-called test research) in patients selected on the presence or 
absence of the disease. But, as we will discuss below and as mentioned by others 
12, test research does not cohere with clinical practice. The fact that test research 
is the most prevailing kind of diagnostic research is probably because, in contrast 
to therapeutic research, a general methodological framework for diagnostic 
research hardly exists. The limited literature on methodology mainly describes 
test research. 10,13-16 
137 
ChapterS 
The use of electronic patient files and the construction of large databases 
including data from routine patient care is of growing interest in medical science. 
In theory, such databases may include all patient data that are relevant to 
ascertain a diagnosis in routine practice in hospital or by the general practitioner. 
Hence, the data allow to quantify the value of diagnostic tests additional to other 
(previously) obtained diagnostic information, which is the relevant knowledge for 
clinical practice. It has been argued, however, that diagnostic research using data 
from routine care may not provide valid results. 3.5.8 In this paper we consider the 
advantages and disadvantages of routine care data for diagnostic research. We 
first put forward the nature of diagnosis in practice and the preferred design for 
evaluating diagnostic tests. Subsequently, we will summarise the potential 
problems that may occur when using routine care data and discuss how these 
problems may be handled. This will all be illustrated by a clinical study on 
diagnostic procedures in children suspected of having bacterial meningitis at a 
paediatric emergency department. 
Clinical example 
At the emergency department of the Sophia Children's Hospital, Rotterdam, The 
Netherlands, we performed a study on children visiting the emergency 
department because of meningeal signs. 17.19 These children pose a diagnostic 
dilemma for the physician, because they are at risk of bacterial meningitis (target 
disease 16), but may have self-limiting diseases in 50 - 60% as well. 18.20.21 The 
question is in which of these children a lumbar puncture should be performed and 
empirical antibiotic treatment should be started, such that not a single case of 
bacterial meningitis will be missed. Therefore, a prediction rule for bacterial 
meningitis was derived and validated in children presenting with meningeal signs 
at the emergency department. The rule included independent predictors of 
bacterial meningitis, obtained from patient history, physical examination and 
laboratory tests of blood and cerebrospinal fluld as performed in routine care. For 
further details, we refer to previous publications. 17,19 
Diagnostic practice and the nature of diagnostic research 
In practice, a diagnosis starts with a patient with a clinical problem (symptoms or 
signs) and suspected of having a particular disease, the so-called target disease 
2.7.22 In our example this would be children with meningeal signs, suspected of 
having bacterial meningitis. As shown in Figure I, the physician commonly 
applies a phased work-up starting with patient history and physical examination. 
Subsequent steps in general may be additional laboratory tests of e.g. blood or 
urine, imaging or other invasive tests such as in our example a lumbar puncture. 
After each phase the physician will consider the available diagnostic information 
to implicitly estimate the probability of the presence of the target disease 
(P(D+lph, pel or p(D+lph, pe, tI) in Figure 1).2,11 In patients with a very low 
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probability of the target disease, the physician may refrain from further 
diagnostic testing for that disease, and if necessary, search (or test) for the 
presence of alternative diseases or even discharge the patient. In patients with a 
high target disease probability, treatment will be initiated. As long as uncertainty 
remains, further diagnostic tests are applied until a treatment decision (including 
no treatment) can safely be made. In this sense, to set a diagnosis is to know that 
more information would not change the decision to act as if the patient has the 
disease; to rule out a disease is to know that more information would not change 
the decision to act as if the patient did not have the disease. 23-25 
r:--:--::-, p(D+) 
-
Patient history and 
physleui axnmirmlion 
p(O+lph. po. t1) 
rM~;;;toicl$ci' 1 ~ ____ ---,I 
~ 
, 
r-T----~ Jp{O+lph.po.t1.12) r:-;----, I f)st2-n l~ ______ ", 
------~ \ 
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Figure 1 illustration of a typical diagnostic process in clinical practice 
PH: patient history; PE: physical examination; tl: result of test 1; t2 - n: result of test 2 up 
to test n; Dashed elements not necessarily occur in all patients 
p(D+): probability of disease; p(D+ Iph, pe): probability of disease given the information 
from ph and pe 
Diagnostic research is pragmatic research, meaning that it should reflect the 
(sequential) process of diagnostic practice. In the conventional outlook of 
diagnostic research (i.e. 'test research'), however, the test result appears to be 
the central source of information. Commonly this test result is expressed as a 
function of presence or absence of the illness in terms such as sensitivity and 
specificity. 2,6,1,10,11,25 In practice, however, as illustrated in Figure 1, every test is 
evaluated with reference to preceding information and a diagnosis is set by 
considering all information combined. Setting a diagnosis is of multivariate 
concern per se. Furthermore, in most diagnostic research patients are selected on 
the known presence or absence of a particular disease (i.e. that they had 
undergone the reference test). For example, studies on the diagnosis of 
meningitis selected patients with (by lumbar puncture) proven presence or 
absence of bacterial meningitis and compared the frequency of symptoms of 
those with and without bacterial meningitis. 26,27 Such study design and analysis, 
however, does not inform about the probability of the presence or absence of a 
disease in patients with a particular set of symptoms or signs. 25 Patient selection 
on the presence or absence of a diagnosis leads to inclusion of selected patient 
groups and will overestimate the true value of the evaluated tests. 2-5,8,9,12 Also, 
studies on the value of a particular diagnostic test (e.g. routine blood values) only 
include those patients that had undergone that test. 28 But, in practice, a physician 
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refers patients selectively for additional diagnostic tests, based on previous 
findings (Figure 1). Thus, selection on whether a patient underwent a particular 
test or not, is influenced by the physicians work-up, which will, again, leads to 
biased estimates of the sensitivity and specificity of that particular test. 3.5,8,29,30. 
To serve clinical practice, diagnostic research should quantify which findings 
contribute to the estimation of the probability of the presence or absence of the 
disease. 2,31,32 The motive of such research is efficiency. From this, it follows that 
every finding that may contribute to probability estimation should be considered. 
To this aim routinely documented data may be used, since they in principle 
comprise all patient data that may be relevant to ascertain a diagnosis in practice. 
Furthermore, as routinely documented data include the entire diagnostic and 
therapeutic process, they allow for the stepwise analysis of tests in the sequence 
as they occurred in routine practice, and to estimate their added value. 2,33 
Problems of using routine data 
Selection of the proper patient population 
As discussed above, in diagnostic research patients should be selected on the 
symptoms or signs by which they come to the physician's attention. 2,5,8,9,11,31,32 In 
our example, we selected children presenting themselves with meningeal signs. 
The aim was to determine the independent (added) value of diagnostic tests 
(including patient history and physical exantination items) in the discrimination 
between presence or absence of bacterial meningitis. This selection included the 
complete spectrum of differential diagnoses of patients with meningeal signs 
conform practice. 18 Of course this population did not reflect all patients with 
meningitis, since meningitis may be present without meningeal signs 34,35, but that 
was the purpose of the study. To enhance the applicability of diagnostic study 
results in future patients, they should be selected on a same, clearly defined, 
patient profile, by which they may visit the physician. 22,36,37 
The selection of patients on symptoms or signs is often not feasible in studies 
using existing databases, since most patient classification systems in hospitals are 
based on the final diagnosis. The presence of a problem-oriented patient 
classification system, however, allows to perform (retrospective) diagnostic 
studies with patients selected on their clinical profile. Such a classification system 
has been used in the Sophia Children's Hospital, Rotterdam since 1988, In this 
system, presenting problems are classified first by organ system and 
subsequently by a sign or symptom, an abnormal laboratory result or a presumed 
diagnosis. The main reason for consulting the outpatient or emergency 
department is prospectively coded for each patient by one of the paediatricians. 
38,39 Using this coding system, we could identify all children with 'meningeal 
signs' as the main reason for encounter. To include such a problem oriented 
coding system in the hospital registration may be recommended to other 
hospitals interested in diagnostic research. 
140 
Diagnostic research in paediatrics 
Verification bias 
Ideally, in diagnostic research all patients suspected of a particular disease have 
the same diagnostic work-up, i.e, undergo the same diagnostic phases, including 
the reference test for the outcome diagnosis. As reference tests sometimes 
convey a (mortality) risk, are invasive or expensive, the results from such a test 
are not always routinely available in all patients. This is particularly likely in 
patients with a low probability of the target disease based on previous 
information. 3,5,6,40-42 For research purposes, the clinical course over time or a 
combination of test results (so-called 'consensus diagnosis') is often used to 
define the final diagnosis in such patients without a reference test result. 32.40.43 
Such an approach is not uncommon in diagnostic studies. 44,45 Of course, such an 
assessment of the final diagnosis is not as 'established' as perhaps preferred for 
research and the true diagnosis may even be missed. This misclassification in the 
diagnostic outcome categories may result in a biased value of tests under study 
(verification or work-up bias). In case of a disease that is fatal or rapidly 
progressing without treatment, however, it seems reasonable to consider the 
target disease to be absent if the patient that did not undergo the reference test 
recovers without treatment. Target diseases with a subclinical or self-limiting 
course, however, are easily subject to misclassification, leading to work-up bias. 
3,12,42 In our example, the outcome diagnosis was the presence or absence of 
bacterial meningitis, which is a rapidly progressing disease without treatment. 46 
In patients without a lumbar puncture, bacterial meningitis was ruled out based on 
an uneventful clinical course without treatment. An alternative outcome definition 
would have been the presence or absence of meningitis (including bacterial, viral 
en aseptic, defined by bacteriologic and viral cultures from cerebrospinal fluid). 
Since viral meningitis, if untreated, may recover uneventfully 47, this alternative 
would have increased misclassification and biased the results. 
Blinding 
If the reference test is interpreted using information from preceding tests, this 
may overestimate the diagnostic value of the preceding test, also referred to as 
'incorporation bias', 'test review bias', or 'diagnostic review bias'. 6,9,15,32,48 
Blinding the interpreter of the reference test from the test under study prevents 
this incorporation bias. In practice, however, each test is always considered with 
knowledge of other information. Hence, in diagnostic studies using routinely 
documented data such blinding is commonly not guaranteed. But, a reference test 
yielding merely objective results, i.e. not based on subjective interpretation (as is 
the case with imaging tests), nor influenced by preceding information, does suffer 
less from this potential bias. In such instances, the reference test result as found in 
the routine care data can be used validly. In our example 17.19, the reference test 
included an increased cell count in cerebrospinal fluid (CSF) and a positive 
culture from CSF of blood, which is rather objective and not influenced by 
subjective interpretation. 
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Missing data and analysis 
Missing data are more likely in routinely documented data than in prospectively 
collected data. Standard data analytical techniques exclude subjects with a 
missing value on a variable. 49.50 Consequently, the data-analysis in diagnostic 
research commonly includes cases without missing data only. In case of a high 
frequency of missing data or if many variables are considered, this may grossly 
reduce the number of patients to be included in the analysis and therefore the 
power of the study. Furthermore, this 'complete case' analysis may yield biased 
results, since the cases excluded because of missing data may systematically 
differ from the complete cases. 49-52 A patient with a very severe condition, for 
example, is probably referred for more sophisticated diagnostic tests, before full 
completion of patient history and physical examination. On the other hand, in a 
patient presenting with a disease of very low severity, additional test information 
may be incomplete, as the physician ruled out a serious disease early in the 
diagnostic process and did not consider additional tests to be necessary. In 
routine care data, therefore, results of diagnostic tests are often missing simply 
because the decision whether or not to perform the test is based on clinical 
judgement of the patient by the physician (Figure I). 24 Missing data in routine 
care tend not to occur at random, but for a reason, e.g. 'on indication'. 
Imputation techniques may serve to overcome the selection bias due to missing 
data in diagnostic research using routine patient care data and to increase the 
efficiency of the analysis. Frequently applied methods, e.g. imputation of mean 
values of available data or the so-called 'indicator method', however, may also 
lead to biased estimates. 50-52 More recent methods, i.e. the maximum-likelihood 
method and multiple imputation, have been proposed which seem to yield valid 
estimates. These imputation methods use all information available from the 
actually documented data to impute the missing values. Furthermore, multiple 
imputation allows to incorporate the uncertainty among the imputed value. 50-52 By 
multiple imputation each missing data is imputed more than once in a Bayesian 
way, such that multiple databases with complete data are obtained. Repeating the 
analyses on each of the imputed datasets and averaging the results according to 
standard statistical techniques 50 will result in unbiased estimates of the 
regression coefficients and their standard errors. The number of repeated 
imputations depends on the fraction of missing data. In case of missing values up 
to 50%, reliable inferences can be obtained by using five imputations. 52 The 
multiple imputation method is an accepted and valid statistical method for the 
problem of missing data, as long as the probability of missing depends on 
observed values only. 50-52 The allowable proportion of missing data in order to 
obtain valid results using routine care data in diagnostic research, however, is not 
known. It may be argued that diagnostic items with a very high proportion of 
missing data should be excluded from the analysis anyway, since they are 
presumably difficult to obtain in practice, often unavailable or not considered 
clinically important. 
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Given a complete dataset after proper imputation, routinely documented data 
including the entire, stepwise, diagnostic work-up and the clinical course 
facilitate proper analysis of diagnostic tests in the sequence as they commonly 
occur in routine practice. In contrast to single test evaluation or test research, 
multivariate logistic regression modelling allows for probability estimation of the 
presence of a disease as a combined function of available characteristics from 
patient history, examination and additional laboratory tests. 1.2.25.31.49 This 
probability estimation based on all diagnostic information together, directly 
coheres with the diagnostic process in practice. Moreover, the logistic model 
obviates the need for sensitivity, specificity or likelihood ratio. The discriminative 
value of a diagnostic model can be expressed by the area under the Receiver 
Operator Characteristic curve (ROC-area). 53.54 From such a logistic model a 
prediction or decision rule can be derived, that is easy applicable in practice. Of 
course, before introducing a diagnostic rule in clinical practice, prospective 
application of the rule in a new group of similar patients is necessary to get insight 
in the rule's usefulness and its impact on the diagnostic process in practice. 25,49 
For specific details on methods of analysis we refer to the statistical literature. 
1,2,31,53-59 
Conclusion 
For meaningful and valid inference, diagnostic research needs to reflect the 
sequential diagnostic work-up of clinical practice. It starts with patients selected 
on their disease suspicion, who underwent all clinically relevant steps in the 
diagnostic work-up. Preferably, the reference test is interpreted independently 
from the preceding information. Commonly, the diagnostic added value of tests is 
of interest, with reference to the preceding information available from patient 
history and physical examination. After some adjustments such as imputation of 
missing data if necessary, valid and useful diagnostic research may be based on 
routinely documented data including the whole diagnostic, therapeutic and 
prognostic phase as recorded in routine practice. 
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Summary and future perspectives 
Introduction 
A child with meningeal signs poses a diagnostic dilemma. Meningeal signs are 
indicative of bacterial meningitis, but a large part of the children with these signs 
have less serious diseases. 1.2 Missing the diagnosis of bacterial meningitis will 
lead to delayed treatment, and thereby increasing the risk of mortality and 
morbidity. 3.4 The aim of this thesis is to determine whether systematic diagnostic 
research, using data that are routinely obtained from clinical practice, can 
optimise the diagnostic work-up of patients with meningeal signs. In particular the 
diagnostic and prognostic aspects of children suspected of bacterial meningitis 
are at issue in this thesis and are used to illustrate the more general 
methodological principles and methods of diagnostic and prognostic research. In 
addition, we address the issues of health-related quality-of-life and economic 
evaluation of clinical practice. 
All studies in this thesis have been performed on patients aged from one month 
up to 15 years, with 'meningeal signs' as the main reason of visiting the paediatric 
emergency department. These patients could be traced retrospectively, using a 
problem-oriented patient classification system as applied in the Sophia Children's 
hospital since 1988. 5 In the retrospective studies (chapter 2.1, 2.2, 2.3, 3.1, 3.2 
and 4.1), we used data collected from children visiting the emergency 
department of the Sophia Children's hospital, Rotterdam between 1988 and 1998. 
Chapter 3.2 used data from similar patients from the Juliana Children's Hospital, 
The Hague as well. Chapter 2.4 used data of similar patients visiting the Sophia 
and Juliana Children's Hospital, the Sint Fransiscus Hospital, Rotterdam, and the 
Reinier de Graaf Hospital, Delft, between 1999 and 2000. All data were collected 
from the paediatric patient record, which has a standardised format. The data 
included patients' general characteristics, and information obtained from patient 
history and physical examination, from the clinical course and from outpatient 
follow-up. Laboratory and radiographic test results were retrieved from the 
hospital information system. 
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Diagnostic dilemmas in children with meningeal signs 
Differential diagnoses in children with meningeal signs 
The diagnoses, as assessed in children visiting the emergency department with 
meningeal signs, have been described in chapter 2.1. Corresponding to previous 
studies 1.2, a large diversity in final diagnoses was found in these children: 30% 
bacterial meningitis, 13% viral or aseptic meningitis, 11 % other serious bacterial 
infections and 46% upper respiratory tract infections, or other self-limiting 
diseases. This reflects the diagnostic dilemma for the physician faced with a child 
with meningeal signs: because of the serious consequences of missing the 
diagnosis bacterial meningitis, even children with very low risk will be referred 
to the paediatrician to rule out this diagnosis. 
In practice, meningeal irritation is considered if Brudszinky signs 1 or 2, Kernig 
sign, nuchal rigidity or the tripod phenomenon are positive, but not all signs need 
to be present. In children younger than one, symptoms of irritability during 
manipulation of head or legs and a bulging fontanel are additional signs of 
meningeal irritation. Some studies have found some signs to be better predictors 
than others have. 2.6.7 In our study (chapter 2.1), we could not identify one of the 
signs as mentioned above, nor combinations of them, that predicted the presence 
or absence of bacterial meningitis better than the other could. 
Predictors ofhacterial meningitis 
In chapter 2.2 we have studied clinical characteristics, obtained at admission, that 
independently contributed to the discrimination between the presence or 
absence of bacterial meningitis in children with 'meningeal signs'. These 
predictors are: duration of the complaint (in days) and vomiting in history, 
presence of meningeal irritation, cyanosis, disturbed consciousness and 
petechiae at physical examination and the serum C-reactive protein concentration 
(CRP). The serum CRP is the only laboratory test that contributed to the 
information already available from patient history and physical examination. 
Meningeal irritation at physical examination is one of the strongest predictors in 
our model. This concords with clinical practice, in which most doctors will 
perform a lumbar puncture in everyone with meningeal irritation. The other 
clinical characteristics included in our rule provide additional help to 
discriminate between the presence of bacterial meningitis versus the absence. A 
prediction rule including all these independent predictors achieved a 
discriminative value (ROC-area) of 0.92 for the presence or absence of bacterial 
meningitis. With this rule, patients could be classified into categories of increased 
risk of bacterial meningitis. Since clinicians do not want to miss a single case of 
bacterial meningitis, we have defined a threshold value for the clinical score 
(score = 9.5) to ascertain the indication for a lumbar puncture. Using the rule with 
this threshold score, a lumbar puncture could be withheld in 35% of children with 
meningeal signs, without missing one case of bacterial meningitis. 
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In those patients in whom a lumbar puncture is indicated by their clinical profile, 
we have assessed the cerebrospinal fluid (CSF) indices that independently 
contributed to the assessment of the diagnosis bacterial meningitis in chapter 2.3. 
No CSF index could solely discriminate between patients with and without 
bacterial meningitis, since the ranges of CSF cell count, glucose etc. as found in 
patients with viral meningitis largely overlapped possible ranges found in those 
with bacterial meningitis. We have shown that the CSF polymorphonuclear cell 
count and the glucose ratio of CSF and blood independently contributed to the 
clinical profile as assessed by clinical risk score (chapter 2.2), in diagnosing 
bacterial meningitis. Using the clinical score and CSF score together, 30% of the 
patients with a lumbar puncture could be identified in whom empirical antibiotic 
treatment could be withheld, without missing one case of bacterial meningitis. 
Combining the CSF score with the clinical score reflects clinical practice, in which 
laboratory tests are always judged in view of clinical signs and symptoms in a 
particular patient. 
In chapter 2.4 the actual performance of the diagnostic decision rule in clinical 
practice has been validated prospectively in four hospitals: one academic 
paediatric hospital, one paediatric hospital, and two general hospitals. For each 
patient, the variables of the decision rule were prospectively assessed by one of 
the paediatricians (in training) of the participating hospitals using a scoring form, 
providing a description of the variable definitions. Of course, some variability 
between clinicians occurred when assessing the variables, due to lack of 
standardised definitions of recording data. This, however, will occur in future 
practice as well, and thus informs on the practical applicability of the rule. 
Application of the rule in 176 new patients, who initially presented themselves 
with meningeal signs, showed a similar performance of the clinical score (ROC-
area: 0.87) as in the derivation population (chapter 2.2). The discriminative value 
of the CSF score in patients with an indication for lumbar puncture (based on the 
clinical score) was 0.95. In the new population, however, some patients with 
bacterial meningitis had lower clinical and CSF scores than in the derivation 
population. Therefore, we adjusted the threshold values for the indication of a 
lumbar puncture or empirical treatment, in order not to misdiagnose one child 
with bacterial meningitis. 
Implications of the rule for clinical practice 
The decision rule aims to guide decisions on two sequential steps in the care of 
children with meningeal signs: whether or not to perform a lumbar puncture and 
whether or not to initiate empirical treatment. The value of the scores, assigned to 
each predictor in the rule, indicates how the presence or absence of one 
characteristic influences the risk of bacterial meningitis in particular. The scoring 
rule enables the physician to classify patients into categories of increased risk of 
bacterial meningitis. We have recommended threshold values in the decision rule 
to decide upon the need of a lumbar puncture or initiating empirical treatment, 
such that no case of bacterial meningitis will be missed in its use. Using these 
threshold values, the diagnostic rule increased the prior probability of bacterial 
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merungitis in all children with merungeal signs from II % to 20% in those selected 
for a lumbar puncture and to 39 % in those selected for empirical treatment. 
In some clinical circumstances, physicians may hesitate to withhold a lumbar 
puncture although it is not indicated by the rule. Therefore, we have evaluated the 
performance of the decision rule in all patients who actually underwent a lumbar 
puncture on the physician's decision. The same clinical and CSF characteristics 
were applicable and a sinti!ar number of patients was selected for empirical 
treatment. Therefore, we state that the rule can validly be applied in patients with 
merungeal signs and undergoing a lumbar puncture based on the physician's 
decision only, as well. 
In developing our decision rule, the outcome diagnosis was presence or absence 
of bacterial merungitis. Therefore, the rule will miss the diagnosis of some cases 
of viral or aseptic merungitis. The question is, however, why diagnostic tests are 
performed: for therapeutic reasons or also for 'the sake of knowing' without clear 
therapeutic consequences. In the first case, a lumbar puncture is not indicated in 
order to detect viral or aseptic merungitis, since these patients generally require 
symptomatic treatment only. 8 Of course, this view may change whenever antiviral 
treatments become available. 
Some generalising aspects of the rule need to be discussed. First; the rule has 
been derived on data from patients in the Sophia Children's Hospital, which is an 
academic paediatric hospital, situated in the inner city of Rotterdam. It receives 
about 2,500 new patients at the emergency department annually; of whom 90% 
needs basic-paediatric care. 9 Therefore, we expect the results to apply to 
general hospitals as well. Application of the rule in three other hospitals with their 
particular patient populations (chapter 2.4) indeed showed good performance of 
the rule. Second, the data on which the rule has been derived partly included the 
period before the routine H. infIuenzae type b (HIE) immunisation of infants. 10 
Since the diagnostic decision rule may be implemented in a future era without 
HIE, we performed a separate analysis with exclusion of the HIE cases. This 
resulted in the same predictors with a sinti!ar rule. In addition, the prospective 
application of the rule during 1999 and 2000 appeared to be valid. Third, our 
study has been based on patients selected on their clinical presentation, i.e. 
'merungeal signs'. Since merungeal signs are less prominent in young children 
11.12, the age distribution in our study population is probably influenced by 
selection on 'merungeal signs'. Of course, our population did not reflect all cases 
of bacterial merungitis, since patients with a dominance of other symptoms of 
meningitis (such as seizures, or coma 11,12) did not meet our inclusion criteria. 
This, however, does not affect the generalisability of the rule, as long as it is used 
in populations selected on the same clinical presentation. 
The principle aim of the development of diagnostic protocols or decision rules is 
to apply them and optimise clinical practice. In the implementation of a rule, 
however, some barriers are met. Although a majority of paediatricians is familiar 
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with decision rules or guidelines, only one third uses them frequently in practice. 
13 Preferably, decision rules should be simple and easy applicable, but should 
allow flexible patient management also. 14 Furthermore, information to physicians 
on the effectiveness of the rule compared to actual practice may improve its use. 
15 
Prognosis 
Description of outcome after bacterial meningitis 
Despite adequate treatment and intensive care support, bacterial meningitis still 
causes mortality and morbidity in 5% and 10 - 15%, respectively. 16 In chapter 3.1 
we assessed the frequency of sequelae occurring after bacterial meningitis in 
children initially presenting with meningeal signs. Among 103 children with 
bacterial meningitis, two died (2%), seven had permanent neurological sequelae 
(7%) and in seven hearing impairment was detected during follow-up (7%). In 
concordance with previous studies, hearing impairment occurred most frequently 
isolated from neurological sequelae in our study; only one child had a 
combination of hearing impairment and neurological sequelae. In two children, 
multiple neurological sequelae were present. The main problem in studies on the 
prognosis of bacterial meningitis is the diversity of sequelae and the low 
frequency of severe sequelae, requiring large study populations for correct 
estimates. An overview of the characteristics of studies on the long-term 
prognosis of bacterial meningitis is presented in Table L These studies 
substantially differ in study design or population, age or pathogen distribution, 
duration of follow-up or the definition of end-points. Due to these differences, the 
results are difficult to compare. 
The risk of sequelae is known to be related to pathogen type. 16 We have found a 
10% mortality after pneumococcal meningitis and sequelae occurring in 56%. 
After meningococcal and HIE-meningitis, sequelae occurred in 6% and 12%, 
respectively. The introduction of routine HIE-vaccination in infants has 
substantially changed the pathogen spectrum of childhood bacterial meningitis. 
10,17,18 In our study on children with meningeal signs, we included 25 cases of 
bacterial meningitis between July 1993 and December 1998, which is only one 
third of the number included between January 1988 and June 1993 (78 cases of 
bacterial meningitis). The relative frequency of sequelae, however, was similar in 
both periOds: 13% (95% CI: 6 - 22%) and 20% (95% CI: 7 - 41 %), respectively. 
Prediction of an adverse outcome 
To determine the independent associates of sequelae or death, we have 
performed a multivariate analysis of potential prognostic indicators in chapter 3. 
From information available within the first 24 hours of presentation, we have found 
male gender, atypical seizures in recent history, and low body temperature at 
admission, to be independently associated with an adverse outcome. A prediction 
153 
Table 1 Overview of long~term prognostic studies of childhood bacterial meningitis (1984 - 2000) 
Author$ Study type Total Age Duration of Adverse Pathogen type 
number of follow~up outcome* HIB NM 8P Other 
patients 
Antila (1994)20 Prospective 134 31%<lyr 12 months 29 (22%)* 100 (76%) 18 (13%) 9 (7%) 7 (6%) 
Akpede (1999)19 Prospective lOS§ 34% < I yr Unknown 47 (43%) 2 (2%) 43 (39%) 8 (8%) 13 (12%) 
Lin (IS84)93 Retrospective 476 5w-llyr Discharge 71 (15%) 335 (70%) 62 (13%) 45 (10%) 34 (37%) 
Madagame (1996)26 Retrospective 32 MedianS.8m Median 41.6 m 21 (69%) 14 (44%) 6 (19%) 9 (2B%) 3 (9%) 
Pomeroy (1990)21 Prospective IB5 Median 10m Median 10 yrs 26 (14%)1 liB (64%) 20 (11 %) 30 (16%) 17 (9%) 
Pikis (1996)2$ Retrospective 90 63%<lyr Mean 12.3 yrs 14 (16%)1 90 (100%) 
Komelisse (1996)24 Retrospective B3 64% < 1 yr Discharge 39 (47%) B3 (100%) 
Kaaresen (1996)22 Retrospective 92 Median 1.9 yr I yr IB (20%) 46 (49%) 21 (23%) 7 (B%) 19 (21%) 
Grimwood (1996)21 Prospective 138 38% < 1 yr 6-9 yr 19 (14%) 104 (76%) 21 (16%) 13 (10%) 
Woolley (1999)30 Retrospective 432 Median 7.7 m 1~5 yr 69 (14%)t 177 (41%) 49 (11%) 63 (16%) 143 (33%) 
Valmari (1987)11 Retrospective 123 Median 20m Mean2m IS (15%) 80 (65%) 23 (19%) 7 (6%) 13 (10%) 
Oostenbrink (2000)'1[ Retrospective 103 26% < I yr Median 7 m 16 (16%) 34 (32%) 51 (60%) 10 (10%) 8 (8%) 
$ all studies were performed on patients of the paediatric ward, except for Madagame et al.23 including intensive care patients only 
* defined as mortality or neurological/audiological sequelae except for t: neurological/audiological sequelae among survivors only and t: hearing loss only 
§ in 46 bacterial meningitis was confirmed by CSF pleocytosis and depressed glucose levels in absence of pathogens identified on Gram-stain or culture 
11 Chapter 3.2 of this thesis 
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model including these variables has a prognostic value (ROC-area) of 0.82 (95% 
CI: 0.72 - 0.93). From the variables obtained later during hospitalisation. only the 
pathogen type is of added prognostic value and increases the prognostic value of 
the model to 0.87 (95% CI: 0.78 - 0.96). In this final model the pathogen type has 
the largest prognostic impact, with an odds ratio of 22.6 if S. pneumoniae is 
present. Other characteristics from the clinical course, such as fever pattern or 
persistence of meningeal signs are not of prognostic added value. 
Although several studies have been performed on the long-term prognostic 
characteristics of children with bacterial meningitis 19-30, their conclusions are 
different and sometimes contradicting, as we showed in chapter 3.2 This may 
result from differences in study population (defined by e.g. presenting symptoms, 
age, pathogen type or disease severity) as presented in Table I and from 
different statistical methods (uni-or multivariate, or stratified analysis). 
Furthermore, the number of patients with sequelae in the study populations is 
often limited, which decreases the power of the study to select important 
predictors. 
Since presence of neurological sequelae may not be clear at the moment of 
discharge, but become visible during follow-up, a short follow-up may 
underestimate the occurrence of sequelae, in young children in particular. In our 
study, the median duration of follow-up was seven months. Half of the children 
younger than one year, however, had a follow-up of more than nine months. 
Therefore, the duration of follow-up appeared not to bias the incidence of 
sequelae in this study. 
Implications for clinical practice 
Based on independent prognostic predictors of bacterial meningitis, a prediction 
rule has been formulated. With this rule, the physician can estimate the 
probability of an adverse outcome after bacterial meningitis based on 
observations in the individual patient. The predictors in the rule are all available 
within three days, and therefore the probability on an adverse outcome can be 
assessed in an early phase of the clinical course. This information may help the 
physician in parental counselling and in guiding plans for long-term follow-up for 
specific subgroups. Unfortunately, the prediction rule can not predict the specific 
type of sequelae, probably due to different causal processes underlying 
audiological sequelae and neurological sequelae. Audiological sequelae are 
probably due to the toxic effect of the pathogen and of inflammatory mediators on 
inner ear hair cells. Neurological sequelae, in contrast, result from direct 
parenchymal damage. 4.31.32 
In the studies of chapter 3, the minor sequelae after bacterial meningitis, such as 
mild behavioural problems, learning disabilities and attention deficits, are not 
addressed. Information on mild sequelae is often not routinely included in the 
patient record and thus not available for us, using routinely collected data from 
the patient record. Moreover, these mild sequelae may remain unnoticed until 
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schoolgoing-age, requiring a long period of follow-up of children with bacterial 
meningitis, using neuropsychological tests for detection. 33.34 
The duration of follow-up may depend on the characteristics of the individual 
patient. Frequently, sequelae present at discharge recover spontaneously. 27 On 
the other hand, seizures may occur after a disease free interval, in particular in 
patients with focal neurological deficits during the acute phase of meningitis. 
These late seizures rarely occur after a disease free interval of two years or more. 
27 
Quality-of-life in children after bacterial meningitis 
Additional to categorising patients according to their type of sequelae, the health 
state associated with a particular sequelae can be valued, to express the relative 
severity of the sub-optimal health state with reference to perfect health or death. 
For cost-utility analysis of the diagnostic rule, we needed such values (preference 
scores) for permanent disabling sequelae after bacterial meningitis. Some studies 
have assessed parents' preference values for outcomes of bacteraemia or 
neonatal care, but the values substantially varied between studies and did not 
include all possible health states following bacterial meningitis. 35-37 Empirical 
description of health-related quality-of-life (HRQoL) in children raises some 
problems. Due to their age-related development, children are a heterogeneous 
group, which has important consequences for description of HRQoL. First, 
children may be too young to provide their own estimation of quality-of-life, since 
it requires the cognitive ability of filling in forms, understanding the 
questionnaires and responding. 38 This problem may be solved by using 
measures adapted to their level of communicative and cognitive development or 
by using a proxy (e.g. a parent or teacher). In general, proxies can reliably 
describe the child's physical, psychological and social functioning (which are at 
issue in health-related quality-of-life) 37-39, in contrast to describing the affective 
dimensions, as at issue in the broader 'quality-of-life'. 40-42 Second, some 
dimensions included in the health status measure may not yet be appropriate for 
children, such as school performance, independence in daily life or fertility 
issues. 38.43 This requires adaptation of the contents of the physical, psychological 
and social domain in the instrument. Finally, the prognostic value of health status 
is of additional importance in the measurement of HRQoL in children. 
Two generic instruments are available in Dutch for measuring health-related 
quality-of-life, i.e. EQ-SD and the Health Utilities Index (HUl), that both yield a 
preference score (utility) reflecting the severity of the sub-optimal health state 
related to perfect health and death. 44-46 No empirical information existed, 
however, on their relative performance. Evaluating these measures, substantial 
differences can be found, with regard to the derivation of their algorithms, 
dimensional contents of the instrument, scaling and underlying concept of health. 
In chapter 3.3 we have studied the differences between the preference scores 
obtained by the two instruments for seven health states associated with 
neurological sequelae of bacterial meningitis. No differences were found with 
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regard to the feasibility of the instruments. The preference scores obtained by the 
HUI were substantially lower than those obtained by the EQ-5D. The largest 
clifferences in preference scores were found for health states associated with 
'deafness' and 'mental retardation'. The differences in preference scores 
obtained by the two instruments lead to a different ranking order of the vignettes, 
as well. These clifferences in preference scores and ranking order may result from 
the fact that the EQ-5D does neither contain a dimension for hearing function nor 
for cognition, in contrast to the HUI. This lack of cognition illustrates one of the 
disadvantages of the EQ-5D for populations characterised (in part) by cognitive 
dysfunction. 4' Evaluation of the variance components of the preference scores 
obtained by the instruments showed that the interaction between the health states 
and instruments substantially influenced the value of the preference scores: one 
instrument values some health states different from others. Because of the impact 
of the dimensional contents of instruments on the value of preference scores for 
particular health states, the type of sequelae at interest should guide decisions on 
the particular instrument for quality-of-life measurement to be used in future 
studies. 
Economic evaluation 
The effects of the use of the decision rule on the number of lumbar punctures 
performed, the number of empirical treatments initiated and the associated cost 
expenditures of interventions have been assessed in chapter 4. 
The possible cost savings following the application of the decision rule compared 
to actual practice are estimated in chapter 4.1 Since in practice a physician does 
not want to miss a single case of bacterial meningitis, we have chosen for a cost 
minimisation study, involving a comparison of costs of two strategies with a 
similar outcome. Using the rule without misdiagnosing a single case of bacterial 
meningitis, reduced total costs by 10%: a mean cost saving of € 292 per patient. 
As could be expected from the high nursery costs compared to those of 
diagnostic tests, the largest costs savings by the rule were achieved in the 
therapeutic phase (90% of total reduction), and only 10% of the total reduction in 
the diagnostic phase. This may suggest that introducing more diagnostic tests, in 
order to rule out some diagnoses and subsequent therapies, increases the cost-
effectiveness of clinical practice. Diagnostic tests, however, are not always 
conclusive and will yield some false positives and false negatives. 48.49 These 
figures will increase by increasing the number of tests, and subsequently reduce 
the cost-effectiveness. The study of chapter 4.1 underlines the importance of 
taking the complete therapeutic course into account, instead of the diagnostic 
tests only. Cost evaluation of diagnostic tests only, without their therapeutic 
consequences may lead to false conclusions. 
Of course, the cost estimates in chapter 4.1 concern the net cost reduction as 
estimated for the Sophia Children's Hospital. The cost savings may be different for 
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hospitals that are more or less reluctant to perform diagnostic tests or to start 
therapeutic interventions. To extrapolate the results to other hospitals, we have 
identified key determinants of changes in the cost estimates by sensitivity 
analysis. The cost savings mainly depend on the inpatient nursing costs, the 
frequency distribution of bacterial meningitis and self-limiting diseases among 
patients with meningeal signs and the hospitalisation rate of the latter group. 
Using these determinants, with corresponding values for one's own hospital, one 
can roughly estimate the possible cost savings following the application of the 
decision rule in one's own hospital. 
In chapter 4.2 we introduce a model to estimate the consequences of adequate 
diagnosis and treatment in patients with meningeal signs in terms of quality-
adjusted-life-years (OALYs) and costs. This model takes into account the entire 
course of diagnosis, treatment and management of long-term sequelae. To 
incorporate the downstream consequences of bacterial meningitis, the model 
includes a time horizon of 15 years. The costs associated with long-term morbidity 
after bacterial meningitis constitute 65 % of all costs. The model is sensitive in 
particular for the prior probability of bacterial meningitis in patients with 
meningeal signs, the risk of neurological sequelae after meningitis, and the costs 
associated with long-term neurological sequelae. Costs of diagnostic tests hardly 
influence the model outcomes. Different diagnostic strategies (ranging from a 
very conservative to a more reluctant approach), however, have a large impact on 
the costs and OALYs of the model by increasing the risk of morbidity. In the 
management of the patient, the physician implicitly considers the trade-offs that 
influence the decision whether to withheld therapy, order another test, or to start 
therapy. 49.50 The study in chapter 4.2 has explicitly shown, from a cost 
perspective, that it is not worth running the risk of missing one case of bacterial 
meningitis by reducing diagnostic tests. Furthermore, the model may allow cost-
effectiveness analysis of future interventions affecting the diagnostic, therapeutic 
or prognostic course of children with meningeal signs, incorporating the long-
term costs and OALYs. This is illustrated by a cost-utility analysis of new 
vaccination strategies in chapter 4.2. Although some previous studies have 
estimated the expected cost-effectiveness of vaccination programmes 51-53, the 
long-term consequences on quality-of-life and costs have not been considered so 
far. The reduction of the prior risk of bacterial meningitis due to vaccination 
strategies substantially reduced costs and increased OAL Y s in our model. This 
long-term benefit should be taken into account in studies on the effect of future 
vaccination strategies. Of course, reduction of other invasive infections, due to 
vaccination, such as pneumococcal pneumonia and otitis, or meningococcal 
septicaemia, were not included in our model. Therefore, this study is not 
conclusive on the cost-effectiveness of new vaccination strategies. Our model, 
however, informs on associated costs and effects of prevention of meningitis, 
which is a major component of the potential cost-effectiveness of vaccination 
programmes. The increase in costs due to vaccination should be considered in 
view of the gain in quality adjusted life-years (incremental cost-utility ratio). Some 
authors have proposed criteria for introduction of new technology. Strong 
158 
Summary 
evidence for adoption would exist for technologies with incremental cost-utility 
ratios of 20,000 €/QALY or less, and a moderate evidence for those with 
incremental cost-utility ratios of 100,000 €/QALY or less. 54 A recently introduced 
Dutch guideline measure on prevention of diabetic nephropathy for type 2 
diabetes had a cost-utility ratio of 14,000 €/QALY. 55 These values may serve as a 
raw indication of acceptable incremental cost-utility ratios of new interventions to 
be introduced. League tables, ranking selected health care interventions by their 
incremental cost-utility ratios, may additionally help to place the results of a 
particular study in a broader context. 56 Decisions on whether or not to introduce a 
new technology, however, may be influenced by other considerations than the 
economic aspects, such as emotional, ethical or political reasons, or personal 
preferences, as well. 
Methodological aspects of diagnostic research 
In practice, diagnosis starts with a patient with a clinical problem (symptoms or 
signs) who is suspected of having a particular disease, the so-called target 
disease. 57-5' The physician commouly applies a phased work-up starting with 
patient history and physical examination. Subsequent steps may be additional 
laboratory tests of e.g. blood or urine, imaging tests or invasive tests such as a 
lurubar puncture in our example. After each phase the physician will consider the 
available diagnostic information to implicitly estimate the probability of the target 
disease. 57.60 In patients with a very low probability of the target disease, the 
physician will refrain from further diagnostic testing and discharge the patient. As 
long as insecurity remains, further diagnostic tests are applied until a treatment 
decision (including no treatment) can be made. 50.61,62 Ideally, diagnostic research 
should reflect this sequential diagnostic process in clinical practice and evaluate 
which of the findings contribute to the estimation of the diagnostic probability. 
57,63,64 
According to practice, we have selected in this thesis patients on their symptoms 
or signs by which they came to the physician's attention, i,e, children with 
meningeal signs, suspected of having bacterial meningitis, We collected all data 
of these children that were routinely documented in practice and were relevant to 
set a diagnosis. Such data allow for a stepwise analysis of predictors in the 
sequence as they occur in routine practice. While performing our study on 
routinely documented data, we have encountered several methodological 
problems as described in chapter S, Although much has been written on methods 
S7,S8,60,6S~71, and various authors have proposed guidelines 72.74, still no general 
framework exists for diagnostic research. 
Study populations selected on the patient's signs and symptoms may still be 
subject to verification and incorporation bias. The first arises, when the reference 
standard to set the final diagnosis has not been performed in all patients, as is 
often the case in clinical practice. 65,67.68,75,76 It can be prevented by using an 
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outcome diagnosis that is rapidly progressing if left untreated, only, incorporation 
bias occurs when the reference test is interpreted using information from 
preceding tests, such that the diagnostic value of the preceding test is 
overestimated. 64.68.70,77 Since blinding the observer of the reference test for 
preceding tests is not feasible in routinely documented databases, an objective 
reference tests is preferred. Routinely documented data are likely to have 
missing data, due to actual practice of the physician. The problem of missing data 
can be solved reliably by multiple imputation techniques, incorporating the 
uncertainty among the imputed values. 78-80 
Given a complete dataset after imputation, routinely documented data including 
the whole diagnostic and therapeutic phase facilitate proper analysis of 
predictors in the sequence as they occur in routine practice. Multivariate logistic 
regression analysis allows for probability estimation of the presence of a disease 
as a combined function of available characteristics from patient history, 
examination and additional laboratory tests. 50,57,63,81,82 in contrast to single test 
evaluation, the logistic model makes no use of sensitivity, specificity or likelihood 
ratio and its discriminative value can be expressed by the area under the 
Receiver Operator Characteristic curve (ROC-area). 83,84 Unfortunately, the 
multivariate logistic regression analysis as most frequently applied, requires a 
dichotomous outcome, i.e. presence or absence of the disease under study. 81,BS In 
some situations, however, one may prefer to discriminate more than two groups 
of diagnostic outcome. This discrimination between three groups of patients, 
however, requires more complicated analytic methods, such as polytomous 
modelling, and larger patient groups. BS 
The principle aim of the development of diagnostic protocols is to apply them in 
clinical practice and influence actual clinical practice. Usually, the performance of 
a diagnostic protocol in a new group of patients is lower than if applied to the 
patients on which the model has been derived. 81,86-88 Therefore, estimation of the 
actual performance of the diagnostic protocol in a new group of similar patients is 
recommended before its implementation in routine practice. 
Future perspectives 
Diagnosis 
During the prospective application of our decision rule in chapter 2.4, we 
focussed on how the rule itself performed in similar new patients. Aspects of 
actual use of the rule by cliricians, and its impact on the diagnostic process were 
not included in this thesis yet and may be subject of future studies. The fact that 
the rule performed well in a prospective cohort of patients in four hospitals, now 
justifies to initiate the actual implementation process of the rule. As a first step we 
suggest the introduction of the rule in hospitals within the adherence of the Sophia 
Children's Hospital. To improve the implementation, information on the practical 
use of the rule to paediatricians should be accompanied by information on its 
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development, validation and effectiveness as presented in chapter 2.2, 2.3 and 
4.1. 
When antiviral treatments become available, a clinician may want to diagnose 
chlldren with viral meningitis additional to determining the presence and the 
absence of bacterial meningitis in children with meningeal signs. Only the latter 
was enabled by our prediction rule. Future studies may focus on the development 
of a model that allows for discrimination between three groups of diagnoses in 
children with meningeal signs: bacterial meningitis, viral meningitis and absence 
of meningitis. 
Prognosis 
Due to routine vaccination of H. influenzae in infants the risk of meningitis in 
childhood and its pathogen spectrum has changed substantially. To gain insight 
into the subsequent alterations of the prognosis after childhood bacterial 
meningitis, larger studies on populations with the present spectrum of pathogens 
are necessary. 
Only few studies have focussed on minor sequelae after chlldhood bacterial 
meningitis, such as mild behavioural problems, learning disabilities and attention 
deficits and uncertainty remains about their frequency. 34 To obtain detailed 
information on these mild sequelae after bacterial meningitis, standardised 
clinical follow-up after bacterial meningitis preferably should include 
neuropsychological functioning tests, besides hearing function tests and 
neurological examination and continue until school-going age. 
In chapter 3.2 we presented a prognostic scoring rule for children with bacterial 
meningitis. Internal validation of the rule by bootstrapping techniques showed 
that the rule was robust. A prospective validation study, however, is necessary 
before implementation of this rule in practice, to inform about the actual 
performance of the rule in new similar patients. 
Bacterial meningitis most frequently occurs in young children, for whom most 
questionnaires to measure health-related quality-of-life are still not suitable. Very 
recently, some generic questionnaires have been developed for young children 
(so-called 'toddler versions'), such as the TAPQoL (Dutch origin) and the Child 
Health Questionnaire (CHQ; American origin). 89.90 Both instruments lead to a 
multidimensional profile score. An algorithm leading to a preference score, as is 
required in cost-utility analysis, however, is not available for these instruments 
and has to be developed. The Dutch translation of the CHQ is currently being 
validated in healthy children. Translations in other languages are also available, 
such that the CHQ allows for international comparison of health-related quality-of-
life. Future studies should inform on its applicability to measure the consequences 
ofHRQoL after e.g. meningitis in children. 
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Economic evaluation 
Cost estimation of tests or treatments are often locally performed and can not 
easily be extrapolated to other clinical settings. Furthermore, discrepancies in the 
methods employed by economic investigators still remain. Consequently, the 
ability to draw general conclusions from cost-effectiveness analysis results is 
usually rather limited. 91.92 Generalisation of the results to other hospitals requires 
general standards for techniques of cost assessment, and use of standard values, 
which are still lacking . 
The unit costs of the diagnostic tests and therapeutic interventions as estimated in 
chapter 4.1 can be used in future economic evaluations of management of other 
acute paediatric diseases as well. The relative contribution of determinants of cost 
savings as we assessed in chapter 4.1 may help to define key parameters in future 
economic studies of paediatric care. Since costs of in-patient nursery and 
therapeutic interventions mainly determined the total costs, we recommend to 
focus on these components in economic studies in particular. 
Most new interventions are associated with increased costs and a gain in quality 
adjusted life-years compared to the existing practice. A norm for incremental 
cost-utility ratios that are considered cost-effective such that new interventions 
deserve to be introduced, has not been defined yet and remains to be discussed 
by experts and policy makers. A league table ranking health care interventions 
by their incremental cost-utility ratios may be helpful in this debate. 
Methodology 
Selection of patients on their clinical profile is often not feasible in retrospective 
studies using routine care data, since most patients classification systems in 
hospitals are based on the diagnosis. The presence of a problem oriented patient 
classification system in the Sophia Children's Hospital since 1988 allowed to 
perform a retrospective diagnostic study with patients selected on their clinical 
profile (e.g. meningeal signs).lmplementation of such a classification system may 
be recommended to hospitals interested in diagnostic research. Of course, when 
such a system is available, other diagnostic problems can be attacked by a similar 
study using routinely documented data to develop a practical applicable 
diagnostic rule. 
Although much has been written on methodology of diagnostic research, no 
general framework exists until now. Future studies are required to inform about 
principles and methods for study design and statistical analyses in diagnostic 
research using existing databases. Polytomous regression analysis offers a 
promising tool for diagnostic research, but has hardly been used so far. 
Imputation techniques seem a valid solution for missing data that are likely to 
occur in routinely documented data. Future studies are necessary to inform on the 
value and limitations of methods for handling missing data and how these 
methods best can be integrated in analysis of diagnostic research. 
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Samenvatting 
Dit proefschrift beschrijft diagnostisch en prognostisch onderzoek op 
routinematig verzamelde gegevens van kinderen die zich presenteren met 
meningeale prikkeling op de acute hulp, met als doe! het huidig klinisch be!eid te 
optimaliseren. Ook aspecten van gezondheidsgerelateerde kwaliteit van leven 
van kinderen, verdacht van meningitis, en de economische effecten van 
verschillen in de klinische praktijk worden hierin belicht. Tevens komen 
algemene methodologische principes van diagnostisch en prognostisch 
onderzoek aan de erde. 
Introductie 
Hoofdstuk 1 beschrijft de klinische presentatie en het diagnostisch probleem bij 
een kind met meningeale prikkeJing. Alhoewel meningeale prikkeJing een 
belangrijk symptoom is van bacterii'ile meningitis, heeft een groot deel van de 
kinderen met dit symptoom een andere (veel minder ernstige) diagnose. 
Vanwege het verhoogde risico op sterfte en morbiditeit bij een vertraagde 
behandeJing van kinderen met bacteriele meningitis, hanteren artsen in de 
praktijk een lage drempel om een lumbaal punctie te verrichten en empirische 
behande!ing te starten. 
Kenmerkende symptomen van bacteriele meningitis bij kinderen zijn O.a. koorts, 
braken, hoofd- en nekpijn en een gestoord bewustzijn. Bij zuigeJingen staan vaak 
meer aspecifieke symptomen zoals prikkelbaarheid en lethargie op de 
voorgrond. Afwijkende liquor parameters verdacht v~~r bacterieJe meningitis 
zijn een verhoogd celgetal, een laag glucose en een verhoogd eiwit gehalte. De 
waarden v~~r deze variabelen, zoals gevonden bij kinderen met bacteriele 
meningitis overlappen echter de waarden zoals gevonden bij kinderen met b.v. 
een virale meningitis. De rneeste onderzoeken naar diagnostische kenmerken 
van bacteriele meningitis zijn verricht op geselecteerde patientengroepen (b.v. 
kinderen geselecteerd op hun diagnose of bij wie een lumbaal punctie is 
uitgevoerd), zodat de resultaten niet altijd even goed te vertalen zijn naar de 
klinische praktijk. 
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Bacteriele meningitis gaat gepaard met ongeveer 5% mortaliteit en 15% 
morbiditeit. Gehoorverlies treedt frequent op na meningitis (10%). Andere 
neurologische restverschijnselen zijn cognitieve steornissen, locemotore 
afwijkingen en epilepsie, welke vaak gecombineerd voorkomen. Verschillende 
voorspellers veer een slechte prognose van bacteriele meningitis worden in de 
literatuur beschreven. De prognose wordt vooral bepaald door de verwekker. 
Door de verbeteringen in de medische zorg krijgen niet alleen morbiditeit, maar 
ook de psychologische en sociale gevolgen van een aandoening toenemend de 
aandacht. Gezondheidsgerelateerde kwaliteit van leven (HRQoL) geeft een 
kwantitatieve maat v~~r iemands functieneren op fysiek, mentaal en sociaal 
gebied met een bepaalde beperking ten opzichte van perfecte gezondheid en 
dood. Er zijn verschillende instrumenten beschikbaar voor het kwantificeren van 
HRQoL, maar er is weinig inzicht in de vraag of ze tot dezelfde resultaten en 
cenclusies leiden. Deze instrumenten zijn in het algemeen weIDig geschikt v~~r 
jonge kinderen. 
In de beoordeling van veranderingen in de klinische praktijk worden veelal de 
gezondheidseffecten afgewogen tegen de financiele aspecten van medisch 
handelen. Over de juiste methoden v~~r kostenonderzoek bestaat nog discussie, 
en resultaten van economische studies zijn daarom meeilijk te generaliseren naar 
andere klinische omstandigheden. De vraag is welke componenten van een 
bepaald klinisch beleid de kosten het meest beinvloeden. 
Diagnostiek bij kinderen met meningeale prikkeling 
Hoofdstuk 2 richt zich op de diagnostiek bij kinderen met meningeale prikkeling. 
Hierbij zijn routinematig verzamelde gegevens gebruikt uit het medisch dossier 
van kinderen die de acute hulp van het Sophia Kinderziekenhuis bezochten tussen 
1988 en 1998 met het probleem 'meningeale prikkeling'. De probleemcode 
'meningeale prikkeling' werd toegekend aan kinderen met pijn in de nek in 
anamnese, of die zijn verwezen met (verdenking) meningeale prikkeling door de 
huisarts, of bij wie de kinderarts dit vaststelt bij lichamelijk onderzoek. In 
hoofdstuk 2.1 worden de uiteindelijke diagnoses beschreven die werden gesteld 
bij deze kinderen: 30% bacteriele meningitis, 13% vitale of aseptische 
menin91tls, II % andere ernstige bacteriele infecties en 46% bovenste 
luchtweginfecties of andere onschuldige ziekten. In tegenstelling tot enkele 
andere studies bleek in ons onderzoek geen enkele van de kenmerken van 
meningeale prikkeling zoals Brudsinsky I of 2, Kernig, het driepootfenomeen, 
nekstijfheid, de bomberende fontanel of luierpijn, noch combinaties van deze 
kenmerken, de aan- of afwezigheid van bacteriele meningitis beter te 
veerspellen. 
In hoofdstuk 2.2 worden klinische kenmerken bij presentatie bestudeerd die 
onafhankelijk bijdragen aan het voorspellen van de aan- of afwezigheid van 
bacteriele meningitis bij kinderen met meningeale prikkeling (periode 1988-
1995). Deze voorspellers waren: de duur van de hoofdklacht (relatief risico (RR): 
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1.5 per dag) en braken (RR: 2.3) in de anamnese, meningeale irritatie (RR: 21.1), 
cyanose (RR: 13.0), petechien (RR: 4.9) en een verminderd bewustzijn (RR: 21.8) 
bij lichamelijk onderzoek en het serum CRP (RR: 1.1 per 10 mg/l). Met deze 
voorspellers werd de volgende diagnostische regel ontwikkeld: 
Score;;;; 1 x duur van de klacht (in dagen) + 2 x braken + 7.5 x meningeale 
prikkeling + 6.5 x cyanose + 4 x petechien + 8 x verminderd bewustzijn 
+ 0.1 x serum CRP (per 10 rng/l) 
In de onderzoekspopulatie varieerde de totale score van 0.5 tot 31 punten. Deze 
diagnostische regel had een onderscheidend vermogen (ROC-area) van 0.92 
voor de aan- of afwezigheid van bacteriele meningitis. Met deze regel konden 
patienten worden ingedeeld in groepen met een toenemend risico op bacterii:He 
meningitis. Er werd een drempelwaarde vastgesteld voor de klinische score 
(score 2 9.5) v~~r de indicatie van een lurnbaal punctie. Deze drempelwaarde 
voorkwam een lurnbaal punctie bij 35% van de kinderen met meningeale 
prikkeling zonder eenmaal de diagnose bacteriele meningitis te missen. Het 
toepassen van de klinische score op gegevens uit het medisch dossier van 
vergelijkbare kinderen uit latere jaren (1996 - 1998) leidde tot dezelfde 
resultaten. 
Bij patienten met een indicatie voor een lurnbaal punctie op basis van de klinische 
score, is in hoofdstuk 2.3 de onafhankelijke diagnostische waarde onderzocht van 
liquor parameters voor de diagnose bacteriele meningitis. Voorspellers die 
onafhankelijk bijdroegen aan de klinische score (hoofdstuk 2.2) v~~r het stellen 
van de diagnose bacteriele meningitis waren het aantal polymorfonucleaire 
cellen (PMN) in de liquor (RR: 3.0 per 101og-toename van PMN/~l) en de 
liquor/bloed glucose ratio (RR: 0.6 per 0.1 ratio toename). Met deze !wee 
parameters werd de volgende CSF score geformuleerd: 
CSF score = 1.0 x e'log absoluut PMN celgetal) - 5 x (CSF/bloed glucose ratio) 
Gecombineerd gebruik van de klinische en liquor score selecteerde 30% van de 
patienten met een lurnbaal punctie bij wie empirische behandeling voor 
bacteriele meningitis achterwege gelaten kon worden. 
In hoofdstuk 2.4 is de effectiviteit van de toepassing van de diagnostische regel 
vastgesteld in de klinische praktijk van vier ziekenhuizen in de periode van 
november 1999 tot november 2000: in het Sophia kinderziekenhuis (academisch 
kinderziekenhuis), in het Juliana kinderziekenhuis, Den Haag (algemeen 
kinderziekenhuis) en op de kinderafdeling van het Sint Fransiscus Gasthuis, 
Rotterdam en het Reinier de Graaf Gasthuis, Delft (algemene ziekenhuizen). Het 
functioneren van de regel in 176 nieuwe patienten die zich in de ziekenhuizen 
presenteerden met meningeale prikkeling was vergelijkbaar met die in de 
populatie waarin de regel was ontwikkeld, zoals beschreven in hoofdstuk 2.2 en 
2.3. In de nieuwe populatie was het onderscheidend vermogen (ROC-area) van 
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de klinische en CSF score respectievelijk 0.82 en 0.95. Er bleken echter lagere 
klinische scores en CSF scores v~~r te komen bij patienten met bacteriele 
meningitis dan in de ontwikkelingsset. Daarom werden de drempelwaarden voor 
de indicatie van lumbaal punctie en empirische behandeling aangepast, zodst 
ook in de toekomst geen enkele patient met bacteriele meningitis zal worden 
gemist. 
Prognose van bacteriiHe meningitis 
In hoofdstuk 3 wordt de prognose van bacteriele meningitis bij kinderen met 
meningeale prikkeling beschreven. Hierbij zijn gegevens van kinderen met 
bacteriele meningitis uit hoofdstuk 2 gebruikt en die van vergelijkbare kinderen 
uit het Juliana kinderziekenhuis, Den Haag. Twee van de 103 kinderen met 
bacteriele meningitis (2%) overleden tijdens de acute ziektefase (hoofdstuk 3.1). 
Bij zeven kinderen (7%) werden permanente neurologische afwijkingen 
vastgesteld en bij zeven bleek het gehoor afwijkend in de follow-up (7%). 
Evenals in eerder onderzoek trad gehoorverlies in onze studie vooral op als een 
gelsoleerde afwijking: slechts een kind had zowel gehoorverlies als 
neurologische afwijkingen. Bij !wee kinderen waren er multipele neurologische 
afwijkingen aanwezig. 
In hoofdstuk 3.2 zijn kenmerken vastgesteld die onafhankelijk gerelateerd waren 
aan permanente restverschijnselen of sterfte na meningitis. Uit de beschikbare 
gegevens in de eerste 24 uur van presentatie bleken het mannelijk geslacht (RR: 
4.4), atypische convulsies in de recente anamnese (RR: 9.7), en een lage 
lichaamstemperatuur bij presentatie (RR: 0.5 voor elke toename in graden 
Celsius) een slechte prognose te voorspellen. Uit kenmerken verkregen tijdens 
opname bleek aileen de verwekker hieraan verder bij te dragen (RR: 22.6 voor S. 
pneumoniae en RR: 4.4 voor N. meningitidis ten opzichte van de andere 
verwekkers). In het uiteindelijke model had de verwekker (met name S. 
pneumoniae) de grootste invloed. Andere kenmerken uit het klinisch be1oop, 
zoals het koortsbeloop of het persisteren van meningeale prikkeling waren van 
geen aanvullende prognostische betekenis. Met het model kon echter het type 
neurologische restafwijking niet specifiek worden voorspeld. Dit prognostisch 
model, waarvan aile voorspellers beschikbaar zijn binnen de eerste 3 dagen, stelt 
de arts in staat de kans op een slechte prognose (sterfte of permanente 
restverschijnselen) in een vroeg stadium in te schatten voor de individuele 
patient met meningeale prikkeling. Deze informatie draagt bij aan een goede 
voorlichting aan ouders en helpt in het bepalen van het lange termijn beleid. 
Hoofdstuk 3.3 beschrijft de waardering van kwallteit van leven (HROoL) van 
gezondheidstoestanden gerelateerd aan restverschijnselen na meningitis. Hierbij 
werd gebruik gemaakt van !wee generieke meetinstrumenten v~~r HROoL, te 
weten de EO-5D en de Health Utilities Index (HUI), die beiden een wegingsfactor 
(utiliteit) opleveren voor de relatieve ernst van de sub-optimale 
gezondheidstoestand ten opzichte van 'gezond' en 'dood'. Deze wegingsfactoren 
v~~r permanente restverschijnselen na bacteriEHe meningitis waren nodig v~~r 
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de kosten utiliteitsanalyse van de diagnostische regel zoals beschreven in 
hoofdstuk 4.2, maar waren niet beschikbaar in de huidige literatuur. Dergelijke 
wegingsfactoren worden idealiter verkregen ruiddels een classificatie van 
gezondheidstoestanden door patienten zelf een vragenlijst in te laten vullen, 
waarna aan elk van deze classificaties een waardering van de 
gezondheidstoestanden door de algemene bevolking wordt toegekend. De 
studieopzet in dit proefschrift, gebaseerd op retrospectieve gegevens, stond een 
dergelijke empirische waardering van gezondheidstoestanden door patienten 
niet toe. Tevens ging het voornamelijk om gegevens van jonge kinderen, v~~r 
wie de meeste vragenlijsten naar kwaliteit van leven niet geschikt zijn. Daarom 
werden van de zeven meest voorkomende emstige restverschijnselen na 
meningitis representatieve casusbeschrijvingen gemaakt. Deze 
restverschijnselen waren: doofheid, mild gehoorverlies, ernstige retardatie met 
tetraplegie, epilepsie, locomotore stoornissen, milde mentale retardatie, en een 
combinatie van deze laatste drie. Vervolgens werd aan een panel van 28 
kinderartsen gevraagd om de vragenlijsten van de EQ-5D en HUI voor elk van 
deze zeven casusbeschrijvingen in te vullen. Er werd geen verschil gevonden in 
toepasbaarheid tussen de instrumenten. De wegingsfactoren verkregen met de 
HUI waren echter aanzienlijk lager dan die van de EQ-5D. Het grootste verschil 
werd gevonden v~~r gezondheidstoestanden gerelateerd aan doofheid en 
mentale retardatie. De verschillen in wegingsfactoren verkregen met de twee 
instrument en leidden ook tot een verschillende rangorde van de 
gezondheidstoestanden. Deze verschillen konden vooral worden verklaard door 
verschil in gezondheidsdimensies tussen de twee instru.m.enten, waardoor 
bepaalde gezondheidstoestanden anders werden gewaardeerd door een 
bepaald instrument dan andere. Dit leidde tot de conclusie dat het van belang is 
om de keuze voor het meetinstrument voor kwaliteit van leven te laten leiden 
door het type restverschijnsel dat bestudeerd word!. 
Economisch evaluatie van de klinische praktijk 
In hoofdsiuk 4.1 wordt de mogelijke kostenbesparing van de beslisregel 
ingeschat ten opzichte van de huidige praktijk. Omdat in de praktijk de arts geen 
enkele patient met bacteriele meningitis zal willen ruissen, werd gekozen v~~r 
een kosten ruiniruisatie studie, die kosten van !wee strategieen met eenzelfde 
gezondheidseffect vergelijkt. De beslisregel leidde tot een 10% verruindering 
van de totale kosten (geruiddeld € 2976 per patient) zonder de diagnose 
bacteriele meningitis eenmaal te ruissen. De meeste kosten werden bespaard in 
de behandelingsfase (90% van het totaal) en slechts 10% in de diagnostische 
fase. De kostenbesparing werd voornamelijk bepaald door de verpleegdagprijs, 
de frequentieverdeling van bacteriele meningitis en zelf-liruiterende ziektes bij 
kinderen met meningeale prikkeling en de opnamefrequentie van deze laatste 
groep. 
In hoofdstuk 4.2 wordt een model gelntroduceerd om de lange terruijn gevolgen 
van adequate diagnostiek en behandeling van kinderen met meningeale 
prikkeling in te schatten in termen van levensjaren gecorrigeerd voor kwaliteit 
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van leven (QAtys) en kosten. Dit model omvatte de gehele diagnostische en 
behandelingsfase en de lange termijn gevolgen van bacteri'He meningitis. Over 
een tijdsspanne van 15 jaar bedroegen de geroiddelde kosten per patient € 8393, 
en de gezondheidseffecten 11.2 QAtys. De kosten van lange termijn morbiditeit 
na bacteriele meningitis omvatten tweederde van alle kosten in het model. De 
model uitkomsten (i.e. kosten en gezondheidseffecten) bleken gevoelig v~~r de 
voorafkans op bacteriele meningitis bij kinderen met meningeale prikkeling (i.e. 
prevalentie), het risico op restverschijnselen na meningitis en de kosten van deze 
lange termijn morbiditeit. Kosten van diagnostiek hadden nauwelijks invloed op 
de modeluitkomsten. Verschillende diagnostische strategieen hadden grote 
invloed op de lange termijn kosten en gezondheidseffecten van het model. Het 
model gaf ook inzicht in de lange termijn gevolgen van eventuele preventieve 
interventies en diagnostische of therapeutische strategieen bij kinderen met 
meningeale prikkeling, in termen van kosten en QAt Y s. Dit werd geillustreerd 
aan de hand van een kesten utiliteitsanalyse van de intreductie van nieuwe 
vaccinatieprogramma's. Daling van de voorafkans op bacteriele meningitis door 
vaccinatie reduceerde de kesten en verhoogde de gezonciheidseffecten in ons 
model aanzienlijk. 
Methodologie van diagnostisch onderzoek 
In hooidstuk 5 worden een aantal problemen van diagnostisch onderzoek op 
routinematig verzamelde gegevens, zeals ondervonden in boven beschreven 
studies, toegelicht en mogelijke oplossingen hiervoor aangedragen. In de 
praktijk is het stellen van de diagnose een gefaseerd proces, dat begint bij een 
patient met een bepaalde klacht of een symptoom, verdacht voor een bepaalde 
ziekte (waarschijnlijkheidsdiagnose). De arts zal allereerst een anamnese 
afnemen en een lichamelijk onderzoek verrichten. Vervolgstappen zijn 
aanvullend laboratoriumonderzoek van bloed of urine, beeldvorroing of 
invasieve testen zoals b.v. een lumbaal punctie. Overeenkomstig met deze 
klinische praktijk dient diagnostisch onderzoek zich te richten op het vaststellen 
van de toegevoegde diagnostische waarde van een test bij de al beschikbare 
informatie. Het gebruik van gegevens van routinematige patientenzorg lijkt 
geschikt voor dergelijk diagnostisch onderzoek. Een valide schatting van de 
diagnostische waarde van een test vereist echter se1ectie van patienten op hun 
klinische presentatie, n.l. de symptomen of klachten waarmee ze de arts 
bezoeken. Daarom is het van belang om in de database de patienten te labelen 
met hun klinisch probleem bij verwijzing, en ruet alleen op basis van hun 
einddiagnose. In onderzoeken op routinematig verzamelde gegevens van 
populaties geselecteerd op een klinisch probleem kan zich echter nog steeds een 
aantal problemen voordoen. Het diagnostisch proces wordt in de praktijk 
bepaald door eerdere onderzoeksgegevens. Daarom zijn routinematig 
verzamelde gegevens geveelig veer 'verificatie~bias' en 'work-up' bias. 
Verificatie bias kan worden voorkomen door gebruik van een uitkomst diagnose 
die een snel progressief beloop kent bij uitblijven van behandeling. Work-up 
bias kan zoveel mogelijk vermeden worden door het gebruik van een objectieve 
referentie test. Bij het gebruik van routinematig verzamelde gegevens bestaat 
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een grote kans op ontbrekende waarden. Multipele imputatie teclmieken lijken 
voor elit probleem een geschikte oplossing te bieden. 
In hoofdstuk 6 worden de resultaten van elit proefschrift samengevat en 
bediscussieerd. Tevens worden aanhevelingen gedaan voor vervolgonderzoek. 
Het gebruik van routinematig verzamelde gegevens lijkt geschikt v~~r het 
ontwikkelen van eliagnostische richtlijnen v~~r de klirische praktijk. In het 
eliagnostisch probleem. zoals in elit proefschrift beschreven, blijkt de 
doeimatigheidswinst bij optimalisering van de eliagnostiek beperkt te zijn. Dit 
probleem biedt echter een goede illustratie van de methoden en het potentieel 
van diagnostisch onderzoek. 
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